≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Infective dermatitis

DOID EFO Endpoint Browser PheWeb

L12_INFECT_DERM

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — L30.3
  • Cause of death: ICD-10 — L30.3

2 out of 7 registries used, show all original rules.

5237

4. Check minimum number of events

None

5237

5. Include endpoints

None

5237

6. Filter based on genotype QC (FinnGen only)

5070

Control definitions (FinnGen only)

Control exclude
L12_DERMATITISECZEMA

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
L30
Name in latin
Dermatitis infectiosa

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 38784 18479 20130
Only index persons 35334 17298 18036
Unadjusted period prevalence (%)
Whole population 0.54 0.53 0.56
Only index persons 0.66 0.64 0.69
Median age at first event (years)
Whole population 52.86 51.94 53.63
Only index persons 52.28 51.57 52.96

-FinnGen-

Key figures

All Female Male
Number of individuals 5070 2640 2430
Unadjusted period prevalence (%) 1.02 0.94 1.11
Median age at first event (years) 55.43 51.77 59.41

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
5237
Matched controls
52370
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E000007, ,
ATC
6.8
315.5
521
833
XQ802
NOMESCO Finland
Epicutan test
59.5
307.7
859
172
D07AB02
ATC
hydrocortisone butyrate; topical
4.3
307.7
2420
8670
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
7.6
307.7
1697
3107
D07CC01
ATC
betamethasone and antibiotics; topical
5.3
307.7
1313
3114
D07AD01
ATC
clobetasol; topical
7.3
307.7
2041
4192
D09AB01
ATC
zinc bandage without supplements; topical
33.8
307.7
571
189
D07BC01
ATC
betamethasone and antiseptics; topical
8.0
307.7
1625
2780
D07BA04
ATC
hydrocortisone and antiseptics; topical
5.9
307.7
1041
2110
D02AE01
ATC
carbamide; topical
6.5
307.7
676
1174
E0000UV, ,
ATC
8.4
307.7
3854
13002
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
7.1
307.7
1063
1805
E000002, ,
ATC
6.9
307.7
1209
2176
E000006, ,
ATC
6.5
307.7
714
1239
XQ800
NOMESCO Finland
Prick test
6.1
307.7
655
1203
D07XC01
ATC
betamethasone; topical
4.4
307.7
1097
2994
TQW80
NOMESCO Finland
Local dermatologic skincare
23.3
307.7
582
280
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
11.3
307.7
1299
1489
D07AC13
ATC
mometasone; topical
6.4
307.7
2847
8248
L30.3
ICD-10 Finland
Infective dermatitis
4503599627370496.0
307.7
5236
237
D07AA02
ATC
hydrocortisone; topical
4.2
307.7
1100
3113
D07AB08
ATC
desonide; topical
7.4
307.7
1221
2079
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
45.2
307.7
374
89
L20.0
ICD-10 Finland
Besnier prurigo
+∞
307.7
911
*
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
+∞
307.7
556
*
D07AC01
ATC
betamethasone; topical
8.9
307.7
3705
11226
E000001, ,
ATC
7.1
307.7
2191
4828
L30.9
ICD-10 Finland
Dermatitis, unspecified
11.4
307.7
2636
4265
E000003, ,
ATC
10.2
307.7
589
645
L30.0
ICD-10 Finland
Nummular dermatitis
22.5
307.7
908
483
H02AB06
ATC
prednisolone; systemic
2.9
301.7
3109
17554
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
128.7
297.1
150
12
L28.1
ICD-10 Finland
Prurigo nodularis
99.1
297.1
154
16
L23.8
ICD-10 Finland
Allergic contact dermatitis due to other agents
136.4
264.7
133
10
L30.8
ICD-10 Finland
Other specified dermatitis
10.2
260.0
299
309
D02AX
ATC
Other emollients and protectives
9.2
256.1
318
364
L20
ICD-10 Finland
Atopic dermatitis
+∞
239.4
228
*
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
81.3
238.9
127
16
D05BB02
ATC
acitretin; oral
9.1
235.1
295
342
L23.9
ICD-10 Finland
Allergic contact dermatitis, unspecified cause
36.5
227.7
142
40
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.8
225.1
1567
7001
A46
ICD-10 Finland
Erysipelas
3.1
218.7
1142
4360
XQ848
NOMESCO Finland
Dermatological photography
7.4
217.8
325
463
R06AE07
ATC
cetirizine; oral
2.4
212.7
2621
15256
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
+∞
202.4
193
*
E000004, ,
ATC
10.0
202.1
235
246
L28.0
ICD-10 Finland
Lichen simplex chronicus
33.6
200.6
128
39
S87
ICPC
Dermatitis/atopic eczema
8.6
197.5
258
314
D07AC14
ATC
methylprednisolone aceponate; topical
5.3
193.8
408
817
L40.0
ICD-10 Finland
Psoriasis vulgaris
5.2
191.2
411
838
N05BB01
ATC
hydroxyzine; systemic
4.4
185.0
492
1195
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
10.6
182.8
203
199
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
65.9
176.7
97
15
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
359.0
174.4
175
5
J01DB01
ATC
cefalexin; oral
3.1
163.5
4611
36783
R06AX27
ATC
desloratadine; oral
2.3
156.7
1694
9035
J01FF01
ATC
clindamycin; systemic
2.3
150.9
1675
9008
L30.1
ICD-10 Finland
Dyshidrosis [pompholyx]
33.7
150.6
96
29
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
6.8
136.0
218
334
L24.9
ICD-10 Finland
Irritant contact dermatitis, unspecified cause
38.3
134.9
83
22
L20.8
ICD-10 Finland
Other atopic dermatitis
+∞
132.9
127
*
L23.5
ICD-10 Finland
Allergic contact dermatitis due to other chemical products
197.9
130.3
135
7
R06AE09
ATC
levocetirizine; oral
2.6
129.9
881
3774
D05AX52
ATC
calcipotriol, combinations; topical
3.8
129.4
425
1197
D07CA01
ATC
hydrocortisone and antibiotics; topical
2.7
126.3
802
3323
J01DA01
ATC
[U] cefalexin
2.0
121.4
3347
24552
D11AH01
ATC
tacrolimus; topical
182.9
120.0
125
7
L04AX03
ATC
methotrexate; systemic
2.8
115.5
662
2597
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.4
105.4
816
3693
D07AB01
ATC
clobetasone; topical
4.7
101.3
240
528
D07XB05
ATC
dexamethasone; topical
5.3
100.4
205
397
S29
ICPC
Skin symptom/complaint other
2.1
94.6
1179
6453
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.3
92.3
794
3750
L29.9
ICD-10 Finland
Pruritus, unspecified
5.4
90.6
182
347
SPAT1263
SPAT
Sampling
1.8
86.7
2234
15401
S97
ICPC
Chronic ulcer skin
2.9
85.3
430
1566
L25.9
ICD-10 Finland
Unspecified contact dermatitis, unspecified cause
16.0
83.0
71
45
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
+∞
82.5
79
*
B35.3
ICD-10 Finland
Tinea pedis
3.2
81.8
336
1087
L04AD01
ATC
ciclosporin; systemic
5.7
81.5
153
274
J01AA04
ATC
lymecycline; systemic
2.2
79.8
746
3632
L50.3
ICD-10 Finland
Dermatographic urticaria
6.2
78.8
135
221
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
9.5
78.7
93
99
SPAT1301
SPAT
No procedures
1.8
77.7
1662
10763
J01DA09
ATC
[U] cefadroxil
1.9
77.5
1414
8724
S76
ICPC
Skin infection other
3.0
77.4
374
1329
L08.0
ICD-10 Finland
Pyoderma
8.3
73.5
97
119
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.1
71.7
306
1012
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.0
71.3
323
1106
L26
ICD-10 Finland
Exfoliative dermatitis
+∞
71.0
68
*
D06AX01
ATC
fusidic acid; topical
2.4
69.5
535
2391
J01AA07
ATC
tetracycline; systemic
2.1
69.4
781
4073
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.6
68.8
168
378
R06AX22
ATC
ebastine; oral
2.0
68.7
879
4800
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
68.3
2488
18463
S21
ICPC
Skin texture symptom/complaint
2.0
66.7
852
4646
SPAT1260
SPAT
Consultation of another employee
1.9
65.7
937
5304
C03CA01
ATC
furosemide; systemic
1.7
65.2
1526
10041
D11AX14
ATC
[U] tacrolimus
+∞
64.7
62
*
J01CF05
ATC
flucloxacillin; systemic
2.5
63.9
441
1874
S18
ICPC
Laceration/cut
1.6
63.7
2461
18420
D07CB01
ATC
triamcinolone and antibiotics; topical
4.7
62.5
148
325
S02
ICPC
Pruritus
3.5
62.0
222
658
L01.1
ICD-10 Finland
Impetiginization of other dermatoses
10.8
61.0
66
62
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
4.2
61.0
164
398
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.2
60.8
255
834
J01CE08
ATC
benzathine benzylpenicillin; parenteral
6.0
59.5
105
177
SPAT1312
SPAT
General health counselling
1.7
58.1
1605
10973
H02AB04
ATC
methylprednisolone; systemic
2.0
57.8
743
4046
L23.1
ICD-10 Finland
Allergic contact dermatitis due to adhesives
295.2
57.4
58
*
L01.0
ICD-10 Finland
Impetigo [any organism] [any site]
5.0
56.4
123
252
B86
ICD-10 Finland
Scabies
3.8
56.3
177
481
S06
ICPC
Rash localized
2.6
56.1
334
1321
R03AC02
ATC
salbutamol; inhalant
1.6
55.8
2727
21332
J04BA02
ATC
dapsone; oral
10.8
55.7
60
56
SPAT1310
SPAT
Counselling related to known health issue
1.6
55.1
1584
10909
D05AX02
ATC
calcipotriol; topical
3.1
55.0
237
787
D11AH04
ATC
alitretinoin; oral
279.2
54.3
55
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.4
53.4
405
1793
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
4.7
53.1
124
269
L04AA01
ATC
[U] ciclosporin
5.5
53.0
102
187
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
52.6
963
5856
S01
ICPC
Pain/tenderness of skin
2.7
51.2
297
1158
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.0
51.2
656
3558
S88
ICPC
Dermatitis contact/allergic
4.2
50.9
138
337
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.2
50.8
484
2354
6929B
ICD-9 Finland
Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]
+∞
50.1
48
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
50.0
1444
9913
L29.8
ICD-10 Finland
Other pruritus
5.9
50.0
90
155
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
49.9
1938
14267
UJF32
NOMESCO Finland
Coloscopy
1.7
49.5
1307
8768
D01AC02
ATC
miconazole; topical
2.3
48.5
411
1906
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
48.3
1489
10369
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
48.0
623
3389
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.1
47.7
473
2335
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
+∞
46.9
45
*
L21.0
ICD-10 Finland
Seborrhoea capitis
7.6
46.6
66
88
WZC30
NOMESCO Finland
Teaching
1.8
46.4
892
5483
S99
ICPC
Skin disease other
3.7
45.8
148
410
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.9
45.7
137
360
L04AX01
ATC
azathioprine; systemic
2.8
45.6
232
845
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
45.1
569
3062
L40.9
ICD-10 Finland
Psoriasis, unspecified
4.3
44.9
116
273
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.7
44.3
942
5946
SPAT1153
SPAT
Removal of sutures
1.6
44.3
1535
10943
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.2
44.2
380
1770
D01AE15
ATC
terbinafine; topical
2.2
43.9
396
1882
D11AH02
ATC
pimecrolimus; topical
431.2
43.2
43
*
L24.0
ICD-10 Finland
Irritant contact dermatitis due to detergents
151.3
42.8
45
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.0
42.8
509
2683
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
42.7
1292
8910
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
42.3
2047
15648
N07BA03
ATC
varenicline; oral
2.5
41.6
282
1185
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
4.5
40.8
101
230
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
7.7
40.7
57
75
R06AX13
ATC
loratadine; oral
1.8
40.1
693
4117
L30.4
ICD-10 Finland
Erythema intertrigo
5.0
39.6
86
176
R06.0
ICD-10 Finland
Dyspnoea
1.6
39.1
1321
9315
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.9
38.8
562
3160
L85.3
ICD-10 Finland
Xerosis cutis
5.3
38.0
77
148
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
38.0
1976
15233
L24.8
ICD-10 Finland
Irritant contact dermatitis due to other agents
196.4
37.8
39
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
37.7
1239
8670
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.8
37.7
195
717
L30
ICD-10 Finland
Other dermatitis
3.4
37.5
136
407
134
Kela drug reimbursment
General erythroderma
10.1
37.1
42
42
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.7
37.0
119
329
SPAT1262
SPAT
Handing over of treatment supplies
1.6
35.9
864
5605
M79.6
ICD-10 Finland
Pain in limb
1.5
35.8
2123
16728
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
35.3
1515
11199
R02
ICPC
Shortness of breath/dyspnoea
1.7
35.2
671
4090
L73.8
ICD-10 Finland
Other specified follicular disorders
5.0
35.2
75
151
N02BE01
ATC
paracetamol; systemic, rectal
1.7
35.1
4524
41426
L23
ICD-10 Finland
Allergic contact dermatitis
7.6
34.8
49
65
D11AH05
ATC
dupilumab; topical
14.0
34.8
32
23
R60.0
ICD-10 Finland
Localized oedema
1.8
34.8
624
3738
T78.4
ICD-10 Finland
Allergy, unspecified
2.6
34.3
209
835
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
34.1
668
4099
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.7
34.0
648
3947
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
33.8
643
3915
J01DB05
ATC
cefadroxil; oral
2.4
33.5
227
953
WZC00, ,
SPAT
1.7
33.3
758
4842
L40.8
ICD-10 Finland
Other psoriasis
6.0
33.2
58
97
N02AX02
ATC
tramadol; systemic, rectal
1.4
33.1
2054
16249
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.1
33.0
320
1561
D01BA02
ATC
terbinafine; oral
1.5
33.0
1227
8784
L13.0
ICD-10 Finland
Dermatitis herpetiformis
9.8
33.0
38
39
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
32.6
1105
7750
J01XC01
ATC
fusidic acid; systemic
4.3
32.1
84
200
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
31.8
1179
8427
R4180
NOMESCO Finland
Podiatric therapy
4.0
31.7
90
228
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
31.4
1521
11463
L12.0
ICD-10 Finland
Bullous pemphigoid
7.4
31.4
45
61
XQ845
NOMESCO Finland
Dermatoscopy
3.4
31.2
112
333
ZY010
NOMESCO Finland
Hospital outpatient
2.2
31.1
260
1196
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
31.0
866
5809
D07AC03
ATC
desoximetasone; topical
3.7
30.7
99
274
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
30.5
2945
25036
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.4
30.5
219
944
N03AX12
ATC
[U] gabapentin; oral
1.6
30.4
754
4912
R50.9
ICD-10 Finland
Fever, unspecified
1.6
30.3
723
4665
L17
ICPC
Foot/toe symptom/complaint
1.5
30.0
1449
10897
I50.9
ICD-10 Finland
Heart failure, unspecified
1.7
29.9
647
4071
SPAT1255
SPAT
Intravenous administration of medicine
2.0
29.9
342
1773
-, ,
ICD-10 Finland
3.1
29.7
122
394
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
29.6
1056
7470
A02BC02
ATC
pantoprazole; systemic
1.4
29.5
3328
28974
E0001A1, ,
ATC
3.5
29.4
100
287
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.3
29.3
240
1094
T90
ICPC
Diabetes non-insulin dependent
1.5
29.1
1182
8582
H02AB07
ATC
prednisone; oral
1.7
29.1
598
3709
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
29.0
898
6158
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
29.0
911
6268
L13.9
ICD-10 Finland
Bullous disorder, unspecified
7.3
28.8
42
58
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.9
28.8
383
2089
L50.9
ICD-10 Finland
Urticaria, unspecified
2.5
28.6
181
736
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
28.5
1184
8632
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
28.5
1283
9504
L01
ICD-10 Finland
Impetigo
3.9
28.3
84
220
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.7
28.1
154
584
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
27.8
643
4110
R03BB04
ATC
tiotropium bromide; inhalant
1.8
27.8
472
2775
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.3
27.8
106
328
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.6
27.7
166
658
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.6
27.5
167
666
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.7
27.4
144
534
D05AX03
ATC
calcitriol; topical
3.9
27.3
81
212
J01MA02
ATC
ciprofloxacin; systemic
1.4
27.1
1826
14512
D11AX15
ATC
[U] pimecrolimus
+∞
27.1
26
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
26.7
2068
16807
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
26.6
1289
9662
C09AA02
ATC
enalapril; systemic
1.5
26.3
881
6131
205
Kela drug reimbursment
Chronic hypertension
1.5
26.3
1194
8837
6929X
ICD-9 Finland
Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]
+∞
26.1
25
*
69282
ICD-8 Finland
Other eczema and dermatitis, E microbis
+∞
26.1
25
*
L28.2
ICD-10 Finland
Other prurigo
23.3
26.0
37
16
C07AB07
ATC
bisoprolol; oral
1.4
26.0
2264
18729
QCA99
NOMESCO Finland
Other local destruction of skin of upper limb
8.9
25.9
32
36
SPAT1254
SPAT
Administration of medicine
1.6
25.9
677
4455
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
25.8
1690
13340
WQ021, ,
NOMESCO Finland
40.3
25.8
32
8
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.5
25.5
165
678
I83.2
ICD-10 Finland
Varicose veins of lower extremities with both ulcer and inflammation
5.2
25.3
51
98
J01FA06
ATC
roxithromycin; oral
1.4
25.3
1791
14313
L04AA06
ATC
mycophenolic acid; systemic
3.1
25.2
106
348
AA1AD
NOMESCO Finland
CT of head and brain
1.4
25.2
1344
10235
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
25.1
444
2639
N06AX11
ATC
mirtazapine; oral
1.4
24.9
1568
12282
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
24.8
839
5845
J01MA14
ATC
moxifloxacin; systemic
1.8
24.7
421
2477
A10BA02
ATC
metformin; oral
1.4
24.5
1332
10164
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
24.5
805
5572
SPAT1211
SPAT
Application of soft bandage
1.8
24.5
406
2369
G47.3
ICD-10 Finland
Sleep apnoea
1.4
24.3
1102
8139
L01BA01
ATC
methotrexate; systemic
2.4
24.2
175
757
N03AX16
ATC
[U] pregabalin
1.5
24.1
1027
7491
J02AC01
ATC
fluconazole; systemic
1.4
24.0
1676
13334
M13.9
ICD-10 Finland
Arthritis, unspecified
1.8
24.0
353
1987
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.9
23.9
306
1647
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
5.0
23.7
50
100
WIX00
NOMESCO Finland
Allergy cleanup guidance
87.2
23.7
26
*
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
125.6
23.6
25
*
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.1
23.4
219
1054
J01AA02
ATC
doxycycline; systemic
1.4
23.3
3741
33748
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
23.3
1344
10350
R96
ICPC
Asthma
1.7
23.2
449
2734
OAB42, ,
SPAT
1.6
23.2
635
4217
ZXD05
NOMESCO Finland
Urgent procedure
1.4
23.2
1364
10536
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.8
23.1
115
415
N05AH04
ATC
quetiapine; oral
1.5
23.1
808
5664
S07
ICPC
Rash generalized
5.7
22.8
42
74
L27.2
ICD-10 Finland
Dermatitis due to ingested food
65.3
22.8
26
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.1
22.8
216
1045
QDB10, ,
SPAT
2.5
22.6
141
570
WQ007, ,
NOMESCO Finland
120.6
22.6
24
*
N05CF01
ATC
zopiclone; oral
1.4
22.6
1431
11184
ZZA00
NOMESCO Finland
Split skin graft
2.5
22.4
144
591
J01MA12
ATC
levofloxacin; systemic
1.5
22.4
828
5867
F10.24
ICD-10 Finland
Alcohol depence active use
3.2
22.4
90
288
C03DA01
ATC
spironolactone; oral
1.6
22.3
566
3691
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.0
22.3
261
1364
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.7
22.1
120
453
SPAT1151
SPAT
Treatment of major wounds
3.6
22.0
72
202
L04AB04
ATC
adalimumab; parenteral
2.7
22.0
119
449
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.6
21.9
131
519
XQ899
NOMESCO Finland
Other assessment of skin
8.1
21.7
29
36
UDC00
NOMESCO Finland
Ear microscopy
1.8
21.7
349
2018
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.6
21.6
127
499
D64.9
ICD-10 Finland
Anaemia, unspecified
1.6
21.6
505
3228
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.2
21.6
177
808
A02BC03
ATC
lansoprazole; oral
1.4
21.5
1250
9615
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.6
21.5
513
3297
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
3.2
21.4
85
270
SPAT1058
SPAT
PEF monitoring instruction
1.8
21.4
362
2124
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.7
21.3
112
416
C08CA01
ATC
amlodipine; oral
1.3
20.9
1760
14339
69299
ICD-8 Finland
Other eczema and dermatitis, Due to other and unspecified cause
+∞
20.8
20
*
K08.3
ICD-10 Finland
Retained dental root
1.7
20.8
370
2200
M04AA01
ATC
allopurinol; systemic
1.6
20.8
593
3970
R03BA05
ATC
fluticasone; inhalant
1.5
20.8
771
5460
L85.9
ICD-10 Finland
Epidermal thickening, unspecified
8.7
20.6
26
30
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.4
20.5
148
640
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
20.5
653
4479
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.0
20.4
238
1242
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.7
20.3
389
2361
J02AC02
ATC
itraconazole; systemic
1.5
20.3
750
5304
L84
ICD-10 Finland
Corns and callosities
2.2
20.3
171
790
P15
ICPC
Chronic alcohol abuse
2.3
20.3
155
688
P01AB01
ATC
metronidazole; oral, rectal
1.3
20.2
1757
14367
N07BB01
ATC
disulfiram; oral
2.1
20.1
202
1000
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
20.1
503
3269
A03
ICPC
Fever
1.5
20.0
766
5454
R03BA01
ATC
beclometasone; inhalant
1.5
19.9
596
4032
WX725
NOMESCO Finland
Noninvasive ventilation
1.9
19.9
278
1539
-1, ,
NOMESCO Finland
1.4
19.9
1484
11854
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.2
19.9
159
719
K02.1
ICD-10 Finland
Caries of dentine
1.3
19.8
2775
24223
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
19.8
551
3667
A02BC01
ATC
omeprazole; systemic
1.4
19.8
1196
9242
A10AB05
ATC
insulin aspart; parenteral
1.7
19.6
358
2144
L73.9
ICD-10 Finland
Follicular disorder, unspecified
5.9
19.6
35
60
395
Kela drug reimbursment
Dupilumab
16.4
19.6
31
19
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.3
19.5
155
699
SPAT1240
SPAT
Therapeutic discussion
1.6
19.5
438
2772
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.7
19.4
403
2498
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.6
19.4
423
2656
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.9
19.4
233
1229
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
19.3
470
3032
J01FA01
ATC
erythromycin; systemic
1.5
19.2
563
3790
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
5.0
19.2
41
83
R03DC03
ATC
montelukast; oral
1.5
19.1
692
4870
JN3AD
NOMESCO Finland
Abdominal CT examination
1.5
19.1
607
4158
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
19.1
2129
17988
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.3
19.1
1423
11352
I50.0
ICD-10 Finland
Congestive heart failure
1.8
19.0
321
1881
D01AC03
ATC
econazole; topical
1.8
19.0
272
1518
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.7
19.0
376
2303
A10AE05
ATC
insulin detemir; parenteral
1.9
18.9
249
1353
C01CA24
ATC
epinephrine; parenteral
1.9
18.9
243
1311
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.5
18.9
114
455
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.8
18.8
287
1634
NHQ40
NOMESCO Finland
Amputation of toe
3.0
18.7
83
282
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
18.7
387
2398
A10AC01
ATC
insulin (human); parenteral
1.7
18.7
336
2005
P17
ICPC
Tobacco abuse
3.1
18.7
79
261
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.7
18.6
354
2145
WXQ24
NOMESCO Finland
UVB/UVA light therapy
100.4
18.6
20
*
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.0
18.5
82
278
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.7
18.5
344
2071
WX704
NOMESCO Finland
Intubation
1.7
18.4
386
2398
OAB50, ,
SPAT
1.7
18.4
392
2445
R05
ICPC
Cough
1.4
17.9
1111
8598
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
17.9
1706
14070
I79.2*E11.5
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
6.7
17.8
28
42
L73.2
ICD-10 Finland
Hidradenitis suppurativa
3.5
17.8
60
172
M54.5
ICD-10 Finland
Low back pain
1.3
17.8
1643
13489
B35.4
ICD-10 Finland
Tinea corporis
3.0
17.7
76
253
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.5
17.7
106
421
L04AA13
ATC
[U] leflunomide
2.5
17.7
115
475
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.7
17.7
370
2298
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
2.4
17.7
121
512
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
3.0
17.7
77
259
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.0
17.6
187
944
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
2.3
17.6
135
600
N06AX21
ATC
duloxetine; oral
1.5
17.6
510
3423
B01AB05
ATC
enoxaparin; parenteral
1.3
17.6
1388
11141
WX720
NOMESCO Finland
Own respiration
1.9
17.6
240
1320
N06AA12
ATC
doxepin; systemic
1.9
17.5
216
1149
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.7
17.4
314
1875
A07EC01
ATC
sulfasalazine; oral, rectal
1.7
17.4
347
2130
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.6
17.3
397
2522
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.6
17.3
103
408
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.5
17.3
540
3682
R53
ICD-10 Finland
Malaise and fatigue
1.4
17.3
1111
8641
J45.1
ICD-10 Finland
Nonallergic asthma
1.7
17.3
300
1772
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
17.2
794
5845
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.0
17.2
190
974
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.7
17.1
340
2085
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
17.0
695
5000
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
17.0
508
3431
WQ020, ,
NOMESCO Finland
31.6
17.0
22
7
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
16.9
435
2841
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.1
16.9
158
762
N02AA05
ATC
oxycodone; systemic
1.4
16.8
797
5891
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
4.8
16.8
37
77
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.1
16.8
156
750
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
16.8
3134
28117
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
16.7
1058
8208
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.7
16.7
299
1783
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.0
16.6
188
971
R95
ICPC
Chron obstructive pulmonary disease
2.2
16.6
145
680
R06AX26
ATC
fexofenadine; oral
1.8
16.6
274
1595
L50.0
ICD-10 Finland
Allergic urticaria
2.4
16.6
113
477
KMAK, ,
NOMESCO Finland
1.3
16.6
2304
19906
EBA00
NOMESCO Finland
Extraction of tooth
1.3
16.5
1669
13840
S08
ICPC
Skin colour change
1.8
16.5
245
1383
WX110
NOMESCO Finland
Infiltration anesthesia
1.3
16.4
3413
30989
F10.20
ICD-10 Finland
Alcohol dependence currently independent
2.5
16.4
101
407
WX213
NOMESCO Finland
Lower leg blockade
3.6
16.4
53
148
WZA90
NOMESCO Finland
Other medical or dental certificate
1.4
16.4
1018
7871
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.3
16.3
126
562
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
3.7
16.3
51
139
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.6
16.2
376
2396
P01BA02
ATC
hydroxychloroquine; oral
1.7
16.1
336
2084
SFA10
NOMESCO Finland
One-surface restoration
1.3
16.1
2545
22309
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
16.1
3400
30892
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
16.1
343
2141
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.6
16.0
352
2213
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.5
16.0
544
3775
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
3.4
16.0
56
165
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
16.0
1960
16649
J04AB02
ATC
rifampicin; systemic
3.0
16.0
68
226
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.7
15.9
317
1943
J45
ICD-10 Finland
Asthma
1.6
15.9
424
2791
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.5
15.7
446
2979
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.6
15.7
415
2728
L43.9
ICD-10 Finland
Lichen planus, unspecified
2.6
15.6
88
340
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.5
15.6
100
411
L71.9
ICD-10 Finland
Rosacea, unspecified
2.3
15.6
113
491
B01AC04
ATC
clopidogrel; oral
1.4
15.6
710
5209
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
15.5
1734
14544
M25.5
ICD-10 Finland
Pain in joint
1.3
15.5
1443
11816
N18.8
ICD-10 Finland
Other chronic renal failure
2.3
15.4
110
475
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.9
15.4
194
1040
N05AA02
ATC
levomepromazine; systemic
2.0
15.4
173
893
J46
ICD-10 Finland
Status asthmaticus
2.2
15.4
121
545
N05CD07
ATC
temazepam; oral
1.5
15.3
464
3142
A41.9
ICD-10 Finland
Sepsis, unspecified
2.0
15.3
160
805
N06AA09
ATC
amitriptyline; systemic
1.6
15.3
384
2495
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.9
15.2
203
1108
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
15.2
2380
20782
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.5
15.2
91
362
S91
ICPC
Psoriasis
3.5
15.2
51
146
A10AE04
ATC
insulin glargine; parenteral
1.5
15.2
430
2868
QXA70
NOMESCO Finland
Guidance related to rash and skin care
28.7
15.2
20
7
L14
ICPC
Leg/thigh symptom/complaint
1.6
15.1
354
2263
L40
ICD-10 Finland
Psoriasis
2.5
15.1
94
382
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.5
15.0
468
3187
N05BA01
ATC
diazepam; systemic, rectal
1.5
15.0
530
3703
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.4
15.0
952
7373
C02AC05
ATC
moxonidine; oral
1.9
15.0
202
1107
R60.9
ICD-10 Finland
Oedema, unspecified
1.8
14.9
242
1402
Z22.3
ICD-10 Finland
Carrier of other specified bacterial diseases
6.5
14.9
24
37
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.9
14.9
191
1030
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
2.5
14.9
96
396
NH3EA
NOMESCO Finland
Feet X-ray examination with load
2.5
14.9
92
372
ZYC06
NOMESCO Finland
Real-time text-based remote transaction
6.8
14.8
23
34
T78.3
ICD-10 Finland
Angioneurotic oedema
3.0
14.8
66
225
M10.9
ICD-10 Finland
Gout, unspecified
1.6
14.7
309
1921
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
14.7
302
1867
B07.9
ICD-10 Finland
Verruca simplex
2.0
14.7
156
789
A01
ICPC
Pain general/multiple sites
1.5
14.6
436
2942
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
14.6
1300
10566
WX290
NOMESCO Finland
Other blockage of nerve
1.3
14.6
2149
18602
H01
ICPC
Ear pain/earache
1.5
14.6
485
3349
XQ801
NOMESCO Finland
Intracutantest
5.1
14.6
30
59
E66.00
ICD-10 Finland
Metabolic syndrome
1.7
14.5
248
1461
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
14.4
1238
10008
SPAT1229
SPAT
Assessment of need for aid
1.6
14.3
306
1911
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.3
14.3
1181
9497
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
14.3
293
1811
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
14.2
1567
13084
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.0
14.2
161
833
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.9
14.1
181
977
ZXX05
NOMESCO Finland
Extent of procedure, 5 units
6.4
14.1
23
36
R42
ICD-10 Finland
Dizziness and giddiness
1.3
14.1
970
7599
L50.8
ICD-10 Finland
Other urticaria
2.7
14.0
75
283
N03AG01
ATC
valproic acid; systemic, rectal
1.7
14.0
242
1429
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
5.4
14.0
27
50
SPAT1097
SPAT
Recording of ECG
1.4
14.0
602
4367
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
13.9
588
4252
S06.0
ICD-10 Finland
Concussion
1.5
13.9
453
3115
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.8
13.9
189
1040
N05AH03
ATC
olanzapine; systemic
1.7
13.8
265
1609
H70
ICPC
Otitis externa
2.3
13.8
100
435
ZYC01
NOMESCO Finland
Remote contact by phone
1.7
13.8
270
1649
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.7
13.7
232
1361
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
13.7
3144
28549
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.3
13.7
962
7556
E66.9
ICD-10 Finland
Obesity, unspecified
1.9
13.7
158
824
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
13.6
301
1898
L85.89
ICD-10 Finland
Other specified epidermal thickening
14.7
13.5
22
15
Z72.0
ICD-10 Finland
Tobacco use
2.1
13.5
124
595
L30.2
ICD-10 Finland
Cutaneous autosensitization
34.1
13.5
17
5
A06AD11
ATC
lactulose; oral
1.4
13.5
603
4404
K07
ICPC
Swollen ankles/oedema
1.8
13.4
199
1125
S01GX08
ATC
ketotifen; ophthalmic
1.9
13.3
177
966
R03BA02
ATC
budesonide; inhalant
1.4
13.3
707
5314
N02BF01
ATC
gabapentin; oral
1.5
13.3
448
3100
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.1
13.3
125
605
L43.8
ICD-10 Finland
Other lichen planus
2.5
13.3
79
314
L29
ICD-10 Finland
Pruritus
2.9
13.3
61
212
D06BX01
ATC
metronidazole; topical
1.5
13.3
418
2853
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.3
13.3
97
424
C09CA01
ATC
losartan; oral
1.3
13.3
1115
8975
A08
ICPC
Swelling
1.7
13.2
241
1444
SFA30
NOMESCO Finland
Three-surface restoration
1.3
13.2
1904
16383
SPAT1059
SPAT
Spirometry at the office
1.8
13.2
214
1241
K52.2
ICD-10 Finland
Allergic and dietetic gastroenteritis and colitis
5.7
13.2
24
42
SPAT1283
SPAT
Restricted health certificate
1.4
13.2
663
4940
N05AH02
ATC
clozapine; systemic
2.5
13.1
81
328
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
2.5
13.1
82
334
QBA10
NOMESCO Finland
Incision of skin of trunk
3.0
13.1
56
187
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
1.8
13.1
201
1148
A10BH01
ATC
sitagliptin; oral
1.5
13.0
408
2781
SPAT1081
SPAT
Cardiorespiratory global assessment
1.7
12.9
217
1272
N06AB04
ATC
citalopram; systemic
1.3
12.9
844
6553
J30.3
ICD-10 Finland
Other allergic rhinitis
2.0
12.9
135
681
N05AF03
ATC
chlorprothixene; systemic
2.2
12.8
110
515
M48.0
ICD-10 Finland
Spinal stenosis
1.4
12.7
498
3548
B35.2
ICD-10 Finland
Tinea manuum
5.8
12.7
23
40
SPAT1285
SPAT
Provision of consultation response
1.7
12.7
220
1300
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
3.4
12.7
45
134
N05AX08
ATC
risperidone; systemic
1.6
12.7
341
2249
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
5.1
12.7
26
51
N06AB03
ATC
fluoxetine; oral
1.4
12.6
492
3502
R03AK08
ATC
formoterol and beclometasone; inhalant
1.8
12.6
182
1020
L23.4
ICD-10 Finland
Allergic contact dermatitis due to dyes
70.0
12.6
14
*
JN4AD
NOMESCO Finland
Body CT examination
1.4
12.5
498
3561
N06AX16
ATC
venlafaxine; oral
1.4
12.5
578
4245
X58
ICD-10 Finland
Exposure to other specified factors
1.4
12.5
625
4652
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
2.6
12.3
72
284
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.9
12.3
159
861
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
1.8
12.3
184
1043
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
2.8
12.3
58
205
L04AB01
ATC
etanercept; parenteral
2.6
12.3
71
279
A07AA02
ATC
nystatin; oral
1.7
12.2
225
1352
127
Kela drug reimbursment
Transplant complication
2.6
12.2
69
268
L71.8
ICD-10 Finland
Other rosacea
2.6
12.2
69
268
L28
ICD-10 Finland
Lichen simplex chronicus and prurigo
3.7
12.2
38
104
D07XB01
ATC
flumetasone; topical
3.6
12.1
39
109
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.2
12.1
2500
22307
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
1.9
12.1
138
718
A10BK03
ATC
empagliflozin; oral
1.5
12.0
451
3186
H02AB09
ATC
hydrocortisone; systemic
2.2
12.0
102
475
PHM76
NOMESCO Finland
Endovenous obliteration of v.saphena magna
1.9
12.0
159
868
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.4
12.0
573
4228
L16
ICPC
Ankle symptom/complaint
1.4
12.0
501
3611
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
2.2
12.0
99
456
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
2.1
12.0
111
535
S22.3
ICD-10 Finland
Fracture of rib
1.6
12.0
318
2092
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
3.8
12.0
36
96
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
4.2
12.0
31
74
UJF92
NOMESCO Finland
Capsular endoscopy
2.2
11.9
96
438
QXB99, ,
SPAT
2.0
11.9
126
638
K70.1
ICD-10 Finland
Alcoholic hepatitis
4.0
11.9
33
83
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
11.9
1003
8063
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.2
11.9
93
419
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
2.7
11.9
63
237
R51.80
ICD-10 Finland
Headache
1.4
11.8
628
4717
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.4
11.8
554
4076
K29.7
ICD-10 Finland
Gastritis, unspecified
1.9
11.8
145
773
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
11.8
544
3991
K50.9
ICD-10 Finland
Crohn disease, unspecified
2.6
11.8
68
267
C09AA05
ATC
ramipril; oral
1.3
11.8
1046
8465
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.6
11.8
240
1482
P16
ICPC
Acute alcohol abuse
2.4
11.8
75
309
R03AK07
ATC
formoterol and budesonide; inhalant
1.3
11.7
873
6897
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.2
11.7
100
467
B01AA03
ATC
warfarin; systemic
1.3
11.7
764
5923
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
2.8
11.7
57
205
A02BC05
ATC
esomeprazole; systemic
1.2
11.7
1741
14980
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.1
11.6
103
488
N18.0
ICD-10 Finland
End-stage renal disease
3.0
11.6
50
168
SPAT1216
SPAT
Assessment of functional ability
1.4
11.6
607
4547
ZYC01, ,
SPAT
1.4
11.6
457
3260
M54.4
ICD-10 Finland
Lumbago with sciatica
1.3
11.6
751
5817
ZXA10
NOMESCO Finland
Bilateral
1.3
11.6
734
5666
NG4AA
NOMESCO Finland
Lower leg X-ray examination
1.9
11.5
138
729
N06AX12
ATC
bupropion; oral
1.6
11.5
280
1805
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
11.5
1080
8798
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
2.7
11.5
60
224
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.0
11.5
130
674
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
11.4
1100
8990
T82
ICPC
Obesity
1.8
11.4
171
970
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.5
11.4
318
2116
P29
ICPC
Psychological sympt/compl other
1.6
11.4
297
1947
R06.2
ICD-10 Finland
Wheezing
1.7
11.3
183
1062
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
2.2
11.3
88
396
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
11.3
670
5121
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
2.3
11.3
83
365
R55
ICD-10 Finland
Syncope and collapse
1.4
11.3
447
3192
S19
ICPC
Skin injury other
1.8
11.2
158
880
WX400
NOMESCO Finland
Inhalation anesthesy
1.8
11.2
171
976
D69.0
ICD-10 Finland
Allergic purpura
3.6
11.2
36
101
OAB74, ,
SPAT
2.8
11.2
56
205
B35.1
ICD-10 Finland
Tinea unguium
1.6
11.1
282
1839
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
2.2
11.0
92
426
L03
ICPC
Low back symptom/complaint
1.3
11.0
1248
10399
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.5
11.0
367
2535
K50.1
ICD-10 Finland
Crohn disease of large intestine
2.8
11.0
53
190
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
11.0
542
4021
N05BA04
ATC
oxazepam; oral
1.3
10.9
1097
9005
WX892
NOMESCO Finland
Monitored bed care
1.5
10.9
306
2037
WZC30, ,
SPAT
1.5
10.9
369
2554
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
2.6
10.9
61
236
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
10.9
949
7652
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.6
10.9
261
1678
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
10.8
866
6904
C08CA13
ATC
lercanidipine; oral
1.4
10.8
586
4413
A05
ICPC
Feeling ill
1.6
10.8
231
1445
J01FA09
ATC
clarithromycin; systemic
1.3
10.8
1292
10831
L70.0
ICD-10 Finland
Acne vulgaris
2.1
10.8
98
470
EBA30
NOMESCO Finland
Extraction of root of tooth
1.6
10.7
252
1612
L40.4
ICD-10 Finland
Guttate psoriasis
4.4
10.7
26
59
R03BA08
ATC
ciclesonide; inhalant
1.5
10.7
330
2243
J01FA10
ATC
azithromycin; systemic
1.2
10.7
2506
22533
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
2.6
10.7
60
233
A12AA04
ATC
calcium carbonate; oral
2.5
10.6
65
263
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.1
10.6
103
506
L25.8
ICD-10 Finland
Unspecified contact dermatitis due to other agents
60.1
10.6
12
*
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
2.6
10.6
58
222
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
2.8
10.6
50
177
L12
ICPC
Hand/finger symptom/complaint
1.3
10.6
718
5592
L40.5
ICD-10 Finland
Arthropathic psoriasis
2.4
10.6
73
312
I50.1
ICD-10 Finland
Left ventricular failure
1.7
10.6
206
1258
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.5
10.5
392
2766
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
2.8
10.5
52
189
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.6
10.5
259
1676
319
Kela drug reimbursment
Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)
3.6
10.5
33
91
M47.82
ICD-10 Finland
Other spondylosis, cervical region
1.8
10.5
167
966
C10AC01
ATC
colestyramine; oral
2.0
10.4
106
530
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.1
10.4
98
476
1653, ,
NOMESCO Finland
110.2
10.4
11
*
WXQ20
NOMESCO Finland
UVA broad spectrum light therapy
110.2
10.4
11
*
L04AC10
ATC
secukinumab; parenteral
4.1
10.4
28
69
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.4
10.4
400
2840
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.6
10.4
225
1412
GD1AD
NOMESCO Finland
Thorax CT examination
1.6
10.4
264
1721
SPAT1247
SPAT
Outpatient detoxication and monitoring
4.2
10.3
27
65
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
2.1
10.3
89
418
E000005, ,
ATC
32.6
10.3
13
*
K28
ICPC
Limited function/disability (K)
2.1
10.3
98
478
TGC00
NOMESCO Finland
Bronchial lavation
2.0
10.3
102
505
L02.8
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of other sites
2.3
10.3
73
316
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
10.3
2159
19177
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
2.8
10.3
51
186
H04.10
ICD-10 Finland
Dry eye syndrome
1.4
10.2
454
3306
L93.0
ICD-10 Finland
Discoid lupus erythematosus
4.9
10.2
22
45
501
Kela drug reimbursment
Cow's milk and / or soy protein allergy in young children
4.9
10.2
22
45
EB1VA, ,
NOMESCO Finland
1.3
10.2
761
6005
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
1.5
10.2
380
2681
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
2.9
10.2
46
159
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.6
10.2
241
1545
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.3
10.2
734
5766
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.4
10.2
380
2683
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
2.2
10.1
83
382
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
4.1
10.1
27
66
S84
ICPC
Impetigo
4.1
10.1
27
66
T74.1
ICD-10 Finland
Physical abuse
2.3
10.1
74
325
RJ411, ,
NOMESCO Finland
3.9
10.1
29
75
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
1.9
10.1
122
648
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
10.1
1059
8732
N02BF02
ATC
pregabalin; oral
1.5
10.1
275
1821
J01CF02
ATC
cloxacillin; systemic
2.1
10.1
90
429
R01AD11
ATC
triamcinolone; nasal
1.5
10.1
325
2231
SPAT1304
SPAT
Counselling and guidance related to ageing
1.6
10.0
263
1726
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.8
10.0
139
771
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.8
10.0
134
735
SPAT1257
SPAT
Teaching of medicine inhalation technique
1.8
10.0
133
728
M10.0
ICD-10 Finland
Idiopathic gout
1.8
10.0
146
823
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.6
10.0
254
1656
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
1.9
10.0
118
622
L98.1
ICD-10 Finland
Factitial dermatitis
14.6
10.0
16
11
C84.0
ICD-10 Finland
Mycosis fungoides
14.6
10.0
16
11
WQ066, ,
NOMESCO Finland
40.1
10.0
12
*
F17.2
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, dependence syndrome
2.9
9.9
45
156
R03AC12
ATC
salmeterol; inhalant
1.7
9.9
160
929
S01GX01
ATC
cromoglicic acid; ophthalmic
1.3
9.9
727
5725
K85
ICD-10 Finland
Acute pancreatitis
2.3
9.9
70
303
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.4
9.9
421
3044
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
2.8
9.9
48
173
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.6
9.9
203
1258
C08CA02
ATC
felodipine; oral
1.4
9.9
366
2581
1200, ,
NOMESCO Finland
16.7
9.9
15
9
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.4
9.8
373
2641
PD4AD
NOMESCO Finland
CT of lower extremity arteries
2.9
9.8
45
157
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
4.3
9.8
25
59
K10.3
ICD-10 Finland
Alveolitis of jaws
1.7
9.8
195
1198
K90.0
ICD-10 Finland
Coeliac disease
1.9
9.8
115
605
R03AC03
ATC
terbutaline; inhalant
1.4
9.8
522
3921
A07EC02
ATC
mesalazine; oral, rectal
1.6
9.8
205
1277
N06
ICPC
Sensation disturbance other
2.7
9.8
51
191
X61
ICD-10 Finland
Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
4.5
9.8
23
51
L43.0
ICD-10 Finland
Hypertrophic lichen planus
4.0
9.8
27
68
E87.6
ICD-10 Finland
Hypokalaemia
1.8
9.7
141
793
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.3
9.7
732
5784
SFA20
NOMESCO Finland
Two-surface restoration
1.2
9.7
2642
24006
J01CA04
ATC
amoxicillin; systemic
1.2
9.7
3873
36514
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
9.7
750
5947
IHZ05, ,
SPAT
1.7
9.7
165
973
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
3.9
9.7
28
73
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.3
9.6
580
4437
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.5
9.6
259
1711
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
2.0
9.6
100
505
L04AB06
ATC
golimumab; parenteral
3.1
9.6
38
122
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
2.5
9.6
60
246
R03AC13
ATC
formoterol; inhalant
1.7
9.6
182
1106
TK800
NOMESCO Finland
Hemodialysis
2.1
9.6
90
438
RS340, ,
NOMESCO Finland
5.0
9.6
20
40
R01BA52
ATC
pseudoephedrine, combinations; oral
1.2
9.5
1186
9964
L56.4
ICD-10 Finland
Polymorphous light eruption
4.4
9.5
23
52
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.5
9.5
256
1692
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
1.6
9.5
200
1248
S17
ICPC
Abrasion/scratch/blister
2.0
9.5
92
453
SPAT1324
SPAT
Screening procedure
1.3
9.5
644
5017
UKC02
NOMESCO Finland
Cystoscopy
1.3
9.4
664
5196
PE1AT
NOMESCO Finland
Femoral artery PTA
2.6
9.4
54
212
A10BJ06
ATC
semaglutide; parenteral
1.6
9.4
223
1431
WVA20
NOMESCO Finland
Medicine administration
1.9
9.4
118
635
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
9.4
990
8160
WVA20, ,
SPAT
1.7
9.4
156
914
WQ022, ,
NOMESCO Finland
+∞
9.4
9
*
Z01.9
ICD-10 Finland
Special examination, unspecified
1.6
9.4
240
1568
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
2.3
9.4
68
298
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
2.2
9.4
76
349
ZX120, ,
SPAT
2.3
9.3
67
292
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.2
9.3
75
343
SCA02
NOMESCO Finland
Preventive oral health care
1.4
9.3
397
2871
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
3.5
9.3
31
89
S91.0
ICD-10 Finland
Open wound of ankle
2.7
9.3
47
173
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
2.7
9.3
47
173
L04AC05
ATC
ustekinumab; parenteral
3.7
9.3
28
75
S01GX02
ATC
levocabastine; ophthalmic
1.6
9.3
203
1278
SGA01
NOMESCO Finland
Emergency treatment
1.3
9.2
674
5300
A10AB04
ATC
insulin lispro; parenteral
1.8
9.2
124
682
QDE35
NOMESCO Finland
Repair of skin defect in lower limb after surgery or injury
4.0
9.2
25
62
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.2
9.2
1157
9727
Z02.7
ICD-10 Finland
Issue of medical certificate
1.5
9.2
302
2081
-50
ICPC
Medication/prescr/renewal
1.7
9.2
156
920
PD4CC
NOMESCO Finland
Very extensive arterigography of lower extremity with X-ray
3.5
9.2
31
90
L08
ICPC
Shoulder symptom/complaint
1.3
9.2
969
7987
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.4
9.2
378
2719
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
1.9
9.2
110
584
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.6
9.1
234
1529
A07EA06
ATC
budesonide; oral, local oral
1.8
9.1
141
809
R52.9
ICD-10 Finland
Pain, unspecified
1.4
9.1
405
2950
R01AD09
ATC
mometasone; nasal
1.2
9.1
1910
16903
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.4
9.1
381
2746
L88
ICPC
Rheumatoid/seropositive arthritis
1.7
9.1
160
952
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
1.9
9.1
106
557
P03
ICPC
Feeling depressed
1.4
9.1
384
2774
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
4.6
9.0
21
46
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
3.2
9.0
35
111
C10AA01
ATC
simvastatin; oral
1.2
9.0
1721
15095
C03AA03
ATC
hydrochlorothiazide; oral
1.4
9.0
337
2381
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.5
9.0
275
1867
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
2.7
9.0
45
165
SPAT1053
SPAT
Memory test
1.3
9.0
528
4025
SFA00
NOMESCO Finland
Small restoration
1.3
9.0
577
4457
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.2
9.0
75
349
SBA00
NOMESCO Finland
Microbiological examinations
1.9
9.0
101
525
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.0
8.9
92
463
K60.3
ICD-10 Finland
Anal fistula
2.2
8.9
73
337
L23.7
ICD-10 Finland
Allergic contact dermatitis due to plants, except food
24.0
8.9
12
5
XF600
NOMESCO Finland
Bloodpressure measurement
1.5
8.9
244
1621
Z01.2
ICD-10 Finland
Dental examination
1.2
8.9
2035
18152
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.8
8.8
128
721
E66.0
ICD-10 Finland
Obesity due to excess calories
2.7
8.8
47
178
C09BA02
ATC
enalapril and diuretics; systemic
1.5
8.8
310
2164
R01AD12
ATC
fluticasone furoate; nasal
1.2
8.8
1272
10846
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
2.6
8.8
50
196
J05AB01
ATC
aciclovir; systemic
1.3
8.8
859
7013
A11CC03
ATC
alfacalcidol; systemic
2.0
8.8
95
487
W19
ICD-10 Finland
Unspecified fall
1.4
8.8
390
2842
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
1.7
8.8
147
864
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.4
8.8
416
3065
Z37.0
ICD-10 Finland
Single live birth
0.5
8.8
92
1724
R18
ICD-10 Finland
Ascites
2.0
8.8
85
419
S10
ICPC
Boil/carbuncle
1.5
8.8
241
1601
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
3.0
8.7
38
129
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.8
8.7
122
680
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.5
8.7
240
1594
SPAT1193
SPAT
Pap smear
1.4
8.7
318
2236
R06AX18
ATC
acrivastine; oral
1.9
8.7
97
502
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
2.6
8.7
49
191
J01CR50
ATC
combinations of penicillins; systemic
7.2
8.7
20
28
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
8.7
1750
15411
WX730
NOMESCO Finland
Conventional respirator
2.3
8.7
66
295
ZXH06, ,
SPAT
1.6
8.7
206
1323
R11
ICD-10 Finland
Nausea and vomiting
1.4
8.7
338
2406
K92.0
ICD-10 Finland
Haematemesis
1.9
8.7
99
517
L40.2
ICD-10 Finland
Acrodermatitis continua
50.1
8.7
10
*
K59.1
ICD-10 Finland
Functional diarrhoea
1.6
8.7
215
1396
A28
ICPC
Limited function/disability NOS
1.3
8.7
696
5544
QXA70, ,
SPAT
2.2
8.6
66
296
Z08
ICPC
Social welfare problem
2.4
8.6
58
246
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
2.9
8.6
40
141
N03AX09
ATC
lamotrigine; oral
1.6
8.6
174
1075
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
2.4
8.6
55
228
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
4.6
8.6
20
44
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.5
8.5
256
1733
E66.8
ICD-10 Finland
Other obesity
1.6
8.5
210
1362
Z94.0
ICD-10 Finland
Kidney transplant status
2.6
8.5
46
176
R04.0
ICD-10 Finland
Epistaxis
1.5
8.5
300
2097
M03BX02
ATC
tizanidine; oral
1.2
8.5
2754
25291
D11
ICPC
Diarrhoea
1.4
8.5
466
3517
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
2.1
8.4
77
371
R52.2
ICD-10 Finland
Other chronic pain
1.7
8.4
148
882
XQ806
NOMESCO Finland
Minimal Erythema Dose (MED) test
90.2
8.4
9
*
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.6
8.4
170
1052
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
1.8
8.4
114
631
J33.0
ICD-10 Finland
Polyp of nasal cavity
1.8
8.4
117
653
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.2
8.4
947
7862
B08.1
ICD-10 Finland
Molluscum contagiosum
4.6
8.3
19
41
69240
ICD-8 Finland
Other eczema and dermatitis, Due to other chemicals
+∞
8.3
8
*
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.8
8.3
118
661
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
3.0
8.3
36
122
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
1.9
8.3
106
575
N05AD01
ATC
haloperidol; systemic
1.8
8.3
120
677
Z00.0
ICD-10 Finland
General medical examination
1.3
8.3
782
6356
H29
ICPC
Ear symptom/complaint other
1.3
8.3
482
3670
L28
ICPC
Limited function/disability (L)
1.3
8.2
752
6086
J43.9
ICD-10 Finland
Emphysema, unspecified
2.2
8.2
65
296
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.4
8.2
404
2995
SPAT1252
SPAT
Overall medication plan or its review
1.5
8.2
252
1714
H3603, E103,
ICD-10 Finland
2.7
8.2
43
162
NHG20
NOMESCO Finland
Fusion of talocrural joint
3.2
8.2
31
97
Z2221
NOMESCO Finland
Medical doctor
0.8
8.2
756
9233
L15
ICPC
Knee symptom/complaint
1.2
8.2
1033
8676
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
2.6
8.2
44
168
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.6
8.2
198
1279
Z49.1
ICD-10 Finland
Extracorporeal dialysis
2.4
8.1
54
228
AN1
HP
Coronary angiography
1.4
8.1
422
3155
M70.6
ICD-10 Finland
Trochanteric bursitis
1.3
8.1
495
3793
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.3
8.1
615
4859
A10AD05
ATC
insulin aspart; parenteral
2.1
8.1
69
324
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
2.6
8.1
44
169
K50.0
ICD-10 Finland
Crohn disease of small intestine
2.3
8.1
59
260
E86
ICD-10 Finland
Volume depletion
1.9
8.1
98
523
L44.0
ICD-10 Finland
Pityriasis rubra pilaris
33.4
8.1
10
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.4
8.1
395
2926
A10AE06
ATC
insulin degludec; parenteral
1.7
8.1
142
847
L24.5
ICD-10 Finland
Irritant contact dermatitis due to other chemical products
17.2
8.1
12
7
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
8.1
995
8336
R21
ICPC
Throat symptom/complaint
1.3
8.0
817
6697
WX212
NOMESCO Finland
Femoral plexus blockade
1.9
8.0
93
489
N05CF02
ATC
zolpidem; oral
1.3
8.0
677
5425
R29
ICPC
Respiratory symptom/complaint other
1.5
8.0
275
1914
WX408
NOMESCO Finland
General anesthesy, balanced
1.2
8.0
1055
8903
S42.0
ICD-10 Finland
Fracture of clavicle
1.8
8.0
111
619
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
1.9
8.0
102
554
M03BC01
ATC
orphenadrine (citrate); systemic
1.2
8.0
889
7364
HMAK, ,
NOMESCO Finland
1.4
8.0
441
3331
M43.1
ICD-10 Finland
Spondylolisthesis
1.7
8.0
150
911
K50.8
ICD-10 Finland
Other Crohn disease
2.3
8.0
60
268
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
3.5
8.0
26
74
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
2.2
7.9
61
275
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
1.6
7.9
162
1006
SAA04
NOMESCO Finland
Special examination of mouth
1.6
7.9
199
1298
WVA40, ,
SPAT
2.9
7.9
36
126
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
1.9
7.9
102
556
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
2.7
7.9
41
154
SPAT1101
SPAT
Orthostatic test
1.7
7.9
150
914
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.5
7.9
201
1315
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
2.0
7.9
76
375
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.6
7.8
178
1133
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.3
7.8
701
5657
WX402
NOMESCO Finland
General anaesthesia
1.2
7.8
932
7776
R07.3
ICD-10 Finland
Other chest pain
1.4
7.8
399
2976
SPAT1139
SPAT
Nutrition survey
1.8
7.8
122
704
NH3CG
NOMESCO Finland
Extensive MRI of foot
3.1
7.8
31
100
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
1.6
7.8
193
1253
NF1AA
NOMESCO Finland
Hip X-ray examination
1.4
7.8
344
2504
SPAT1104
SPAT
Monitoring of emergency patient
1.5
7.8
247
1691
H01.1
ICD-10 Finland
Noninfectious dermatoses of eyelid
4.1
7.8
21
52
K04.0
ICD-10 Finland
Pulpitis
1.4
7.8
349
2548
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.3
7.8
506
3914
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
3.2
7.8
29
90
SPAT1284
SPAT
Extensive health certificate
1.8
7.8
104
573
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.7
7.8
151
925
L04AC18
ATC
risankizumab; parenteral
6.9
7.8
18
26
V03AE01
ATC
polystyrene sulfonate; oral
2.4
7.7
52
221
XQ855, ,
SPAT
2.3
7.7
56
246
L09
ICPC
Arm symptom/complaint
1.6
7.7
188
1216
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.2
7.7
65
304
S91.3
ICD-10 Finland
Open wound of other parts of foot
1.8
7.7
103
567
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.5
7.7
230
1556
F60.9
ICD-10 Finland
Personality disorder, unspecified
2.4
7.7
52
222
B01AB10
ATC
tinzaparin; parenteral
1.3
7.7
443
3368
L24
ICD-10 Finland
Irritant contact dermatitis
7.4
7.7
17
23
IHZ04, ,
SPAT
2.1
7.7
68
325
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.6
7.7
192
1251
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.3
7.6
640
5122
L57.8
ICD-10 Finland
Other skin changes due to chronic exposure to nonionizing radiation
4.5
7.6
18
40
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
2.4
7.6
48
198
R31
ICD-10 Finland
Unspecified haematuria
1.4
7.6
414
3120
M70.2
ICD-10 Finland
Olecranon bursitis
1.7
7.6
136
816
SPAT1325
SPAT
Vaccination
1.2
7.6
1331
11545
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.4
7.6
286
2026
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.6
7.6
178
1143
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
1.8
7.6
107
600
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
2.5
7.6
44
175
M07.3
ICD-10 Finland
Other psoriatic arthropathies
2.5
7.6
44
175
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
1.5
7.5
235
1604
B03BA03
ATC
hydroxocobalamin; parenteral
1.5
7.5
208
1384
OAB44, ,
SPAT
1.4
7.5
400
3002
D82
ICPC
Teeth/gum disease
1.2
7.5
1581
13937
H60.3
ICD-10 Finland
Other infective otitis externa
1.9
7.5
91
486
QXB10
NOMESCO Finland
Exchange of dressing for large skin wound, unspecified location
4.2
7.5
19
45
SPA47
NOMESCO Finland
Precision impression for denture
1.8
7.5
108
610
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
2.2
7.4
62
289
XG410
NOMESCO Finland
Flow-volume spirometry
1.6
7.4
146
897
-44
ICPC
Preventive immunization/medic
1.4
7.4
300
2151
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.3
7.4
498
3869
K05.31
ICD-10 Finland
Periodontitis pronounced
1.3
7.4
442
3376
Z72.1
ICD-10 Finland
Alcohol use
2.3
7.4
53
232
GX1E5, ,
SPAT
2.2
7.4
56
251
L29.2
ICD-10 Finland
Pruritus vulvae
2.5
7.4
43
171
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
3.1
7.4
29
93
M54.6
ICD-10 Finland
Pain in thoracic spine
1.4
7.4
277
1960
-69
ICPC
Other reason for encounter NEC
1.7
7.4
139
845
0350X
ICD-9 Finland
Erysipelas[ERYSIPELAS ALIA DEFINITA SEU NUD]
2.9
7.4
32
109
B35.8
ICD-10 Finland
Other dermatophytoses
4.0
7.3
20
50
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
4.0
7.3
20
50
XX3DW
NOMESCO Finland
Time consuming IT work
1.3
7.3
426
3242
SPAT1157
SPAT
Guidance concerning treatment of mouth and mucous membranes
2.3
7.3
52
227
B82
ICPC
Anaemia other/unspecified
1.7
7.3
117
681
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
2.7
7.3
38
143
69009
ICD-8 Finland
Seborrhoeic dermatitis, Unspecified
+∞
7.3
7
*
A10AD04
ATC
insulin lispro; parenteral
3.6
7.3
23
64
L04AC21
ATC
bimekizumab; systemic
10.9
7.3
13
12
AA3AD
NOMESCO Finland
CT of face
2.6
7.3
39
149
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.5
7.3
192
1266
L85.1
ICD-10 Finland
Acquired keratosis [keratoderma] palmaris et plantaris
9.4
7.3
14
15
Z49.2
ICD-10 Finland
Other dialysis
2.8
7.2
34
121
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.0
7.2
74
373
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
3.8
7.2
21
55
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.5
7.2
239
1651
WX702
NOMESCO Finland
Supraglottic ventilation device
1.5
7.2
225
1536
R09
ICPC
Sinus symptom/complaint
1.4
7.2
308
2230
F29
ICD-10 Finland
Unspecified nonorganic psychosis
1.7
7.2
133
804
K04.7
ICD-10 Finland
Periapical abscess without sinus
1.5
7.2
232
1595
QDA10
NOMESCO Finland
Incision of skin of lower limb
2.9
7.2
33
116
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
2.9
7.2
33
116
N05AF05
ATC
zuclopenthixol; systemic
2.6
7.2
39
150
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
2.0
7.2
76
388
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
1.6
7.2
141
867
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.5
7.2
234
1613
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
7.2
718
5871
A29
ICPC
General symptom/complaint other
1.3
7.1
536
4228
WXQ26
NOMESCO Finland
UVB broad spectrum light therapy
30.0
7.1
9
*
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.3
7.1
453
3492
A41.8
ICD-10 Finland
Other specified sepsis
2.0
7.1
75
382
S92.3
ICD-10 Finland
Fracture of metatarsal bone
1.7
7.1
130
784
Z3231
NOMESCO Finland
Registered nurse
1.2
7.1
1085
9276
WZB00, ,
SPAT
1.4
7.1
353
2621
L03.8
ICD-10 Finland
Cellulitis of other sites
3.1
7.1
28
90
SPAT1210
SPAT
Application of cast or individual aid
1.6
7.1
145
900
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
1.6
7.1
143
885
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
3.2
7.1
27
85
WX950, ,
SPAT
2.4
7.1
47
199
A10BB12
ATC
glimepiride; oral
1.5
7.1
246
1716
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
7.1
113
657
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
2.5
7.1
42
169
P01
ICPC
Feeling anxious/nervous/tense
1.3
7.0
459
3552
R5140
NOMESCO Finland
Monitoring the use of the aid
1.3
7.0
448
3455
J45.8
ICD-10 Finland
Mixed asthma
1.7
7.0
110
636
120
Kela drug reimbursment
Hypogammaglobulinaemia
8.8
7.0
14
16
49300
ICD-8 Finland
Asthma, bronchiale
1.9
7.0
82
433
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
1.9
7.0
82
433
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.5
7.0
236
1636
WX780
NOMESCO Finland
Remote monitoring CPAP
1.5
7.0
182
1196
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.5
7.0
177
1156
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
1.7
7.0
114
667
A40.8
ICD-10 Finland
Other streptococcal sepsis
2.5
7.0
42
170
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.2
7.0
1487
13109
OAB95, ,
SPAT
0.6
7.0
150
2322
ZXC50
NOMESCO Finland
Cryotherapy
1.8
7.0
107
616
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.5
6.9
217
1483
NHL14
NOMESCO Finland
Shortening or lengthening of achilles tendon
3.0
6.9
30
102
C07AG02
ATC
carvedilol; oral
1.5
6.9
214
1459
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.6
6.9
152
961
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.3
6.9
513
4040
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
1.8
6.9
92
507
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
2.5
6.9
40
159
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.5
6.9
220
1510
QDG00
NOMESCO Finland
Debridement of bedsore of lower limb
7.5
6.9
15
20
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.7
6.9
124
746
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
4.0
6.9
19
48
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
4.0
6.9
19
48
R05
ICD-10 Finland
Cough
1.2
6.9
860
7206
N06AB10
ATC
escitalopram; oral
1.2
6.9
789
6551
N17.8
ICD-10 Finland
Other acute renal failure
2.2
6.9
55
253
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.4
6.8
265
1887
C07AB02
ATC
metoprolol; systemic
1.2
6.8
759
6277
R03DA04
ATC
theophylline; systemic, rectal
1.6
6.8
170
1107
NG4AD
NOMESCO Finland
Lower leg CT
3.4
6.8
23
67
SPD01
NOMESCO Finland
Mucosa-supported complete denture
2.5
6.8
42
172
SDA03
NOMESCO Finland
Periodontal treatment
1.2
6.8
1741
15578
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.5
6.8
238
1663
A12BA01
ATC
potassium chloride; oral
1.6
6.8
143
895
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.5
6.8
203
1375
C10AA05
ATC
atorvastatin; oral
1.2
6.8
1812
16268
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
2.2
6.8
53
241
S01AD03
ATC
aciclovir; ophthalmic
1.7
6.8
118
703
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.3
6.8
447
3464
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
1.5
6.8
175
1149
N05BA02
ATC
chlordiazepoxide; systemic
1.8
6.8
90
496
XF600, ,
SPAT
1.6
6.8
157
1006
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
9.3
6.8
13
14
H3601, E103,
ICD-10 Finland
2.6
6.8
37
143
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
2.6
6.8
38
149
L10.2
ICD-10 Finland
Pemphigus foliaceus
40.1
6.8
8
*
F20.9
ICD-10 Finland
Schizophrenia, unspecified
1.9
6.8
79
418
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
2.4
6.7
43
179
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
1.8
6.7
93
519
Z2446
NOMESCO Finland
Social worker
1.5
6.7
227
1576
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
2.1
6.7
57
269
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.3
6.7
490
3855
M01AE02
ATC
naproxen; oral, rectal
1.2
6.7
2451
22555
SPAT1172
SPAT
Guidance concerning hydration
1.9
6.7
78
413
L53.9
ICD-10 Finland
Erythematous condition, unspecified
2.3
6.7
47
205
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
2.3
6.7
47
205
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.3
6.7
481
3776
P06
ICPC
Sleep disturbance
1.3
6.6
504
3982
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
0.6
6.6
89
1547
C01DA14
ATC
isosorbide mononitrate; oral
1.3
6.6
575
4622
K85.2
ICD-10 Finland
Alcohol-induced acute pancreatitis
3.0
6.6
27
89
R20.2
ICD-10 Finland
Paraesthesia of skin
1.4
6.6
261
1867
S80.0
ICD-10 Finland
Contusion of knee
1.4
6.6
288
2096
S86
ICPC
Dermatitis seborrhoeic
3.6
6.6
21
59
S01.0
ICD-10 Finland
Open wound of scalp
1.4
6.6
310
2285
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
1.9
6.6
78
415
S74
ICPC
Dermatophytosis
1.9
6.6
76
401
Z72.8
ICD-10 Finland
Other problems related to lifestyle
3.2
6.6
25
79
Y09
ICD-10 Finland
Assault by unspecified means
3.4
6.6
22
64
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.3
6.5
376
2859
Q82.88
ICD-10 Finland
Other specified congenital malformations of skin
10.0
6.5
12
12
L04AD02
ATC
tacrolimus; systemic
2.4
6.5
42
176
H60.5
ICD-10 Finland
Acute otitis externa, noninfective
2.5
6.5
37
146
PE1YT
NOMESCO Finland
Femoral or popliteal artery PTA with stent
2.5
6.5
40
164
ZXA05
NOMESCO Finland
Left side
1.2
6.5
935
7944
-34
ICPC
Blood test
1.7
6.5
109
644
A01AB09
ATC
miconazole; local oral
1.4
6.5
294
2153
F29
ICPC
Eye symptom/complaint other
1.3
6.5
406
3125
F05.9
ICD-10 Finland
Delirium, unspecified
1.8
6.5
84
460
N05AX12
ATC
aripiprazole; systemic
1.6
6.5
137
860
A10AD01
ATC
insulin (human); parenteral
2.0
6.5
64
320
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.4
6.4
328
2447
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
6.4
4344
41897
S09
ICPC
Infected finger/toe
1.7
6.4
121
737
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
2.5
6.4
39
159
K86.3
ICD-10 Finland
Pseudocyst of pancreas
3.4
6.4
22
65
A02BA02
ATC
ranitidine; systemic
1.2
6.4
715
5916
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
1.5
6.4
161
1052
R33
ICD-10 Finland
Retention of urine
1.4
6.4
313
2321
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
6.4
107
632
S20.2
ICD-10 Finland
Contusion of thorax
1.5
6.4
206
1419
Z71.4
ICD-10 Finland
Alcohol abuse counselling and surveillance
3.0
6.4
27
91
L50
ICD-10 Finland
Urticaria
2.0
6.4
62
308
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
1.9
6.4
80
434
137
Kela drug reimbursment
Uraemia requiring dialysis
2.6
6.4
35
136
H61.0
ICD-10 Finland
Perichondritis of external ear
4.1
6.3
17
42
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
2.5
6.3
36
142
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
1.7
6.3
115
694
VALMI, ,
NOMESCO Finland
1.2
6.3
952
8121
SPAT1044
SPAT
Tympanometry
1.9
6.3
75
399
M71.0
ICD-10 Finland
Abscess of bursa
2.7
6.3
32
119
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.2
6.3
843
7106
K08.80
ICD-10 Finland
Toothache NOS
1.4
6.3
339
2551
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
2.0
6.3
63
316
L41.1
ICD-10 Finland
Pityriasis lichenoides chronica
11.0
6.3
11
10
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
1.8
6.3
85
472
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
3.5
6.3
21
61
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
2.6
6.3
35
137
SPAT1361
SPAT
Collection of tissue sample
3.8
6.3
18
47
69109
ICD-8 Finland
Infantile eczema and related conditions, Unspecified
+∞
6.2
6
*
K92
ICPC
Atherosclerosis/periph vascular dis
2.1
6.2
53
250
A10BJ02
ATC
liraglutide; parenteral
1.7
6.2
110
659
PD5AD
NOMESCO Finland
CT of aorta
1.8
6.2
94
539
I50
ICD-10 Finland
Heart failure
1.7
6.2
104
614
K92.1
ICD-10 Finland
Melaena
1.5
6.2
199
1368
N03AE01
ATC
clonazepam; systemic
1.5
6.2
204
1410
L91.0
ICD-10 Finland
Hypertrophic scar
2.2
6.2
50
231
N30.0
ICD-10 Finland
Acute cystitis
1.2
6.2
640
5249
F51.0
ICD-10 Finland
Nonorganic insomnia
1.2
6.2
648
5323
N04AA02
ATC
biperiden; systemic
1.9
6.2
71
374
XLD00, ,
SPAT
2.2
6.2
51
238
A04
ICPC
Weakness/tiredness general
1.3
6.2
607
4951
L78
ICPC
Sprain/strain of knee
2.1
6.2
54
258
K04.1
ICD-10 Finland
Necrosis of pulp
1.3
6.2
426
3325
RS211, ,
NOMESCO Finland
4.0
6.2
17
43
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.5
6.2
194
1330
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
3.1
6.2
24
77
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.1
6.1
52
245
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
2.9
6.1
27
93
K51.5
ICD-10 Finland
Left sided colitis
1.7
6.1
97
564
NA7BT
NOMESCO Finland
Injection to spinal facet joint with radiological guidance
3.3
6.1
22
67
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
2.6
6.1
33
127
S00.0
ICD-10 Finland
Superficial injury of scalp
1.8
6.1
90
513
L04AK01
ATC
leflunomide; oral
2.7
6.1
30
110
M54.1
ICD-10 Finland
Radiculopathy
1.6
6.1
151
984
S94
ICPC
Ingrowing nail
1.9
6.1
67
348
D06BB04
ATC
podophyllotoxin; topical
1.5
6.1
168
1121
SPE90
NOMESCO Finland
Other partial denture
1.8
6.1
78
426
ZX120
NOMESCO Finland
Intravenous
1.3
6.1
342
2592
T79.3
ICD-10 Finland
Post-traumatic wound infection, not elsewhere classified
2.0
6.1
59
293
348
Kela drug reimbursment
Roflumilast
4.1
6.1
16
39
S04
ICPC
Lump/swelling localized
1.3
6.1
424
3314
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.4
6.1
262
1904
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.3
6.1
473
3751
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.4
6.1
294
2178
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
2.9
6.0
27
94
J05AB11
ATC
valaciclovir; oral
1.3
6.0
535
4313
WX419
NOMESCO Finland
Other general anesthesy
2.5
6.0
36
146
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.3
6.0
362
2772

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Dermatitis, unspecified
L30.9 [45572271]
2.3e+00
4.1e+00
5.7e+00
—
5.0e+00
3.8e+00
2.3e+00
cases:7.14%
controls:0.77%
cases:15.02%
controls:0.30%
cases:9.73%
controls:0.03%
—
—
cases:4.55%
controls:0.03%
cases:12.42%
controls:0.32%
cases:11.98%
controls:1.41%
373
403
4848
51769
784
155
4437
52017
508
18
4713
52154
—
237
16
4976
52059
631
162
4448
50723
551
645
4047
45172
combinations of corticosteroids
D07XB30 [21602188]
1.4e+00
2.8e+00
3.5e+00
6.6e+00
3.9e+00
2.5e+00
1.7e+00
cases:28.31%
controls:8.64%
cases:33.35%
controls:2.81%
cases:10.76%
controls:0.35%
cases:12.81%
controls:0.02%
cases:14.60%
controls:0.35%
cases:27.07%
controls:2.88%
cases:34.19%
controls:8.85%
1478
4506
3743
47666
1741
1468
3480
50704
562
184
4659
51988
669
10
4552
52162
761
181
4452
51894
1375
1465
3704
49420
1572
4056
3026
41761
combinations of corticosteroids
D07AB30 [21602118]
1.4e+00
2.8e+00
3.5e+00
6.6e+00
3.9e+00
2.5e+00
1.7e+00
cases:28.31%
controls:8.64%
cases:33.35%
controls:2.81%
cases:10.76%
controls:0.35%
cases:12.81%
controls:0.02%
cases:14.60%
controls:0.35%
cases:27.07%
controls:2.88%
cases:34.19%
controls:8.85%
1478
4506
3743
47666
1741
1468
3480
50704
562
184
4659
51988
669
10
4552
52162
761
181
4452
51894
1375
1465
3704
49420
1572
4056
3026
41761
hydrocortisone; local oral
A01AC03 [21600036]
1.9e+00
3.5e+00
4.6e+00
1.0e+50
6.0e+00
3.4e+00
2.4e+00
cases:4.90%
controls:0.80%
cases:7.28%
controls:0.23%
cases:2.53%
controls:0.03%
cases:3.14%
controls:0.00%
cases:4.32%
controls:0.01%
cases:6.34%
controls:0.24%
cases:8.42%
controls:0.85%
256
418
4965
51754
380
122
4841
52050
132
14
5089
52158
164
0
5057
52172
225
6
4988
52069
322
120
4757
50765
387
389
4211
45428
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
1.5e+00
2.9e+00
4.3e+00
—
5.3e+00
4.5e+00
2.4e+00
cases:16.63%
controls:4.24%
cases:23.81%
controls:1.66%
cases:15.25%
controls:0.24%
—
—
cases:36.31%
controls:0.29%
cases:59.99%
controls:1.68%
cases:34.04%
controls:4.56%
868
2210
4353
49962
1243
864
3978
51308
796
125
4425
52047
—
1893
152
3320
51923
3047
855
2032
50030
1565
2090
3033
43727
Infective dermatitis
L30.3 [45577034]
2.6e+00
3.7e+00
—
1.0e+50
—
8.3e+00
5.7e+00
cases:0.57%
controls:0.04%
cases:1.26%
controls:0.03%
—
—
cases:99.27%
controls:0.00%
—
—
cases:43.34%
controls:0.02%
cases:17.38%
controls:0.07%
30
22
5191
52150
66
17
5155
52155
—
5183
0
38
52172
—
2201
10
2878
50875
799
33
3799
45784
other antifungals for topical use - combinations; ointment
D01AE20 [21601959]
1.8e+00
3.3e+00
4.3e+00
—
5.2e+00
3.2e+00
2.2e+00
cases:7.95%
controls:1.42%
cases:10.13%
controls:0.40%
cases:3.72%
controls:0.05%
—
—
cases:6.22%
controls:0.04%
cases:8.94%
controls:0.41%
cases:11.53%
controls:1.41%
415
739
4806
51433
529
208
4692
51964
194
26
5027
52146
—
324
20
4889
52055
454
208
4625
50677
530
645
4068
45172
chlorhexidine
S03AA04 [21605193]
1.8e+00
3.3e+00
4.3e+00
—
5.2e+00
3.2e+00
2.2e+00
cases:7.95%
controls:1.42%
cases:10.13%
controls:0.40%
cases:3.72%
controls:0.05%
—
—
cases:6.22%
controls:0.04%
cases:8.94%
controls:0.41%
cases:11.53%
controls:1.41%
415
739
4806
51433
529
208
4692
51964
194
26
5027
52146
—
324
20
4889
52055
454
208
4625
50677
530
645
4068
45172
chlorhexidine, combinations
D08AC52 [21602208]
1.8e+00
3.3e+00
4.3e+00
—
5.2e+00
3.2e+00
2.2e+00
cases:7.95%
controls:1.42%
cases:10.13%
controls:0.40%
cases:3.72%
controls:0.05%
—
—
cases:6.22%
controls:0.04%
cases:8.94%
controls:0.41%
cases:11.53%
controls:1.41%
415
739
4806
51433
529
208
4692
51964
194
26
5027
52146
—
324
20
4889
52055
454
208
4625
50677
530
645
4068
45172
chlorhexidine
D09AA12 [21602275]
1.8e+00
3.3e+00
4.3e+00
—
5.2e+00
3.2e+00
2.2e+00
cases:7.95%
controls:1.42%
cases:10.13%
controls:0.40%
cases:3.72%
controls:0.05%
—
—
cases:6.22%
controls:0.04%
cases:8.94%
controls:0.41%
cases:11.53%
controls:1.41%
415
739
4806
51433
529
208
4692
51964
194
26
5027
52146
—
324
20
4889
52055
454
208
4625
50677
530
645
4068
45172
chlorhexidine
S02AA09 [21605155]
1.8e+00
3.3e+00
4.3e+00
—
5.2e+00
3.2e+00
2.2e+00
cases:7.95%
controls:1.42%
cases:10.13%
controls:0.40%
cases:3.72%
controls:0.05%
—
—
cases:6.22%
controls:0.04%
cases:8.94%
controls:0.41%
cases:11.53%
controls:1.41%
415
739
4806
51433
529
208
4692
51964
194
26
5027
52146
—
324
20
4889
52055
454
208
4625
50677
530
645
4068
45172
hydrocortisone and antiseptics
D07BA04 [21602146]
1.8e+00
3.3e+00
4.3e+00
—
5.2e+00
3.2e+00
2.2e+00
cases:7.95%
controls:1.42%
cases:10.13%
controls:0.40%
cases:3.72%
controls:0.05%
—
—
cases:6.22%
controls:0.04%
cases:8.94%
controls:0.41%
cases:11.53%
controls:1.41%
415
740
4806
51432
529
208
4692
51964
194
26
5027
52146
—
324
20
4889
52055
454
210
4625
50675
530
646
4068
45171
hydrocortisone
D07XA01 [21602180]
1.8e+00
3.3e+00
4.3e+00
—
5.2e+00
3.2e+00
2.2e+00
cases:7.95%
controls:1.42%
cases:10.13%
controls:0.40%
cases:3.72%
controls:0.05%
—
—
cases:6.22%
controls:0.04%
cases:8.94%
controls:0.41%
cases:11.53%
controls:1.41%
415
740
4806
51432
529
208
4692
51964
194
26
5027
52146
—
324
20
4889
52055
454
210
4625
50675
530
646
4068
45171
triamcinolone and antiseptics
D07BB03 [21602150]
1.8e+00
3.3e+00
4.3e+00
—
5.2e+00
3.2e+00
2.2e+00
cases:8.03%
controls:1.49%
cases:10.17%
controls:0.41%
cases:3.72%
controls:0.05%
—
—
cases:6.22%
controls:0.04%
cases:8.96%
controls:0.42%
cases:11.59%
controls:1.45%
419
775
4802
51397
531
216
4690
51956
194
27
5027
52145
—
324
20
4889
52055
455
213
4624
50672
533
663
4065
45154
desonide
D07AB08 [21602112]
1.7e+00
3.0e+00
3.8e+00
—
5.3e+00
3.0e+00
2.3e+00
cases:4.39%
controls:0.81%
cases:5.17%
controls:0.26%
cases:1.49%
controls:0.03%
—
—
cases:3.22%
controls:0.02%
cases:5.91%
controls:0.30%
cases:7.48%
controls:0.82%
229
421
4992
51751
270
137
4951
52035
78
18
5143
52154
—
168
9
5045
52066
300
152
4779
50733
344
377
4254
45440
clobetasol
D07AD01 [21602141]
1.7e+00
2.9e+00
3.8e+00
—
4.3e+00
3.2e+00
2.4e+00
cases:7.66%
controls:1.43%
cases:9.54%
controls:0.59%
cases:2.34%
controls:0.06%
—
—
cases:5.01%
controls:0.07%
cases:12.29%
controls:0.57%
cases:15.46%
controls:1.62%
400
748
4821
51424
498
308
4723
51864
122
29
5099
52143
—
261
38
4952
52037
624
292
4455
50593
711
740
3887
45077
hydrocortisone; oral, parenteral
H02AB09 [21602737]
1.7e+00
3.0e+00
3.7e+00
1.0e+50
4.4e+00
2.9e+00
2.2e+00
cases:5.23%
controls:1.00%
cases:7.60%
controls:0.39%
cases:2.60%
controls:0.07%
cases:3.16%
controls:0.00%
cases:4.39%
controls:0.05%
cases:6.69%
controls:0.38%
cases:8.90%
controls:1.08%
273
522
4948
51650
397
203
4824
51969
136
36
5085
52136
165
0
5056
52172
229
28
4984
52047
340
195
4739
50690
409
495
4189
45322
betamethasone
A07EA04 [21600656]
1.6e+00
3.0e+00
3.5e+00
—
4.6e+00
2.9e+00
2.1e+00
cases:19.04%
controls:4.60%
cases:24.90%
controls:1.67%
cases:6.42%
controls:0.22%
—
—
cases:14.14%
controls:0.17%
cases:24.49%
controls:1.74%
cases:29.82%
controls:5.03%
994
2400
4227
49772
1300
873
3921
51299
335
113
4886
52059
—
737
90
4476
51985
1244
884
3835
50001
1371
2303
3227
43514
betamethasone
C05AA05 [21601610]
1.6e+00
3.0e+00
3.5e+00
—
4.6e+00
2.9e+00
2.1e+00
cases:19.04%
controls:4.60%
cases:24.90%
controls:1.67%
cases:6.42%
controls:0.22%
—
—
cases:14.14%
controls:0.17%
cases:24.49%
controls:1.74%
cases:29.82%
controls:5.03%
994
2400
4227
49772
1300
873
3921
51299
335
113
4886
52059
—
737
90
4476
51985
1244
884
3835
50001
1371
2303
3227
43514
betamethasone
S02BA07 [21605169]
1.6e+00
3.0e+00
3.5e+00
—
4.6e+00
2.9e+00
2.1e+00
cases:19.04%
controls:4.60%
cases:24.90%
controls:1.67%
cases:6.42%
controls:0.22%
—
—
cases:14.14%
controls:0.17%
cases:24.49%
controls:1.74%
cases:29.82%
controls:5.03%
994
2400
4227
49772
1300
873
3921
51299
335
113
4886
52059
—
737
90
4476
51985
1244
884
3835
50001
1371
2303
3227
43514
betamethasone
D07AC01 [21602120]
1.6e+00
3.0e+00
3.5e+00
—
4.6e+00
2.9e+00
2.1e+00
cases:19.04%
controls:4.60%
cases:24.90%
controls:1.67%
cases:6.42%
controls:0.22%
—
—
cases:14.14%
controls:0.17%
cases:24.49%
controls:1.74%
cases:29.82%
controls:5.03%
994
2400
4227
49772
1300
873
3921
51299
335
113
4886
52059
—
737
90
4476
51985
1244
884
3835
50001
1371
2303
3227
43514
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
1.4e+00
3.0e+00
3.9e+00
1.0e+50
3.8e+00
3.2e+00
2.1e+00
cases:2.20%
controls:0.56%
cases:3.14%
controls:0.16%
cases:1.00%
controls:0.02%
cases:3.93%
controls:0.00%
cases:0.88%
controls:0.02%
cases:3.60%
controls:0.15%
cases:4.15%
controls:0.52%
115
290
5106
51882
164
82
5057
52090
52
11
5169
52161
205
0
5016
52172
46
10
5167
52065
183
78
4896
50807
191
239
4407
45578
hydrocortisone and antiinfectives
S01CA03 [21603654]
1.6e+00
2.9e+00
4.0e+00
—
4.3e+00
2.6e+00
1.9e+00
cases:3.77%
controls:0.76%
cases:3.33%
controls:0.20%
cases:1.28%
controls:0.02%
—
—
cases:2.00%
controls:0.03%
cases:3.07%
controls:0.22%
cases:4.35%
controls:0.70%
197
399
5024
51773
174
103
5047
52069
67
13
5154
52159
—
104
14
5109
52061
156
114
4923
50771
200
320
4398
45497
Hypersensitivity skin testing
268377001 [4147813]
1.6e+00
3.3e+00
5.5e+00
1.0e+50
—
4.5e+00
2.3e+00
cases:2.39%
controls:0.47%
cases:2.95%
controls:0.11%
cases:3.24%
controls:0.01%
cases:4.50%
controls:0.00%
—
—
cases:8.47%
controls:0.10%
cases:3.61%
controls:0.38%
125
245
5096
51927
154
57
5067
52115
169
7
5052
52165
235
0
4986
52172
—
430
52
4649
50833
166
175
4432
45642
Erysipelas
A46 [45561706]
1.3e+00
2.1e+00
3.1e+00
4.5e+00
2.9e+00
1.8e+00
1.3e+00
cases:3.96%
controls:1.15%
cases:3.39%
controls:0.44%
cases:1.36%
controls:0.06%
cases:0.88%
controls:0.01%
cases:0.88%
controls:0.05%
cases:3.11%
controls:0.51%
cases:5.98%
controls:1.75%
207
602
5014
51570
177
230
5044
51942
71
32
5150
52140
46
5
5175
52167
46
26
5167
52049
158
258
4921
50627
275
803
4323
45014
mometasone
D07AC13 [21602132]
1.7e+00
3.0e+00
3.4e+00
—
4.0e+00
2.8e+00
2.1e+00
cases:15.00%
controls:3.05%
cases:16.26%
controls:0.96%
cases:3.47%
controls:0.12%
—
—
cases:5.41%
controls:0.11%
cases:13.66%
controls:0.97%
cases:18.25%
controls:2.79%
783
1593
4438
50579
849
500
4372
51672
181
62
5040
52110
—
282
57
4931
52018
694
496
4385
50389
839
1278
3759
44539
hydrocortisone
S02BA01 [21605166]
1.5e+00
3.0e+00
3.9e+00
—
4.3e+00
2.5e+00
1.6e+00
cases:17.66%
controls:4.58%
cases:21.39%
controls:1.38%
cases:6.97%
controls:0.15%
—
—
cases:8.98%
controls:0.13%
cases:14.51%
controls:1.32%
cases:20.03%
controls:4.78%
922
2390
4299
49782
1117
720
4104
51452
364
78
4857
52094
—
468
67
4745
52008
737
671
4342
50214
921
2189
3677
43628
hydrocortisone buteprate
D07AB11 [21602115]
1.5e+00
2.9e+00
3.9e+00
—
4.3e+00
2.5e+00
1.6e+00
cases:19.17%
controls:5.21%
cases:23.14%
controls:1.58%
cases:7.55%
controls:0.16%
—
—
cases:10.05%
controls:0.16%
cases:16.28%
controls:1.53%
cases:22.40%
controls:5.41%
1001
2718
4220
49454
1208
826
4013
51346
394
86
4827
52086
—
524
81
4689
51994
827
777
4252
50108
1030
2480
3568
43337
hydrocortisone
D07AA02 [21602102]
1.5e+00
2.9e+00
3.9e+00
—
4.3e+00
2.5e+00
1.6e+00
cases:19.17%
controls:5.21%
cases:23.14%
controls:1.58%
cases:7.55%
controls:0.16%
—
—
cases:10.05%
controls:0.16%
cases:16.28%
controls:1.53%
cases:22.40%
controls:5.41%
1001
2718
4220
49454
1208
826
4013
51346
394
86
4827
52086
—
524
81
4689
51994
827
777
4252
50108
1030
2480
3568
43337
hydrocortisone aceponate
D07AC16 [21602135]
1.5e+00
2.9e+00
3.9e+00
—
4.3e+00
2.5e+00
1.6e+00
cases:19.17%
controls:5.21%
cases:23.14%
controls:1.58%
cases:7.55%
controls:0.16%
—
—
cases:10.05%
controls:0.16%
cases:16.28%
controls:1.53%
cases:22.40%
controls:5.41%
1001
2718
4220
49454
1208
826
4013
51346
394
86
4827
52086
—
524
81
4689
51994
827
777
4252
50108
1030
2480
3568
43337
hydrocortisone butyrate
D07AB02 [21602106]
1.5e+00
2.9e+00
3.9e+00
—
4.3e+00
2.5e+00
1.6e+00
cases:19.17%
controls:5.21%
cases:23.14%
controls:1.58%
cases:7.55%
controls:0.16%
—
—
cases:10.05%
controls:0.16%
cases:16.28%
controls:1.53%
cases:22.40%
controls:5.41%
1001
2718
4220
49454
1208
826
4013
51346
394
86
4827
52086
—
524
81
4689
51994
827
777
4252
50108
1030
2480
3568
43337
hydrocortisone
A07EA02 [21600654]
1.4e+00
2.9e+00
3.9e+00
—
4.2e+00
2.5e+00
1.6e+00
cases:19.25%
controls:5.34%
cases:23.21%
controls:1.62%
cases:7.57%
controls:0.17%
—
—
cases:10.05%
controls:0.16%
cases:16.30%
controls:1.56%
cases:22.42%
controls:5.47%
1005
2788
4216
49384
1212
847
4009
51325
395
90
4826
52082
—
524
84
4689
51991
828
795
4251
50090
1031
2504
3567
43313
hydrocortisone
C05AA01 [21601608]
1.4e+00
2.9e+00
3.9e+00
—
4.2e+00
2.5e+00
1.6e+00
cases:19.25%
controls:5.34%
cases:23.21%
controls:1.62%
cases:7.57%
controls:0.17%
—
—
cases:10.05%
controls:0.16%
cases:16.30%
controls:1.56%
cases:22.42%
controls:5.47%
1005
2788
4216
49384
1212
847
4009
51325
395
90
4826
52082
—
524
84
4689
51991
828
795
4251
50090
1031
2504
3567
43313
Nummular dermatitis
L30.0 [45562535]
2.9e+00
4.7e+00
—
1.0e+50
—
5.1e+00
3.5e+00
cases:1.69%
controls:0.10%
cases:3.96%
controls:0.04%
—
—
cases:1.46%
controls:0.00%
—
—
cases:5.79%
controls:0.04%
cases:4.44%
controls:0.14%
88
51
5133
52121
207
20
5014
52152
—
76
0
5145
52172
—
294
20
4785
50865
204
65
4394
45752
zinc preparations; ointment
C05AX04 [21601632]
3.0e+00
4.0e+00
—
1.0e+50
—
5.0e+00
3.8e+00
cases:1.03%
controls:0.05%
cases:1.44%
controls:0.03%
—
—
cases:1.34%
controls:0.00%
—
—
cases:2.91%
controls:0.02%
cases:2.81%
controls:0.07%
54
28
5167
52144
75
14
5146
52158
—
70
0
5151
52172
—
148
10
4931
50875
129
30
4469
45787
zinc bandage without supplements
D09AB01 [21602278]
3.0e+00
4.0e+00
—
1.0e+50
—
5.0e+00
3.8e+00
cases:1.03%
controls:0.05%
cases:1.44%
controls:0.03%
—
—
cases:1.34%
controls:0.00%
—
—
cases:2.91%
controls:0.02%
cases:2.81%
controls:0.07%
54
28
5167
52144
75
14
5146
52158
—
70
0
5151
52172
—
148
10
4931
50875
129
30
4469
45787
hydroxyzine; oral, parenteral
N05BB01 [21604590]
1.4e+00
2.8e+00
3.8e+00
1.0e+50
3.4e+00
2.5e+00
1.9e+00
cases:4.25%
controls:1.13%
cases:6.99%
controls:0.43%
cases:3.26%
controls:0.08%
cases:0.90%
controls:0.00%
cases:2.19%
controls:0.08%
cases:5.00%
controls:0.41%
cases:7.11%
controls:1.15%
222
590
4999
51582
365
226
4856
51946
170
41
5051
52131
47
0
5174
52172
114
40
5099
52035
254
211
4825
50674
327
526
4271
45291
cefalexin; oral
J01DB01 [21602870]
7.7e-01
1.7e+00
2.8e+00
6.0e+00
2.4e+00
1.1e+00
8.6e-01
cases:43.31%
controls:26.07%
cases:33.77%
controls:8.16%
cases:12.49%
controls:0.83%
cases:8.96%
controls:0.02%
cases:8.96%
controls:0.93%
cases:21.74%
controls:8.19%
cases:45.95%
controls:26.49%
2261
13603
2960
38569
1763
4257
3458
47915
652
433
4569
51739
468
13
4753
52159
467
483
4746
51592
1104
4165
3975
46720
2113
12137
2485
33680
carbamide
D02AE01 [21601975]
1.8e+00
2.7e+00
—
—
4.6e+00
3.4e+00
2.8e+00
cases:1.36%
controls:0.23%
cases:1.57%
controls:0.11%
—
—
—
—
cases:0.96%
controls:0.01%
cases:2.40%
controls:0.08%
cases:3.37%
controls:0.21%
71
121
5150
52051
82
58
5139
52114
—
—
50
5
5163
52070
122
40
4957
50845
155
94
4443
45723
antibiotics in combination with corticosteroids
D01AA20 [21601918]
1.4e+00
2.6e+00
3.2e+00
—
3.8e+00
2.4e+00
1.6e+00
cases:4.65%
controls:1.14%
cases:3.62%
controls:0.29%
cases:1.30%
controls:0.05%
—
—
cases:2.01%
controls:0.05%
cases:3.37%
controls:0.31%
cases:4.87%
controls:1.03%
243
594
4978
51578
189
152
5032
52020
68
28
5153
52144
—
105
24
5108
52051
171
158
4908
50727
224
472
4374
45345
acitretin; oral
D05BB02 [21602051]
1.9e+00
2.7e+00
—
—
3.3e+00
3.7e+00
3.0e+00
cases:0.71%
controls:0.11%
cases:0.79%
controls:0.05%
—
—
—
—
cases:0.54%
controls:0.02%
cases:2.01%
controls:0.05%
cases:2.15%
controls:0.11%
37
55
5184
52117
41
27
5180
52145
—
—
28
10
5185
52065
102
26
4977
50859
99
49
4499
45768
Psoriasis vulgaris
L40.0 [45543370]
1.4e+00
2.0e+00
2.9e+00
1.0e+50
3.2e+00
2.9e+00
2.2e+00
cases:1.24%
controls:0.31%
cases:1.34%
controls:0.18%
cases:0.63%
controls:0.03%
cases:1.32%
controls:0.00%
cases:1.07%
controls:0.04%
cases:3.03%
controls:0.17%
cases:3.48%
controls:0.38%
65
164
5156
52008
70
96
5151
52076
33
18
5188
52154
69
0
5152
52172
56
23
5157
52052
154
89
4925
50796
160
175
4438
45642
tacrolimus
D11AH01 [21602338]
1.9e+00
2.9e+00
3.7e+00
1.0e+50
—
3.5e+00
2.7e+00
cases:1.65%
controls:0.25%
cases:1.69%
controls:0.10%
cases:0.44%
controls:0.01%
cases:0.38%
controls:0.00%
—
—
cases:3.19%
controls:0.10%
cases:4.68%
controls:0.33%
86
132
5135
52040
88
51
5133
52121
23
6
5198
52166
20
0
5201
52172
—
162
50
4917
50835
215
151
4383
45666
hydrocortisone and antiinfectives
S02CA03 [21605175]
1.3e+00
2.3e+00
3.4e+00
—
3.8e+00
2.2e+00
1.4e+00
cases:4.54%
controls:1.31%
cases:3.70%
controls:0.37%
cases:1.38%
controls:0.05%
—
—
cases:2.01%
controls:0.04%
cases:3.56%
controls:0.40%
cases:5.52%
controls:1.49%
237
685
4984
51487
193
193
5028
51979
72
24
5149
52148
—
105
23
5108
52052
181
203
4898
50682
254
683
4344
45134
hydrocortisone and antiinfectives
S03CA04 [21605208]
1.3e+00
2.3e+00
3.4e+00
—
3.8e+00
2.2e+00
1.4e+00
cases:4.54%
controls:1.31%
cases:3.70%
controls:0.37%
cases:1.38%
controls:0.05%
—
—
cases:2.01%
controls:0.04%
cases:3.56%
controls:0.40%
cases:5.52%
controls:1.49%
237
685
4984
51487
193
193
5028
51979
72
24
5149
52148
—
105
23
5108
52052
181
203
4898
50682
254
683
4344
45134
Tinea pedis
B35.3 [45581158]
1.2e+00
2.4e+00
3.3e+00
1.0e+50
3.7e+00
2.5e+00
9.7e-01
cases:0.73%
controls:0.23%
cases:0.96%
controls:0.09%
cases:0.27%
controls:0.01%
cases:0.86%
controls:0.00%
cases:0.38%
controls:0.01%
cases:1.02%
controls:0.08%
cases:0.91%
controls:0.35%
38
119
5183
52053
50
47
5171
52125
14
5
5207
52167
45
0
5176
52172
20
5
5193
52070
52
42
5027
50843
42
159
4556
45658
Local dermatologic skincare
TQW80 [2001310149]
2.3e+00
3.4e+00
1.0e+50
1.0e+50
—
4.9e+00
3.4e+00
cases:0.79%
controls:0.08%
cases:1.09%
controls:0.04%
cases:0.33%
controls:0.00%
cases:3.05%
controls:0.00%
—
—
cases:2.91%
controls:0.02%
cases:3.00%
controls:0.10%
41
40
5180
52132
57
20
5164
52152
17
0
5204
52172
159
0
5062
52172
—
148
11
4931
50874
138
48
4460
45769
Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
71368-5 [42870308]
2.9e+00
3.7e+00
—
1.0e+50
1.0e+50
3.9e+00
3.4e+00
cases:0.17%
controls:0.01%
cases:0.40%
controls:0.01%
—
—
cases:0.13%
controls:0.00%
cases:0.63%
controls:0.00%
cases:0.57%
controls:0.01%
cases:0.52%
controls:0.02%
9
5
5212
52167
21
5
5200
52167
—
7
0
5214
52172
33
0
5180
52075
29
6
5050
50879
24
8
4574
45809
prednisolone; oral, parenteral
H02AB06 [21602734]
9.0e-01
1.5e+00
1.7e+00
5.2e+00
2.0e+00
1.4e+00
1.1e+00
cases:17.12%
controls:7.72%
cases:14.92%
controls:3.62%
cases:3.62%
controls:0.66%
cases:3.83%
controls:0.02%
cases:4.62%
controls:0.66%
cases:12.74%
controls:3.52%
cases:22.55%
controls:9.03%
894
4027
4327
48145
779
1891
4442
50281
189
345
5032
51827
200
11
5021
52161
241
342
4972
51733
647
1790
4432
49095
1037
4139
3561
41678
prednisolone
A07EA01 [21600653]
8.9e-01
1.5e+00
1.7e+00
5.2e+00
2.0e+00
1.4e+00
1.1e+00
cases:17.12%
controls:7.79%
cases:14.94%
controls:3.64%
cases:3.62%
controls:0.66%
cases:3.83%
controls:0.02%
cases:4.62%
controls:0.66%
cases:12.78%
controls:3.53%
cases:22.62%
controls:9.09%
894
4062
4327
48110
780
1898
4441
50274
189
345
5032
51827
200
11
5021
52161
241
342
4972
51733
649
1798
4430
49087
1040
4166
3558
41651
Prick test
37968009 [4242723]
1.1e+00
2.9e+00
4.2e+00
1.0e+50
—
3.6e+00
1.9e+00
cases:1.05%
controls:0.35%
cases:1.23%
controls:0.07%
cases:0.92%
controls:0.01%
cases:1.32%
controls:0.00%
—
—
cases:2.82%
controls:0.08%
cases:1.46%
controls:0.23%
55
181
5166
51991
64
34
5157
52138
48
7
5173
52165
69
0
5152
52172
—
143
40
4936
50845
67
105
4531
45712
Basement membrane Ab [Titer] in Serum by Immunofluorescence
57737-9 [40760847]
2.9e+00
3.7e+00
—
1.0e+50
1.0e+50
3.8e+00
3.3e+00
cases:0.17%
controls:0.01%
cases:0.40%
controls:0.01%
—
—
cases:0.15%
controls:0.00%
cases:0.65%
controls:0.00%
cases:0.55%
controls:0.01%
cases:0.52%
controls:0.02%
9
5
5212
52167
21
5
5200
52167
—
8
0
5213
52172
34
0
5179
52075
28
6
5051
50879
24
9
4574
45808
imidazoles/triazoles in combination with corticosteroids
D01AC20 [21601936]
1.3e+00
2.3e+00
2.9e+00
—
3.6e+00
2.1e+00
1.4e+00
cases:10.04%
controls:2.94%
cases:8.71%
controls:0.96%
cases:2.26%
controls:0.12%
—
—
cases:4.16%
controls:0.12%
cases:8.21%
controls:1.04%
cases:11.46%
controls:3.08%
524
1536
4697
50636
455
499
4766
51673
118
65
5103
52107
—
217
61
4996
52014
417
529
4662
50356
527
1412
4071
44405
IgE [Units/volume] in Serum or Plasma
19113-0 [3005322]
7.5e-01
1.7e+00
2.7e+00
1.0e+50
5.0e+00
2.2e+00
1.4e+00
cases:1.23%
controls:0.58%
cases:1.03%
controls:0.19%
cases:0.34%
controls:0.02%
cases:0.36%
controls:0.00%
cases:1.38%
controls:0.01%
cases:1.61%
controls:0.19%
cases:2.59%
controls:0.68%
64
304
5157
51868
54
99
5167
52073
18
12
5203
52160
19
0
5202
52172
72
5
5141
52070
82
97
4997
50788
119
310
4479
45507
Pustulosis palmaris et plantaris
L40.3 [45591634]
2.3e+00
4.3e+00
—
1.0e+50
—
3.9e+00
3.0e+00
cases:0.54%
controls:0.05%
cases:1.15%
controls:0.02%
—
—
cases:0.29%
controls:0.00%
—
—
cases:1.22%
controls:0.03%
cases:1.35%
controls:0.07%
28
27
5193
52145
60
8
5161
52164
—
15
0
5206
52172
—
62
13
5017
50872
62
30
4536
45787
Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
57738-7 [40760848]
2.5e+00
3.6e+00
—
1.0e+50
1.0e+50
4.1e+00
3.3e+00
cases:0.27%
controls:0.02%
cases:0.36%
controls:0.01%
—
—
cases:0.21%
controls:0.00%
cases:0.69%
controls:0.00%
cases:0.85%
controls:0.01%
cases:0.76%
controls:0.03%
14
12
5207
52160
19
5
5202
52167
—
11
0
5210
52172
36
0
5177
52075
43
7
5036
50878
35
13
4563
45804
Other specified dermatitis
L30.8 [45581941]
3.1e+00
4.1e+00
—
—
—
3.9e+00
2.4e+00
cases:0.73%
controls:0.03%
cases:1.05%
controls:0.02%
—
—
—
—
—
—
cases:1.26%
controls:0.03%
cases:1.26%
controls:0.12%
38
18
5183
52154
55
9
5166
52163
—
—
—
64
13
5015
50872
58
53
4540
45764
methylprednisolone aceponate
D07AC14 [21602133]
1.9e+00
3.3e+00
3.0e+00
1.0e+50
—
2.9e+00
2.2e+00
cases:0.92%
controls:0.14%
cases:1.24%
controls:0.05%
cases:0.19%
controls:0.01%
cases:0.15%
controls:0.00%
—
—
cases:0.59%
controls:0.03%
cases:1.37%
controls:0.15%
48
75
5173
52097
65
24
5156
52148
10
5
5211
52167
8
0
5213
52172
—
30
17
5049
50868
63
71
4535
45746
methylprednisolone
D07AA01 [21602101]
1.9e+00
3.3e+00
3.0e+00
1.0e+50
—
2.9e+00
2.2e+00
cases:0.92%
controls:0.14%
cases:1.24%
controls:0.05%
cases:0.19%
controls:0.01%
cases:0.15%
controls:0.00%
—
—
cases:0.59%
controls:0.03%
cases:1.37%
controls:0.15%
48
75
5173
52097
65
24
5156
52148
10
5
5211
52167
8
0
5213
52172
—
30
17
5049
50868
63
71
4535
45746
desloratadine; oral
R06AX27 [21603526]
6.9e-01
1.4e+00
2.0e+00
4.6e+00
2.1e+00
1.3e+00
9.2e-01
cases:6.53%
controls:3.38%
cases:6.30%
controls:1.56%
cases:2.05%
controls:0.27%
cases:1.17%
controls:0.01%
cases:1.69%
controls:0.20%
cases:5.73%
controls:1.70%
cases:9.53%
controls:4.04%
341
1762
4880
50410
329
812
4892
51360
107
143
5114
52029
61
6
5160
52166
88
105
5125
51970
291
867
4788
50018
438
1852
4160
43965
other preparations, combinations; ointment
C05AX03 [21601631]
1.2e+00
2.1e+00
3.0e+00
—
3.4e+00
2.0e+00
1.4e+00
cases:6.32%
controls:2.05%
cases:4.96%
controls:0.63%
cases:1.47%
controls:0.07%
—
—
cases:2.49%
controls:0.08%
cases:4.71%
controls:0.69%
cases:7.13%
controls:1.90%
330
1068
4891
51104
259
330
4962
51842
77
38
5144
52134
—
130
43
5083
52032
239
349
4840
50536
328
869
4270
44948
Patch test
41778007 [4218642]
3.1e+00
—
—
1.0e+50
1.0e+50
5.9e+00
4.0e+00
cases:1.03%
controls:0.05%
—
—
—
—
cases:1.99%
controls:0.00%
cases:1.13%
controls:0.00%
cases:5.45%
controls:0.02%
cases:2.15%
controls:0.04%
54
25
5167
52147
—
—
104
0
5117
52172
59
0
5154
52075
277
8
4802
50877
99
19
4499
45798
Outpatient Visit
OP [9202]
4.9e-01
7.6e-01
1.2e+00
6.1e+00
1.9e+00
1.5e+00
8.3e-01
cases:72.59%
controls:61.98%
cases:61.20%
controls:42.37%
cases:25.63%
controls:9.15%
cases:62.88%
controls:0.37%
cases:39.54%
controls:9.22%
cases:77.73%
controls:42.89%
cases:85.47%
controls:72.03%
3790
32338
1431
19834
3195
22105
2026
30067
1338
4776
3883
47396
3283
195
1938
51977
2061
4803
3152
47272
3948
21823
1131
29062
3930
33000
668
12817
cetirizine; oral
R06AE07 [21603497]
7.4e-01
1.4e+00
1.8e+00
4.4e+00
2.0e+00
1.2e+00
9.6e-01
cases:13.25%
controls:6.78%
cases:11.40%
controls:3.11%
cases:3.14%
controls:0.51%
cases:1.44%
controls:0.02%
cases:3.01%
controls:0.44%
cases:9.75%
controls:3.05%
cases:15.31%
controls:6.46%
692
3535
4529
48637
595
1620
4626
50552
164
267
5057
51905
75
9
5146
52163
157
228
5056
51847
495
1551
4584
49334
704
2961
3894
42856
antibiotics in combination with other drugs
S01AA20 [21603571]
7.1e-01
1.1e+00
2.1e+00
4.1e+00
2.4e+00
1.2e+00
7.3e-01
cases:10.65%
controls:5.53%
cases:5.27%
controls:1.83%
cases:1.61%
controls:0.20%
cases:1.19%
controls:0.02%
cases:2.28%
controls:0.20%
cases:5.22%
controls:1.69%
cases:12.70%
controls:6.53%
556
2887
4665
49285
275
954
4946
51218
84
104
5137
52068
62
10
5159
52162
119
105
5094
51970
265
860
4814
50025
584
2991
4014
42826
Chronic ulcer of skin, not elsewhere classified
L98.4 [45533667]
1.6e+00
2.6e+00
—
1.0e+50
3.3e+00
2.8e+00
2.1e+00
cases:0.44%
controls:0.09%
cases:0.44%
controls:0.03%
—
—
cases:0.48%
controls:0.00%
cases:0.25%
controls:0.01%
cases:0.69%
controls:0.04%
cases:0.83%
controls:0.11%
23
48
5198
52124
23
18
5198
52154
—
25
0
5196
52172
13
5
5200
52070
35
21
5044
50864
38
49
4560
45768
flucloxacillin; oral, parenteral
J01CF05 [21602857]
8.2e-01
1.7e+00
3.2e+00
—
3.9e+00
1.5e+00
1.1e+00
cases:0.61%
controls:0.27%
cases:0.77%
controls:0.14%
cases:0.34%
controls:0.01%
—
—
cases:0.63%
controls:0.01%
cases:0.79%
controls:0.17%
cases:1.67%
controls:0.59%
32
141
5189
52031
40
75
5181
52097
18
7
5203
52165
—
33
7
5180
52068
40
89
5039
50796
77
269
4521
45548
Chronic ulcer skin
S97 [2002001061]
9.3e-01
2.0e+00
2.6e+00
—
2.8e+00
1.9e+00
1.4e+00
cases:0.96%
controls:0.38%
cases:1.23%
controls:0.16%
cases:0.67%
controls:0.05%
—
—
cases:0.71%
controls:0.04%
cases:1.18%
controls:0.18%
cases:2.26%
controls:0.57%
50
198
5171
51974
64
86
5157
52086
35
25
5186
52147
—
37
23
5176
52052
60
93
5019
50792
104
259
4494
45558
betamethasone
S03BA03 [21605203]
1.0e+00
1.9e+00
2.1e+00
1.0e+50
3.0e+00
2.0e+00
1.5e+00
cases:4.39%
controls:1.60%
cases:3.85%
controls:0.61%
cases:0.63%
controls:0.07%
cases:1.30%
controls:0.00%
cases:1.65%
controls:0.08%
cases:4.67%
controls:0.63%
cases:6.66%
controls:1.58%
229
833
4992
51339
201
316
5020
51856
33
39
5188
52133
68
0
5153
52172
86
44
5127
52031
237
323
4842
50562
306
724
4292
45093
Office Visit
OMOP4822458 [581477]
5.5e-01
8.2e-01
1.3e+00
5.2e+00
2.0e+00
9.4e-01
6.8e-01
cases:12.05%
controls:7.35%
cases:5.29%
controls:2.40%
cases:1.05%
controls:0.30%
cases:1.76%
controls:0.01%
cases:2.38%
controls:0.31%
cases:5.67%
controls:2.28%
cases:13.40%
controls:7.24%
629
3834
4592
48338
276
1254
4945
50918
55
158
5166
52014
92
5
5129
52167
124
164
5089
51911
288
1162
4791
49723
616
3318
3982
42499
terbinafine; ointment
D01AE15 [21601954]
9.7e-01
2.1e+00
2.5e+00
1.0e+50
3.6e+00
1.5e+00
8.3e-01
cases:1.61%
controls:0.62%
cases:1.32%
controls:0.16%
cases:0.19%
controls:0.02%
cases:0.57%
controls:0.00%
cases:0.35%
controls:0.01%
cases:0.63%
controls:0.15%
cases:1.44%
controls:0.63%
84
322
5137
51850
69
85
5152
52087
10
8
5211
52164
30
0
5191
52172
18
5
5195
52070
32
74
5047
50811
66
288
4532
45529
Treatment of chronic ulcer or burn
SPAT1148 [2001700249]
8.7e-01
1.9e+00
2.7e+00
—
2.9e+00
1.8e+00
1.1e+00
cases:2.57%
controls:1.09%
cases:2.59%
controls:0.40%
cases:1.34%
controls:0.09%
—
—
cases:1.38%
controls:0.08%
cases:2.46%
controls:0.40%
cases:4.02%
controls:1.41%
134
571
5087
51601
135
207
5086
51965
70
46
5151
52126
—
72
40
5141
52035
125
205
4954
50680
185
645
4413
45172
Major dressing of wound of skin of lower limb
QDB10 [2001309970]
1.0e+00
1.9e+00
2.9e+00
1.0e+50
2.6e+00
1.6e+00
1.2e+00
cases:0.92%
controls:0.33%
cases:0.90%
controls:0.13%
cases:0.38%
controls:0.02%
cases:0.25%
controls:0.00%
cases:0.35%
controls:0.02%
cases:0.69%
controls:0.14%
cases:1.44%
controls:0.45%
48
171
5173
52001
47
69
5174
52103
20
11
5201
52161
13
0
5208
52172
18
13
5195
52062
35
72
5044
50813
66
206
4532
45611
clobetasone
D07AB01 [21602105]
1.5e+00
2.4e+00
—
—
3.3e+00
2.1e+00
1.9e+00
cases:0.77%
controls:0.16%
cases:0.67%
controls:0.06%
—
—
—
—
cases:0.25%
controls:0.01%
cases:0.39%
controls:0.05%
cases:0.85%
controls:0.13%
40
86
5181
52086
35
31
5186
52141
—
—
13
5
5200
52070
20
24
5059
50861
39
60
4559
45757
Guidance concerning treatment of rash and skin
SPAT1156 [2001700257]
9.0e-01
1.8e+00
2.0e+00
2.0e+00
2.0e+00
1.5e+00
1.0e+00
cases:2.55%
controls:1.06%
cases:2.30%
controls:0.40%
cases:0.69%
controls:0.10%
cases:0.11%
controls:0.02%
cases:0.81%
controls:0.11%
cases:1.83%
controls:0.42%
cases:3.94%
controls:1.46%
133
551
5088
51621
120
207
5101
51965
36
51
5185
52121
6
8
5215
52164
42
55
5171
52020
93
216
4986
50669
181
667
4417
45150
UVB narrow spectrum light therapy
WXQ27 [2001310161]
2.9e+00
3.8e+00
1.0e+50
1.0e+50
1.0e+50
—
4.4e+00
cases:0.52%
controls:0.03%
cases:0.69%
controls:0.02%
cases:0.44%
controls:0.00%
cases:0.79%
controls:0.00%
cases:1.98%
controls:0.00%
—
—
cases:2.17%
controls:0.03%
27
15
5194
52157
36
8
5185
52164
23
0
5198
52172
41
0
5180
52172
103
0
5110
52075
—
100
12
4498
45805
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
7.4e-01
1.8e+00
3.2e+00
—
2.5e+00
1.7e+00
1.1e+00
cases:2.41%
controls:1.16%
cases:2.55%
controls:0.41%
cases:1.21%
controls:0.05%
—
—
cases:0.77%
controls:0.07%
cases:2.30%
controls:0.43%
cases:5.07%
controls:1.74%
126
606
5095
51566
133
216
5088
51956
63
26
5158
52146
—
40
34
5173
52041
117
217
4962
50668
233
795
4365
45022
glycerol
A06AX01 [21600597]
1.8e+00
3.1e+00
—
1.0e+50
—
3.4e+00
2.8e+00
cases:0.75%
controls:0.13%
cases:0.80%
controls:0.04%
—
—
cases:0.34%
controls:0.00%
—
—
cases:1.22%
controls:0.04%
cases:1.96%
controls:0.13%
39
66
5182
52106
42
19
5179
52153
—
18
0
5203
52172
—
62
21
5017
50864
90
58
4508
45759
glycerol; rectal
A06AG04 [21600587]
1.8e+00
3.1e+00
—
1.0e+50
—
3.4e+00
2.8e+00
cases:0.75%
controls:0.13%
cases:0.80%
controls:0.04%
—
—
cases:0.34%
controls:0.00%
—
—
cases:1.22%
controls:0.04%
cases:1.96%
controls:0.13%
39
66
5182
52106
42
19
5179
52153
—
18
0
5203
52172
—
62
21
5017
50864
90
58
4508
45759
Dermatographic urticaria
L50.3 [45596376]
1.8e+00
2.9e+00
—
1.0e+50
—
3.6e+00
2.7e+00
cases:0.38%
controls:0.06%
cases:0.36%
controls:0.02%
—
—
cases:0.61%
controls:0.00%
—
—
cases:0.73%
controls:0.02%
cases:0.74%
controls:0.05%
20
32
5201
52140
19
11
5202
52161
—
32
0
5189
52172
—
37
10
5042
50875
34
24
4564
45793
lymecycline; oral, parenteral
J01AA04 [21602802]
7.6e-01
1.7e+00
1.6e+00
—
3.4e+00
2.2e+00
1.2e+00
cases:2.18%
controls:1.03%
cases:1.69%
controls:0.33%
cases:0.21%
controls:0.04%
—
—
cases:1.04%
controls:0.03%
cases:2.70%
controls:0.30%
cases:2.87%
controls:0.87%
114
539
5107
51633
88
170
5133
52002
11
22
5210
52150
—
54
18
5159
52057
137
152
4942
50733
132
397
4466
45420
Other specified follicular disorders
L73.8 [45567366]
2.2e+00
2.9e+00
—
1.0e+50
—
3.4e+00
2.4e+00
cases:0.23%
controls:0.02%
cases:0.17%
controls:0.01%
—
—
cases:0.17%
controls:0.00%
—
—
cases:0.39%
controls:0.01%
cases:0.24%
controls:0.02%
12
13
5209
52159
9
5
5212
52167
—
9
0
5212
52172
—
20
7
5059
50878
11
10
4587
45807
dapsone; oral
J04BA02 [21603124]
2.3e+00
2.8e+00
—
—
—
3.2e+00
2.6e+00
cases:0.23%
controls:0.02%
cases:0.21%
controls:0.01%
—
—
—
—
—
—
cases:0.24%
controls:0.01%
cases:0.33%
controls:0.02%
12
12
5209
52160
11
7
5210
52165
—
—
—
12
5
5067
50880
15
11
4583
45806
carbamide, combinations
D02AE51 [21601976]
1.5e+00
2.1e+00
—
—
2.8e+00
2.5e+00
2.0e+00
cases:0.56%
controls:0.12%
cases:0.34%
controls:0.04%
—
—
—
—
cases:0.19%
controls:0.01%
cases:0.43%
controls:0.04%
cases:0.87%
controls:0.12%
29
65
5192
52107
18
23
5203
52149
—
—
10
6
5203
52069
22
19
5057
50866
40
53
4558
45764
Pharmacy visit
OMOP4822462 [581458]
7.9e-01
1.6e+00
1.1e+00
3.4e+00
1.4e+00
1.4e+00
1.2e+00
cases:96.38%
controls:92.38%
cases:95.35%
controls:80.24%
cases:66.27%
controls:40.53%
cases:37.96%
controls:2.06%
cases:73.20%
controls:40.83%
cases:94.43%
controls:81.13%
cases:98.35%
controls:94.55%
5032
48194
189
3978
4978
41864
243
10308
3460
21145
1761
31027
1982
1077
3239
51095
3816
21260
1397
30815
4796
41284
283
9601
4522
43319
76
2498
miconazole
D01AC02 [21601921]
9.4e-01
1.7e+00
2.9e+00
1.0e+50
2.9e+00
1.4e+00
8.7e-01
cases:2.18%
controls:0.86%
cases:1.09%
controls:0.20%
cases:0.17%
controls:0.01%
cases:0.15%
controls:0.00%
cases:0.35%
controls:0.02%
cases:0.75%
controls:0.19%
cases:1.26%
controls:0.53%
114
451
5107
51721
57
104
5164
52068
9
5
5212
52167
8
0
5213
52172
18
10
5195
52065
38
95
5041
50790
58
243
4540
45574
Rash and other nonspecific skin eruption
R21 [45553721]
1.1e+00
2.9e+00
3.5e+00
1.0e+50
—
2.3e+00
7.6e-01
cases:0.65%
controls:0.21%
cases:1.07%
controls:0.06%
cases:0.46%
controls:0.01%
cases:0.11%
controls:0.00%
—
—
cases:0.49%
controls:0.05%
cases:0.70%
controls:0.33%
34
109
5187
52063
56
30
5165
52142
24
7
5197
52165
6
0
5215
52172
—
25
26
5054
50859
32
149
4566
45668
Pruritus, unspecified
L29.9 [45548195]
2.0e+00
3.4e+00
—
—
—
3.0e+00
2.1e+00
cases:0.46%
controls:0.06%
cases:0.57%
controls:0.02%
—
—
—
—
—
—
cases:0.69%
controls:0.03%
cases:0.67%
controls:0.08%
24
31
5197
52141
30
10
5191
52162
—
—
—
35
17
5044
50868
31
37
4567
45780
Scabies
B86 [45561769]
1.6e+00
2.8e+00
—
1.0e+50
2.6e+00
2.6e+00
1.0e+00
cases:0.34%
controls:0.07%
cases:0.79%
controls:0.05%
—
—
cases:0.38%
controls:0.00%
cases:0.13%
controls:0.01%
cases:0.53%
controls:0.04%
cases:0.41%
controls:0.15%
18
38
5203
52134
41
25
5180
52147
—
20
0
5201
52172
7
5
5206
52070
27
21
5052
50864
19
68
4579
45749
Skin infection other
S76 [2002001040]
1.2e+00
2.2e+00
2.1e+00
—
2.5e+00
1.2e+00
1.4e+00
cases:0.92%
controls:0.29%
cases:0.82%
controls:0.09%
cases:0.19%
controls:0.02%
—
—
cases:0.27%
controls:0.02%
cases:0.45%
controls:0.14%
cases:1.74%
controls:0.42%
48
152
5173
52020
43
49
5178
52123
10
12
5211
52160
—
14
11
5199
52064
23
73
5056
50812
80
194
4518
45623
clindamycin; oral, parenteral
J01FF01 [21602985]
8.1e-01
1.8e+00
2.9e+00
—
2.7e+00
1.4e+00
9.8e-01
cases:6.26%
controls:2.88%
cases:4.23%
controls:0.75%
cases:1.44%
controls:0.08%
—
—
cases:1.50%
controls:0.10%
cases:3.15%
controls:0.80%
cases:7.68%
controls:3.04%
327
1501
4894
50671
221
391
5000
51781
75
42
5146
52130
—
78
53
5135
52022
160
406
4919
50479
353
1393
4245
44424
cefadroxil; oral
J01DB05 [21602874]
6.7e-01
2.1e+00
2.9e+00
—
2.7e+00
1.2e+00
8.2e-01
cases:3.93%
controls:2.05%
cases:2.85%
controls:0.36%
cases:0.61%
controls:0.03%
—
—
cases:0.46%
controls:0.03%
cases:1.10%
controls:0.32%
cases:2.07%
controls:0.92%
205
1067
5016
51105
149
190
5072
51982
32
17
5189
52155
—
24
16
5189
52059
56
164
5023
50721
95
422
4503
45395
ciclosporin; oral, parenteral
L04AD01 [21603924]
1.4e+00
1.7e+00
1.5e+00
—
1.6e+00
2.1e+00
2.2e+00
cases:0.90%
controls:0.22%
cases:0.79%
controls:0.14%
cases:0.25%
controls:0.06%
—
—
cases:0.27%
controls:0.05%
cases:1.26%
controls:0.16%
cases:1.87%
controls:0.22%
47
114
5174
52058
41
75
5180
52097
13
30
5208
52142
—
14
28
5199
52047
64
83
5015
50802
86
99
4512
45718
Emergency Room Visit
ER [9203]
5.2e-01
7.1e-01
1.5e+00
5.2e+00
1.0e+00
8.0e-01
5.7e-01
cases:40.01%
controls:28.41%
cases:19.15%
controls:10.41%
cases:5.59%
controls:1.28%
cases:9.86%
controls:0.06%
cases:3.43%
controls:1.23%
cases:20.48%
controls:10.34%
cases:42.93%
controls:29.93%
2089
14822
3132
37350
1000
5433
4221
46739
292
668
4929
51504
515
30
4706
52142
179
642
5034
51433
1040
5260
4039
45625
1974
13712
2624
32105
levocetirizine; oral
R06AE09 [21603498]
1.0e+00
1.8e+00
2.2e+00
—
2.3e+00
1.6e+00
1.3e+00
cases:4.02%
controls:1.47%
cases:3.83%
controls:0.66%
cases:1.07%
controls:0.12%
—
—
cases:0.86%
controls:0.09%
cases:3.15%
controls:0.66%
cases:5.05%
controls:1.49%
210
768
5011
51404
200
346
5021
51826
56
60
5165
52112
—
45
45
5168
52030
160
338
4919
50547
232
681
4366
45136
Inpatient Hospital
21 [8717]
5.0e-01
6.6e-01
1.1e+00
5.3e+00
1.4e+00
7.6e-01
6.0e-01
cases:41.54%
controls:30.14%
cases:18.41%
controls:10.44%
cases:4.12%
controls:1.45%
cases:8.70%
controls:0.05%
cases:5.20%
controls:1.39%
cases:18.76%
controls:9.72%
cases:38.60%
controls:25.68%
2169
15727
3052
36445
961
5448
4260
46724
215
759
5006
51413
454
26
4767
52146
271
726
4942
51349
953
4947
4126
45938
1775
11765
2823
34052
Ulcer of lower limb, not elsewhere classified
L97 [45591659]
1.2e+00
1.6e+00
2.1e+00
—
1.9e+00
1.8e+00
1.4e+00
cases:0.75%
controls:0.23%
cases:0.61%
controls:0.12%
cases:0.23%
controls:0.03%
—
—
cases:0.21%
controls:0.03%
cases:0.71%
controls:0.12%
cases:1.35%
controls:0.33%
39
122
5182
52050
32
65
5189
52107
12
14
5209
52158
—
11
16
5202
52059
36
59
5043
50826
62
151
4536
45666
Dermatitis/atopic eczema
S87 [2002001051]
1.7e+00
3.3e+00
1.0e+50
—
—
2.9e+00
2.1e+00
cases:0.38%
controls:0.07%
cases:0.75%
controls:0.03%
cases:0.23%
controls:0.00%
—
—
—
—
cases:0.32%
controls:0.02%
cases:0.87%
controls:0.11%
20
36
5201
52136
39
14
5182
52158
12
0
5209
52172
—
—
16
9
5063
50876
40
50
4558
45767
Skin texture symptom/complaint
S21 [2002000986]
8.1e-01
2.1e+00
3.2e+00
1.0e+50
1.9e+00
1.2e+00
8.0e-01
cases:2.16%
controls:0.97%
cases:2.78%
controls:0.34%
cases:0.80%
controls:0.03%
cases:0.10%
controls:0.00%
cases:0.29%
controls:0.04%
cases:1.24%
controls:0.39%
cases:3.22%
controls:1.47%
113
506
5108
51666
145
175
5076
51997
42
18
5179
52154
5
0
5216
52172
15
22
5198
52053
63
199
5016
50686
148
673
4450
45144
tetracycline; oral, parenteral
J01AA07 [21602805]
7.7e-01
1.5e+00
2.3e+00
—
2.8e+00
1.8e+00
8.2e-01
cases:3.03%
controls:1.43%
cases:1.80%
controls:0.40%
cases:0.36%
controls:0.04%
—
—
cases:0.79%
controls:0.05%
cases:2.36%
controls:0.39%
cases:2.52%
controls:1.13%
158
744
5063
51428
94
209
5127
51963
19
20
5202
52152
—
41
25
5172
52050
120
197
4959
50688
116
516
4482
45301
infliximab; parenteral
L04AB02 [21603909]
1.5e+00
2.1e+00
—
—
2.9e+00
1.9e+00
1.5e+00
cases:0.44%
controls:0.10%
cases:0.36%
controls:0.05%
—
—
—
—
cases:0.17%
controls:0.01%
cases:0.30%
controls:0.04%
cases:0.39%
controls:0.09%
23
52
5198
52120
19
24
5202
52148
—
—
9
5
5204
52070
15
22
5064
50863
18
42
4580
45775
Fungus identified in Specimen by Culture
580-1 [3000494]
6.7e-01
1.8e+00
2.8e+00
—
2.1e+00
1.5e+00
9.7e-01
cases:2.13%
controls:1.10%
cases:2.03%
controls:0.35%
cases:0.48%
controls:0.03%
—
—
cases:0.33%
controls:0.04%
cases:1.65%
controls:0.37%
cases:4.00%
controls:1.56%
111
573
5110
51599
106
185
5115
51987
25
15
5196
52157
—
17
21
5196
52054
84
187
4995
50698
184
715
4414
45102
fusidic acid; ointment
D06AX01 [21602062]
7.9e-01
1.5e+00
3.0e+00
1.0e+50
2.2e+00
1.3e+00
9.6e-01
cases:5.06%
controls:2.36%
cases:3.28%
controls:0.73%
cases:1.21%
controls:0.06%
cases:0.84%
controls:0.00%
cases:0.71%
controls:0.08%
cases:2.78%
controls:0.76%
cases:6.70%
controls:2.68%
264
1233
4957
50939
171
379
5050
51793
63
33
5158
52139
44
0
5177
52172
37
40
5176
52035
141
386
4938
50499
308
1228
4290
44589
fusidic acid
D09AA02 [21602265]
7.9e-01
1.5e+00
3.0e+00
1.0e+50
2.2e+00
1.3e+00
9.6e-01
cases:5.06%
controls:2.36%
cases:3.28%
controls:0.73%
cases:1.21%
controls:0.06%
cases:0.84%
controls:0.00%
cases:0.71%
controls:0.08%
cases:2.78%
controls:0.76%
cases:6.70%
controls:2.68%
264
1233
4957
50939
171
379
5050
51793
63
33
5158
52139
44
0
5177
52172
37
40
5176
52035
141
386
4938
50499
308
1228
4290
44589
Atherosclerosis of arteries of extremities
I70.2 [45538421]
7.0e-01
8.3e-01
1.5e+00
3.6e+00
1.4e+00
9.4e-01
8.4e-01
cases:2.03%
controls:1.02%
cases:1.44%
controls:0.63%
cases:0.69%
controls:0.15%
cases:0.34%
controls:0.01%
cases:0.67%
controls:0.17%
cases:1.63%
controls:0.64%
cases:3.15%
controls:1.39%
106
531
5115
51641
75
329
5146
51843
36
79
5185
52093
18
5
5203
52167
35
91
5178
51984
83
327
4996
50558
145
636
4453
45181
calcipotriol; ointment
D05AX02 [21602039]
1.3e+00
1.9e+00
1.9e+00
—
2.5e+00
2.1e+00
1.6e+00
cases:1.02%
controls:0.27%
cases:0.71%
controls:0.10%
cases:0.11%
controls:0.02%
—
—
cases:0.27%
controls:0.02%
cases:0.85%
controls:0.10%
cases:0.98%
controls:0.21%
53
141
5168
52031
37
54
5184
52118
6
9
5215
52163
—
14
11
5199
52064
43
51
5036
50834
45
94
4553
45723
Varicose veins of lower extremities with inflammation
I83.1 [45581827]
1.2e+00
2.8e+00
—
1.0e+50
—
3.4e+00
2.1e+00
cases:0.34%
controls:0.11%
cases:0.42%
controls:0.02%
—
—
cases:0.82%
controls:0.00%
—
—
cases:1.24%
controls:0.04%
cases:1.07%
controls:0.14%
18
57
5203
52115
22
13
5199
52159
—
43
0
5178
52172
—
63
22
5016
50863
49
63
4549
45754
Skin symptom/complaint other
S29 [2002000993]
5.6e-01
1.9e+00
3.0e+00
—
1.8e+00
1.2e+00
8.6e-01
cases:2.62%
controls:1.51%
cases:3.37%
controls:0.53%
cases:1.38%
controls:0.07%
—
—
cases:0.44%
controls:0.07%
cases:1.67%
controls:0.53%
cases:4.74%
controls:2.07%
137
788
5084
51384
176
274
5045
51898
72
35
5149
52137
—
23
39
5190
52036
85
271
4994
50614
218
949
4380
44868
pimecrolimus
D11AH02 [21602339]
1.5e+00
2.0e+00
2.1e+00
1.0e+50
—
2.1e+00
1.5e+00
cases:0.92%
controls:0.20%
cases:0.69%
controls:0.09%
cases:0.11%
controls:0.01%
cases:0.13%
controls:0.00%
—
—
cases:0.63%
controls:0.08%
cases:1.30%
controls:0.29%
48
105
5173
52067
36
49
5185
52123
6
7
5215
52165
7
0
5214
52172
—
32
41
5047
50844
60
133
4538
45684
fusidic acid; oral, parenteral
J01XC01 [21603052]
1.6e+00
3.4e+00
—
—
—
2.2e+00
2.0e+00
cases:0.31%
controls:0.06%
cases:0.29%
controls:0.01%
—
—
—
—
—
—
cases:0.16%
controls:0.02%
cases:0.28%
controls:0.04%
16
32
5205
52140
15
5
5206
52167
—
—
—
8
9
5071
50876
13
17
4585
45800
Ankylosing spondylitis
M45 [45591841]
1.1e+00
1.4e+00
2.4e+00
—
2.1e+00
1.3e+00
8.9e-01
cases:0.75%
controls:0.26%
cases:0.65%
controls:0.16%
cases:0.33%
controls:0.03%
—
—
cases:0.25%
controls:0.03%
cases:0.59%
controls:0.16%
cases:0.72%
controls:0.29%
39
135
5182
52037
34
81
5187
52091
17
15
5204
52157
—
13
16
5200
52059
30
82
5049
50803
33
135
4565
45682
adalimumab; parenteral
L04AB04 [21603911]
1.7e+00
1.8e+00
1.6e+00
—
1.4e+00
1.5e+00
1.1e+00
cases:0.80%
controls:0.15%
cases:0.82%
controls:0.13%
cases:0.25%
controls:0.05%
—
—
cases:0.25%
controls:0.06%
cases:0.63%
controls:0.14%
cases:0.65%
controls:0.21%
42
77
5179
52095
43
69
5178
52103
13
27
5208
52145
—
13
32
5200
52043
32
71
5047
50814
30
96
4568
45721
Other psoriasis
L40.8 [45567355]
2.1e+00
2.6e+00
—
—
—
2.3e+00
2.2e+00
cases:0.19%
controls:0.02%
cases:0.17%
controls:0.01%
—
—
—
—
—
—
cases:0.20%
controls:0.02%
cases:0.35%
controls:0.04%
10
12
5211
52160
9
7
5212
52165
—
—
—
10
10
5069
50875
16
18
4582
45799
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
7.9e-01
1.2e+00
2.3e+00
—
2.4e+00
1.5e+00
9.8e-01
cases:1.67%
controls:0.76%
cases:0.84%
controls:0.25%
cases:0.29%
controls:0.03%
—
—
cases:0.29%
controls:0.03%
cases:0.98%
controls:0.22%
cases:2.31%
controls:0.88%
87
398
5134
51774
44
132
5177
52040
15
15
5206
52157
—
15
14
5198
52061
50
113
5029
50772
106
401
4492
45416
General Practice
1 [38004446]
5.4e-01
6.9e-01
1.1e+00
4.5e+00
1.0e+00
7.3e-01
5.6e-01
cases:15.53%
controls:9.70%
cases:7.76%
controls:4.04%
cases:1.78%
controls:0.63%
cases:2.80%
controls:0.03%
cases:1.59%
controls:0.57%
cases:8.76%
controls:4.42%
cases:20.33%
controls:12.73%
811
5059
4410
47113
405
2110
4816
50062
93
327
5128
51845
146
16
5075
52156
83
296
5130
51779
445
2249
4634
48636
935
5832
3663
39985
Hidradenitis suppurativa
L73.2 [45557711]
2.0e+00
2.5e+00
—
1.0e+50
—
2.5e+00
2.1e+00
cases:0.33%
controls:0.05%
cases:0.27%
controls:0.02%
—
—
cases:0.31%
controls:0.00%
—
—
cases:0.37%
controls:0.03%
cases:0.48%
controls:0.06%
17
24
5204
52148
14
11
5207
52161
—
16
0
5205
52172
—
19
16
5060
50869
22
26
4576
45791
Counselling and guidance which enhance independent living
R2130 [2001310196]
7.0e-01
1.1e+00
1.7e+00
1.0e+50
3.0e+00
1.5e+00
1.1e+00
cases:1.55%
controls:0.78%
cases:0.98%
controls:0.34%
cases:0.23%
controls:0.04%
cases:0.75%
controls:0.00%
cases:0.52%
controls:0.03%
cases:1.48%
controls:0.32%
cases:2.63%
controls:0.93%
81
407
5140
51765
51
175
5170
51997
12
21
5209
52151
39
0
5182
52172
27
14
5186
52061
75
165
5004
50720
121
427
4477
45390
Application of soft bandage
SPAT1211 [2001700312]
6.7e-01
1.5e+00
2.2e+00
—
2.3e+00
1.3e+00
8.7e-01
cases:1.23%
controls:0.63%
cases:0.67%
controls:0.14%
cases:0.23%
controls:0.02%
—
—
cases:0.19%
controls:0.02%
cases:0.65%
controls:0.17%
cases:1.70%
controls:0.72%
64
329
5157
51843
35
75
5186
52097
12
13
5209
52159
—
10
10
5203
52065
33
89
5046
50796
78
328
4520
45489
Skin Pathology biopsy report
65754-4 [40768443]
1.3e+00
3.1e+00
—
1.0e+50
—
2.9e+00
1.7e+00
cases:1.17%
controls:0.32%
cases:2.15%
controls:0.10%
—
—
cases:1.55%
controls:0.00%
—
—
cases:1.71%
controls:0.10%
cases:2.02%
controls:0.39%
61
168
5160
52004
112
54
5109
52118
—
81
0
5140
52172
—
87
50
4992
50835
93
177
4505
45640
Crohn disease, unspecified
K50.9 [45562490]
1.4e+00
1.9e+00
—
—
2.3e+00
1.8e+00
1.5e+00
cases:0.44%
controls:0.11%
cases:0.29%
controls:0.04%
—
—
—
—
cases:0.12%
controls:0.01%
cases:0.28%
controls:0.05%
cases:0.50%
controls:0.12%
23
55
5198
52117
15
23
5206
52149
—
—
6
6
5207
52069
14
23
5065
50862
23
53
4575
45764
Other procedure to treat skin wound, unspecified location
QXB99 [2001310054]
2.0e+00
2.0e+00
—
1.0e+50
—
2.6e+00
2.3e+00
cases:0.34%
controls:0.05%
cases:0.15%
controls:0.02%
—
—
cases:0.13%
controls:0.00%
—
—
cases:0.39%
controls:0.03%
cases:0.54%
controls:0.05%
18
25
5203
52147
8
11
5213
52161
—
7
0
5214
52172
—
20
15
5059
50870
25
25
4573
45792
Disorder of skin and subcutaneous tissue, unspecified
L98.9 [45562566]
1.6e+00
3.3e+00
—
—
—
2.4e+00
1.6e+00
cases:0.25%
controls:0.05%
cases:0.50%
controls:0.02%
—
—
—
—
—
—
cases:0.18%
controls:0.02%
cases:0.24%
controls:0.05%
13
27
5208
52145
26
10
5195
52162
—
—
—
9
8
5070
50877
11
23
4587
45794
Laceration/cut
S18 [2002000983]
3.8e-01
9.5e-01
1.8e+00
2.4e+00
1.9e+00
7.2e-01
6.2e-01
cases:7.30%
controls:5.12%
cases:5.02%
controls:2.00%
cases:1.49%
controls:0.25%
cases:0.17%
controls:0.02%
cases:1.55%
controls:0.24%
cases:3.94%
controls:1.97%
cases:12.40%
controls:7.05%
381
2669
4840
49503
262
1043
4959
51129
78
128
5143
52044
9
8
5212
52164
81
123
5132
51952
200
1000
4879
49885
570
3231
4028
42586
Monocytes [#/volume] in Blood
26484-6 [3001604]
3.1e-01
6.4e-01
1.1e+00
3.3e+00
1.7e+00
1.0e+00
7.1e-01
cases:8.66%
controls:6.51%
cases:7.37%
controls:4.02%
cases:2.34%
controls:0.78%
cases:0.79%
controls:0.03%
cases:4.01%
controls:0.76%
cases:10.34%
controls:3.91%
cases:17.64%
controls:9.53%
452
3398
4769
48774
385
2099
4836
50073
122
406
5099
51766
41
16
5180
52156
209
394
5004
51681
525
1992
4554
48893
811
4367
3787
41450
Basophils [#/volume] in Blood
26444-0 [3006315]
3.1e-01
6.3e-01
1.1e+00
3.3e+00
1.7e+00
1.0e+00
7.1e-01
cases:8.73%
controls:6.53%
cases:7.35%
controls:4.05%
cases:2.34%
controls:0.78%
cases:0.79%
controls:0.03%
cases:3.99%
controls:0.75%
cases:10.34%
controls:3.93%
cases:17.70%
controls:9.55%
456
3409
4765
48763
384
2114
4837
50058
122
406
5099
51766
41
16
5180
52156
208
393
5005
51682
525
2002
4554
48883
814
4377
3784
41440
Juvenile polyarthritis (seronegative)
M08.3 [45596450]
1.7e+00
1.6e+00
—
—
2.3e+00
1.7e+00
1.5e+00
cases:0.29%
controls:0.05%
cases:0.19%
controls:0.04%
—
—
—
—
cases:0.12%
controls:0.01%
cases:0.22%
controls:0.04%
cases:0.24%
controls:0.05%
15
28
5206
52144
10
20
5211
52152
—
—
6
6
5207
52069
11
21
5068
50864
11
25
4587
45792
Chronic kidney disease, unspecified
N18.9 [45553438]
7.7e-01
8.2e-01
1.4e+00
2.6e+00
1.3e+00
8.5e-01
9.0e-01
cases:0.92%
controls:0.43%
cases:0.67%
controls:0.30%
cases:0.29%
controls:0.07%
cases:0.15%
controls:0.01%
cases:0.29%
controls:0.07%
cases:0.75%
controls:0.32%
cases:1.63%
controls:0.67%
48
224
5173
51948
35
155
5186
52017
15
36
5206
52136
8
6
5213
52166
15
39
5198
52036
38
164
5041
50721
75
307
4523
45510
inFLIXimab Ab [Units/volume] in Serum by Immunoassay
90780-8 [1175556]
1.8e+00
2.9e+00
—
—
—
2.2e+00
1.8e+00
cases:0.31%
controls:0.05%
cases:0.21%
controls:0.01%
—
—
—
—
—
—
cases:0.12%
controls:0.01%
cases:0.24%
controls:0.04%
16
27
5205
52145
11
6
5210
52166
—
—
—
6
7
5073
50878
11
18
4587
45799
Eosinophils [#/volume] in Blood
26449-9 [3013115]
3.0e-01
6.4e-01
1.1e+00
3.2e+00
1.7e+00
1.0e+00
6.9e-01
cases:9.04%
controls:6.83%
cases:7.72%
controls:4.21%
cases:2.43%
controls:0.83%
cases:0.84%
controls:0.03%
cases:4.14%
controls:0.81%
cases:10.49%
controls:4.08%
cases:18.05%
controls:9.91%
472
3564
4749
48608
403
2197
4818
49975
127
434
5094
51738
44
18
5177
52154
216
420
4997
51655
533
2076
4546
48809
830
4542
3768
41275
Granulocytes [#/volume] in Blood
30394-1 [3035715]
9.5e-01
1.5e+00
—
—
2.3e+00
2.0e+00
1.9e+00
cases:0.77%
controls:0.30%
cases:0.29%
controls:0.07%
—
—
—
—
cases:0.12%
controls:0.01%
cases:0.41%
controls:0.06%
cases:1.11%
controls:0.17%
40
155
5181
52017
15
35
5206
52137
—
—
6
6
5207
52069
21
30
5058
50855
51
77
4547
45740
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
2.9e-01
6.2e-01
1.1e+00
3.1e+00
1.7e+00
1.0e+00
6.8e-01
cases:9.04%
controls:6.90%
cases:7.58%
controls:4.22%
cases:2.39%
controls:0.80%
cases:0.79%
controls:0.03%
cases:4.07%
controls:0.79%
cases:10.38%
controls:4.10%
cases:17.92%
controls:9.98%
472
3600
4749
48572
396
2200
4825
49972
125
415
5096
51757
41
18
5180
52154
212
413
5001
51662
527
2084
4552
48801
824
4574
3774
41243
Emergency Medicine
93 [38004510]
3.3e-01
5.0e-01
1.1e+00
4.6e+00
8.4e-01
5.8e-01
4.4e-01
cases:11.53%
controls:8.55%
cases:7.62%
controls:4.79%
cases:2.03%
controls:0.67%
cases:2.32%
controls:0.02%
cases:1.57%
controls:0.68%
cases:8.56%
controls:4.98%
cases:21.05%
controls:14.70%
602
4461
4619
47711
398
2498
4823
49674
106
350
5115
51822
121
12
5100
52160
82
356
5131
51719
435
2532
4644
48353
968
6733
3630
39084
Arthropathic psoriasis
L40.5 [45557703]
1.1e+00
1.6e+00
2.1e+00
1.0e+50
—
1.9e+00
1.7e+00
cases:0.48%
controls:0.15%
cases:0.38%
controls:0.08%
cases:0.11%
controls:0.01%
cases:0.17%
controls:0.00%
—
—
cases:0.43%
controls:0.07%
cases:0.70%
controls:0.13%
25
80
5196
52092
20
41
5201
52131
6
7
5215
52165
9
0
5212
52172
—
22
34
5057
50851
32
59
4566
45758
Monocytes/Leukocytes in Blood
26485-3 [3019069]
2.9e-01
6.1e-01
1.1e+00
3.1e+00
1.7e+00
1.0e+00
6.6e-01
cases:8.24%
controls:6.31%
cases:6.76%
controls:3.78%
cases:2.15%
controls:0.74%
cases:0.65%
controls:0.03%
cases:3.59%
controls:0.71%
cases:9.41%
controls:3.63%
cases:15.62%
controls:8.77%
430
3291
4791
48881
353
1974
4868
50198
112
385
5109
51787
34
15
5187
52157
187
368
5026
51707
478
1845
4601
49040
718
4016
3880
41801
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
2.9e-01
6.0e-01
1.1e+00
3.1e+00
1.7e+00
1.0e+00
6.5e-01
cases:8.22%
controls:6.30%
cases:6.72%
controls:3.80%
cases:2.15%
controls:0.73%
cases:0.65%
controls:0.03%
cases:3.59%
controls:0.70%
cases:9.37%
controls:3.62%
cases:15.48%
controls:8.73%
429
3286
4792
48886
351
1980
4870
50192
112
382
5109
51790
34
15
5187
52157
187
366
5026
51709
476
1842
4603
49043
712
3998
3886
41819
Basophils/Leukocytes in Blood
30180-4 [3022096]
2.8e-01
6.0e-01
1.1e+00
3.1e+00
1.7e+00
1.0e+00
6.4e-01
cases:8.16%
controls:6.26%
cases:6.70%
controls:3.78%
cases:2.16%
controls:0.74%
cases:0.65%
controls:0.03%
cases:3.61%
controls:0.70%
cases:9.29%
controls:3.62%
cases:15.35%
controls:8.71%
426
3268
4795
48904
350
1970
4871
50202
113
385
5108
51787
34
15
5187
52157
188
367
5025
51708
472
1841
4607
49044
706
3992
3892
41825
Other seborrhoeic dermatitis
L21.8 [45548192]
3.0e+00
—
—
1.0e+50
—
3.2e+00
2.2e+00
cases:0.34%
controls:0.02%
—
—
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.28%
controls:0.01%
cases:0.26%
controls:0.03%
18
9
5203
52163
—
—
18
0
5203
52172
—
14
6
5065
50879
12
13
4586
45804
Dermatological photography
XQ848 [2001310110]
7.9e-01
2.7e+00
—
1.0e+50
—
3.2e+00
2.4e+00
cases:0.29%
controls:0.13%
cases:0.65%
controls:0.04%
—
—
cases:1.36%
controls:0.00%
—
—
cases:1.20%
controls:0.05%
cases:1.61%
controls:0.15%
15
68
5206
52104
34
23
5187
52149
—
71
0
5150
52172
—
61
25
5018
50860
74
70
4524
45747
Asthma, unspecified
J45.9 [45562456]
5.3e-01
6.7e-01
9.1e-01
3.4e+00
1.3e+00
6.8e-01
8.1e-01
cases:3.72%
controls:2.22%
cases:1.97%
controls:1.02%
cases:0.44%
controls:0.18%
cases:0.34%
controls:0.01%
cases:0.52%
controls:0.15%
cases:2.01%
controls:1.03%
cases:6.20%
controls:2.87%
194
1159
5027
51013
103
530
5118
51642
23
93
5198
52079
18
6
5203
52166
27
76
5186
51999
102
523
4977
50362
285
1314
4313
44503
Internal Medicine
11 [38004456]
5.1e-01
6.1e-01
1.1e+00
3.8e+00
9.5e-01
6.5e-01
5.9e-01
cases:28.67%
controls:19.51%
cases:14.35%
controls:8.34%
cases:4.16%
controls:1.39%
cases:2.26%
controls:0.05%
cases:3.43%
controls:1.36%
cases:14.88%
controls:8.38%
cases:29.97%
controls:19.15%
1497
10179
3724
41993
749
4350
4472
47822
217
727
5004
51445
118
27
5103
52145
179
707
5034
51368
756
4265
4323
46620
1378
8775
3220
37042
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
2.6e-01
5.9e-01
1.1e+00
3.1e+00
1.6e+00
9.8e-01
6.2e-01
cases:8.31%
controls:6.52%
cases:6.84%
controls:3.90%
cases:2.20%
controls:0.76%
cases:0.65%
controls:0.03%
cases:3.63%
controls:0.74%
cases:9.47%
controls:3.78%
cases:15.83%
controls:9.22%
434
3403
4787
48769
357
2034
4864
50138
115
396
5106
51776
34
16
5187
52156
189
384
5024
51691
481
1923
4598
48962
728
4225
3870
41592
miconazole
S02AA13 [21605159]
9.6e-01
1.9e+00
—
1.0e+50
2.8e+00
1.4e+00
1.1e+00
cases:1.57%
controls:0.61%
cases:0.90%
controls:0.14%
—
—
cases:0.11%
controls:0.00%
cases:0.25%
controls:0.02%
cases:0.57%
controls:0.14%
cases:1.00%
controls:0.34%
82
318
5139
51854
47
72
5174
52100
—
6
0
5215
52172
13
8
5200
52067
29
69
5050
50816
46
156
4552
45661
inFLIXimab [Mass/volume] in Serum or Plasma
39803-2 [3042299]
1.6e+00
2.8e+00
—
—
—
2.2e+00
1.6e+00
cases:0.27%
controls:0.05%
cases:0.21%
controls:0.01%
—
—
—
—
—
—
cases:0.16%
controls:0.02%
cases:0.24%
controls:0.05%
14
27
5207
52145
11
7
5210
52165
—
—
—
8
9
5071
50876
11
23
4587
45794
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
2.4e-01
5.5e-01
1.1e+00
3.1e+00
1.6e+00
9.4e-01
5.9e-01
cases:7.89%
controls:6.32%
cases:6.40%
controls:3.79%
cases:2.09%
controls:0.71%
cases:0.63%
controls:0.03%
cases:3.45%
controls:0.71%
cases:8.94%
controls:3.68%
cases:15.07%
controls:8.97%
412
3299
4809
48873
334
1978
4887
50194
109
371
5112
51801
33
15
5188
52157
180
372
5033
51703
454
1871
4625
49014
693
4111
3905
41706
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 [45552036]
6.0e-01
1.4e+00
2.3e+00
—
2.0e+00
9.6e-01
7.8e-01
cases:0.94%
controls:0.52%
cases:0.65%
controls:0.16%
cases:0.11%
controls:0.01%
—
—
cases:0.12%
controls:0.02%
cases:0.43%
controls:0.17%
cases:1.20%
controls:0.55%
49
271
5172
51901
34
82
5187
52090
6
6
5215
52166
—
6
8
5207
52067
22
85
5057
50800
55
254
4543
45563
desoximetasone
D07AC03 [21602122]
1.5e+00
2.7e+00
—
—
1.0e+50
2.2e+00
1.7e+00
cases:0.46%
controls:0.10%
cases:0.38%
controls:0.03%
—
—
—
—
cases:0.10%
controls:0.00%
cases:0.28%
controls:0.03%
cases:0.37%
controls:0.07%
24
52
5197
52120
20
14
5201
52158
—
—
5
0
5208
52075
14
16
5065
50869
17
31
4581
45786
Outpatient Hospital
22 [8756]
4.2e-01
5.4e-01
7.8e-01
3.9e+00
1.1e+00
6.9e-01
6.0e-01
cases:31.26%
controls:23.07%
cases:11.55%
controls:7.09%
cases:1.88%
controls:0.87%
cases:1.59%
controls:0.03%
cases:2.34%
controls:0.78%
cases:11.75%
controls:6.27%
cases:30.21%
controls:19.25%
1632
12036
3589
40136
603
3701
4618
48471
98
453
5123
51719
83
17
5138
52155
122
405
5091
51670
597
3190
4482
47695
1389
8822
3209
36995
Rash localized
S06 [2002000971]
8.8e-01
2.1e+00
2.4e+00
—
—
1.3e+00
1.2e+00
cases:0.77%
controls:0.32%
cases:0.84%
controls:0.10%
cases:0.15%
controls:0.01%
—
—
—
—
cases:0.39%
controls:0.10%
cases:1.41%
controls:0.44%
40
167
5181
52005
44
52
5177
52120
8
7
5213
52165
—
—
20
53
5059
50832
65
202
4533
45615
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
5.8e-01
9.9e-01
1.5e+00
—
2.7e+00
1.3e+00
8.7e-01
cases:2.60%
controls:1.48%
cases:1.24%
controls:0.47%
cases:0.21%
controls:0.05%
—
—
cases:0.54%
controls:0.03%
cases:1.65%
controls:0.46%
cases:3.85%
controls:1.65%
136
771
5085
51401
65
243
5156
51929
11
25
5210
52147
—
28
18
5185
52057
84
234
4995
50651
177
758
4421
45059
Differential panel, method unspecified - Blood
69738-3 [42870588]
3.8e-01
6.1e-01
8.6e-01
2.8e+00
1.6e+00
9.7e-01
6.9e-01
cases:6.13%
controls:4.29%
cases:4.69%
controls:2.60%
cases:1.28%
controls:0.55%
cases:0.46%
controls:0.03%
cases:2.44%
controls:0.50%
cases:6.28%
controls:2.47%
cases:10.46%
controls:5.52%
320
2240
4901
49932
245
1356
4976
50816
67
285
5154
51887
24
14
5197
52158
127
262
5086
51813
319
1255
4760
49630
481
2528
4117
43289
Varicose veins of lower extremities with ulcer
I83.0 [45557601]
1.5e+00
2.5e+00
—
1.0e+50
—
2.4e+00
1.5e+00
cases:0.50%
controls:0.11%
cases:0.50%
controls:0.04%
—
—
cases:0.31%
controls:0.00%
—
—
cases:0.65%
controls:0.06%
cases:0.67%
controls:0.16%
26
57
5195
52115
26
21
5195
52151
—
16
0
5205
52172
—
33
29
5046
50856
31
72
4567
45745
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
8.0e-01
1.3e+00
—
—
2.1e+00
1.8e+00
1.7e+00
cases:0.77%
controls:0.35%
cases:0.33%
controls:0.09%
—
—
—
—
cases:0.12%
controls:0.01%
cases:0.41%
controls:0.07%
cases:1.17%
controls:0.22%
40
180
5181
51992
17
45
5204
52127
—
—
6
7
5207
52068
21
36
5058
50849
54
100
4544
45717
calcitriol; ointment
D05AX03 [21602040]
1.5e+00
2.0e+00
—
—
—
2.4e+00
1.8e+00
cases:0.36%
controls:0.08%
cases:0.19%
controls:0.02%
—
—
—
—
—
—
cases:0.32%
controls:0.03%
cases:0.39%
controls:0.06%
19
43
5202
52129
10
13
5211
52159
—
—
—
16
15
5063
50870
18
29
4580
45788
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
2.6e-01
5.5e-01
1.1e+00
3.2e+00
1.4e+00
6.7e-01
5.0e-01
cases:14.58%
controls:11.62%
cases:9.60%
controls:5.80%
cases:2.47%
controls:0.80%
cases:0.52%
controls:0.02%
cases:2.97%
controls:0.75%
cases:10.85%
controls:5.84%
cases:24.25%
controls:16.26%
761
6060
4460
46112
501
3024
4720
49148
129
419
5092
51753
27
11
5194
52161
155
390
5058
51685
551
2974
4528
47911
1115
7449
3483
38368
Erythema intertrigo
L30.4 [45601221]
—
2.8e+00
—
1.0e+50
—
2.9e+00
2.0e+00
—
—
cases:0.15%
controls:0.01%
—
—
cases:0.21%
controls:0.00%
—
—
cases:0.30%
controls:0.02%
cases:0.30%
controls:0.04%
—
8
5
5213
52167
—
11
0
5210
52172
—
15
8
5064
50877
14
19
4584
45798
Ultrasound examination of lower leg veins
PH2AE [2001309451]
6.1e-01
1.1e+00
1.9e+00
1.0e+50
1.8e+00
1.2e+00
1.0e+00
cases:1.42%
controls:0.78%
cases:0.82%
controls:0.27%
cases:0.19%
controls:0.03%
cases:0.13%
controls:0.00%
cases:0.19%
controls:0.03%
cases:0.93%
controls:0.29%
cases:2.48%
controls:0.88%
74
405
5147
51767
43
140
5178
52032
10
15
5211
52157
7
0
5214
52172
10
16
5203
52059
47
150
5032
50735
114
405
4484
45412
Gastroenterology
10 [38004455]
6.3e-01
8.5e-01
1.1e+00
1.9e+00
1.3e+00
1.1e+00
8.4e-01
cases:6.44%
controls:3.54%
cases:3.66%
controls:1.59%
cases:0.92%
controls:0.31%
cases:0.15%
controls:0.02%
cases:1.07%
controls:0.31%
cases:4.25%
controls:1.51%
cases:10.13%
controls:4.66%
336
1847
4885
50325
191
831
5030
51341
48
163
5173
52009
8
12
5213
52160
56
160
5157
51915
216
768
4863
50117
466
2136
4132
43681
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
3.6e-01
8.2e-01
2.2e+00
—
2.8e+00
8.8e-01
5.0e-01
cases:3.64%
controls:2.56%
cases:2.01%
controls:0.90%
cases:0.71%
controls:0.08%
—
—
cases:1.13%
controls:0.07%
cases:2.09%
controls:0.87%
cases:5.72%
controls:3.54%
190
1334
5031
50838
105
467
5116
51705
37
40
5184
52132
—
59
36
5154
52039
106
444
4973
50441
263
1623
4335
44194
Acute pancreatitis caused by alcohol
K86.00 [2000502944]
1.6e+00
1.9e+00
—
—
—
2.2e+00
1.8e+00
cases:0.33%
controls:0.07%
cases:0.15%
controls:0.02%
—
—
—
—
—
—
cases:0.30%
controls:0.03%
cases:0.30%
controls:0.05%
17
34
5204
52138
8
12
5213
52160
—
—
—
15
16
5064
50869
14
22
4584
45795
Venous insufficiency (chronic)(peripheral)
I87.2 [45552867]
7.7e-01
9.3e-01
1.7e+00
—
2.1e+00
1.3e+00
7.4e-01
cases:1.57%
controls:0.73%
cases:0.88%
controls:0.35%
cases:0.23%
controls:0.04%
—
—
cases:0.42%
controls:0.05%
cases:1.42%
controls:0.39%
cases:2.52%
controls:1.22%
82
383
5139
51789
46
182
5175
51990
12
22
5209
52150
—
22
28
5191
52047
72
199
5007
50686
116
558
4482
45259
Dermatitis contact/allergic
S88 [2002001052]
1.6e+00
3.8e+00
—
—
—
1.8e+00
2.0e+00
cases:0.29%
controls:0.06%
cases:0.71%
controls:0.02%
—
—
—
—
—
—
cases:0.12%
controls:0.02%
cases:0.61%
controls:0.08%
15
30
5206
52142
37
8
5184
52164
—
—
—
6
10
5073
50875
28
37
4570
45780
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
2.5e-01
5.2e-01
8.5e-01
3.0e+00
1.3e+00
8.5e-01
6.7e-01
cases:9.86%
controls:7.89%
cases:8.20%
controls:5.04%
cases:2.78%
controls:1.21%
cases:0.88%
controls:0.04%
cases:4.26%
controls:1.17%
cases:10.63%
controls:4.85%
cases:19.53%
controls:11.02%
515
4116
4706
48056
428
2627
4793
49545
145
632
5076
51540
46
23
5175
52149
222
609
4991
51466
540
2466
4539
48419
898
5051
3700
40766
Predominantly allergic asthma
J45.0 [45557624]
8.7e-01
1.0e+00
1.5e+00
—
1.9e+00
1.1e+00
1.1e+00
cases:2.05%
controls:0.87%
cases:1.09%
controls:0.39%
cases:0.29%
controls:0.06%
—
—
cases:0.27%
controls:0.04%
cases:1.22%
controls:0.41%
cases:2.26%
controls:0.80%
107
453
5114
51719
57
202
5164
51970
15
33
5206
52139
—
14
22
5199
52053
62
208
5017
50677
104
365
4494
45452
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
5.6e-01
9.9e-01
1.7e+00
—
1.7e+00
1.6e+00
9.2e-01
cases:0.96%
controls:0.55%
cases:0.50%
controls:0.19%
cases:0.19%
controls:0.04%
—
—
cases:0.17%
controls:0.03%
cases:0.83%
controls:0.16%
cases:1.33%
controls:0.53%
50
288
5171
51884
26
97
5195
52075
10
19
5211
52153
—
9
17
5204
52058
42
82
5037
50803
61
244
4537
45573
Sepsis due to Staphylococcus aureus
A41.0 [45532832]
1.4e+00
2.2e+00
—
—
—
2.3e+00
1.5e+00
cases:0.34%
controls:0.09%
cases:0.31%
controls:0.03%
—
—
—
—
—
—
cases:0.30%
controls:0.03%
cases:0.52%
controls:0.11%
18
46
5203
52126
16
18
5205
52154
—
—
—
15
15
5064
50870
24
51
4574
45766
clozapine; oral, parenteral
N05AH02 [21604542]
1.2e+00
1.3e+00
1.2e+00
—
1.0e+00
1.3e+00
1.4e+00
cases:0.90%
controls:0.27%
cases:0.96%
controls:0.27%
cases:0.77%
controls:0.23%
—
—
cases:0.63%
controls:0.23%
cases:0.98%
controls:0.27%
cases:1.15%
controls:0.30%
47
142
5174
52030
50
140
5171
52032
40
118
5181
52054
—
33
119
5180
51956
50
138
5029
50747
53
136
4545
45681
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
6.1e-01
7.9e-01
2.3e+00
—
2.5e+00
1.0e+00
9.6e-01
cases:0.77%
controls:0.42%
cases:0.36%
controls:0.16%
cases:0.15%
controls:0.02%
—
—
cases:0.12%
controls:0.01%
cases:0.43%
controls:0.16%
cases:1.15%
controls:0.44%
40
218
5181
51954
19
86
5202
52086
8
8
5213
52164
—
6
5
5207
52070
22
80
5057
50805
53
203
4545
45614
fluconazole; oral, parenteral
J02AC01 [21603080]
3.5e-01
8.6e-01
1.3e+00
2.5e+00
1.4e+00
5.4e-01
3.9e-01
cases:8.31%
controls:6.00%
cases:4.39%
controls:1.91%
cases:0.86%
controls:0.24%
cases:0.13%
controls:0.01%
cases:0.82%
controls:0.20%
cases:3.25%
controls:1.91%
cases:7.87%
controls:5.47%
434
3132
4787
49040
229
995
4992
51177
45
125
5176
52047
7
6
5214
52166
43
102
5170
51973
165
972
4914
49913
362
2505
4236
43312
benzathine benzylpenicillin; parenteral
J01CE08 [21602848]
1.7e+00
1.9e+00
1.1e+00
—
1.1e+00
1.6e+00
2.1e+00
cases:0.46%
controls:0.08%
cases:0.46%
controls:0.07%
cases:0.10%
controls:0.03%
—
—
cases:0.10%
controls:0.03%
cases:0.45%
controls:0.09%
cases:1.00%
controls:0.13%
24
43
5197
52129
24
36
5197
52136
5
17
5216
52155
—
5
17
5208
52058
23
46
5056
50839
46
58
4552
45759
benzylpenicillin; parenteral
J01CE01 [21602841]
1.7e+00
1.9e+00
1.1e+00
—
1.1e+00
1.6e+00
2.1e+00
cases:0.46%
controls:0.08%
cases:0.46%
controls:0.07%
cases:0.10%
controls:0.03%
—
—
cases:0.10%
controls:0.03%
cases:0.45%
controls:0.09%
cases:1.00%
controls:0.13%
24
43
5197
52129
24
36
5197
52136
5
17
5216
52155
—
5
17
5208
52058
23
46
5056
50839
46
58
4552
45759
procaine benzylpenicillin; parenteral
J01CE09 [21602849]
1.7e+00
1.9e+00
1.1e+00
—
1.1e+00
1.6e+00
2.1e+00
cases:0.46%
controls:0.08%
cases:0.46%
controls:0.07%
cases:0.10%
controls:0.03%
—
—
cases:0.10%
controls:0.03%
cases:0.45%
controls:0.09%
cases:1.00%
controls:0.13%
24
43
5197
52129
24
36
5197
52136
5
17
5216
52155
—
5
17
5208
52058
23
46
5056
50839
46
58
4552
45759
itraconazole; oral, parenteral
J02AC02 [21603081]
5.4e-01
1.5e+00
2.0e+00
—
2.2e+00
1.1e+00
3.0e-01
cases:2.57%
controls:1.51%
cases:1.55%
controls:0.35%
cases:0.33%
controls:0.04%
—
—
cases:0.31%
controls:0.03%
cases:0.85%
controls:0.29%
cases:1.24%
controls:0.92%
134
786
5087
51386
81
182
5140
51990
17
23
5204
52149
—
16
18
5197
52057
43
150
5036
50735
57
423
4541
45394
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
4.3e-01
8.1e-01
1.3e+00
2.6e+00
1.2e+00
4.1e-01
4.6e-01
cases:7.53%
controls:5.04%
cases:3.18%
controls:1.43%
cases:0.56%
controls:0.15%
cases:0.13%
controls:0.01%
cases:0.54%
controls:0.16%
cases:2.19%
controls:1.46%
cases:8.31%
controls:5.41%
393
2631
4828
49541
166
748
5055
51424
29
80
5192
52092
7
5
5214
52167
28
83
5185
51992
111
744
4968
50141
382
2479
4216
43338
terbinafine; oral
D01BA02 [21601967]
4.0e-01
1.7e+00
1.8e+00
—
1.7e+00
1.2e+00
4.0e-01
cases:4.29%
controls:2.92%
cases:4.16%
controls:0.81%
cases:0.69%
controls:0.12%
—
—
cases:0.73%
controls:0.13%
cases:2.66%
controls:0.81%
cases:4.28%
controls:2.92%
224
1521
4997
50651
217
423
5004
51749
36
62
5185
52110
—
38
69
5175
52006
135
411
4944
50474
197
1337
4401
44480
Sleep apnoea
G47.3 [45562094]
5.7e-01
6.4e-01
4.2e-01
3.5e+00
1.1e+00
6.6e-01
7.1e-01
cases:5.57%
controls:3.22%
cases:3.72%
controls:1.99%
cases:0.67%
controls:0.44%
cases:0.44%
controls:0.01%
cases:1.11%
controls:0.39%
cases:3.92%
controls:2.07%
cases:8.24%
controls:4.23%
291
1679
4930
50493
194
1038
5027
51134
35
231
5186
51941
23
7
5198
52165
58
204
5155
51871
199
1054
4880
49831
379
1937
4219
43880
Pruritus
S02 [2002000967]
1.4e+00
2.8e+00
—
—
—
1.6e+00
1.4e+00
cases:0.54%
controls:0.13%
cases:0.82%
controls:0.05%
—
—
—
—
—
—
cases:0.26%
controls:0.05%
cases:0.70%
controls:0.18%
28
70
5193
52102
43
27
5178
52145
—
—
—
13
27
5066
50858
32
82
4566
45735
Infectious Disease
44 [38004484]
6.1e-01
9.9e-01
1.6e+00
1.0e+50
1.8e+00
1.1e+00
1.0e+00
cases:2.03%
controls:1.11%
cases:1.24%
controls:0.47%
cases:0.46%
controls:0.10%
cases:0.27%
controls:0.00%
cases:0.46%
controls:0.08%
cases:1.42%
controls:0.47%
cases:3.65%
controls:1.37%
106
581
5115
51591
65
243
5156
51929
24
50
5197
52122
14
0
5207
52172
24
40
5189
52035
72
238
5007
50647
168
627
4430
45190
Teaching
WZC30 [2001310891]
3.6e-01
8.2e-01
2.1e+00
—
1.9e+00
1.4e+00
9.1e-01
cases:1.61%
controls:1.13%
cases:1.24%
controls:0.55%
cases:0.50%
controls:0.06%
—
—
cases:0.50%
controls:0.08%
cases:2.05%
controls:0.52%
cases:4.05%
controls:1.66%
84
589
5137
51583
65
288
5156
51884
26
33
5195
52139
—
26
41
5187
52034
104
264
4975
50621
186
762
4412
45055
Tinea corporis
B35.4 [45576265]
1.7e+00
2.6e+00
—
1.0e+50
—
2.7e+00
1.1e+00
cases:0.19%
controls:0.04%
cases:0.13%
controls:0.01%
—
—
cases:0.10%
controls:0.00%
—
—
cases:0.18%
controls:0.01%
cases:0.26%
controls:0.08%
10
19
5211
52153
7
5
5214
52167
—
5
0
5216
52172
—
9
6
5070
50879
12
38
4586
45779
Other Crohn disease
K50.8 [45533599]
1.1e+00
1.2e+00
1.4e+00
—
1.8e+00
1.4e+00
1.4e+00
cases:0.46%
controls:0.16%
cases:0.38%
controls:0.12%
cases:0.17%
controls:0.04%
—
—
cases:0.19%
controls:0.03%
cases:0.47%
controls:0.11%
cases:0.65%
controls:0.15%
24
81
5197
52091
20
60
5201
52112
9
22
5212
52150
—
10
16
5203
52059
24
58
5055
50827
30
71
4568
45746
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
6.4e-01
9.3e-01
1.4e+00
—
1.8e+00
1.3e+00
9.6e-01
cases:4.73%
controls:2.55%
cases:3.60%
controls:1.45%
cases:1.02%
controls:0.26%
—
—
cases:1.44%
controls:0.24%
cases:5.04%
controls:1.44%
cases:9.90%
controls:4.05%
247
1331
4974
50841
188
759
5033
51413
53
138
5168
52034
—
75
124
5138
51951
256
735
4823
50150
455
1855
4143
43962
Other pruritus
L29.8 [45601220]
1.8e+00
—
—
1.0e+50
—
3.2e+00
2.0e+00
cases:0.13%
controls:0.02%
—
—
—
—
cases:0.17%
controls:0.00%
—
—
cases:0.24%
controls:0.01%
cases:0.46%
controls:0.06%
7
12
5214
52160
—
—
9
0
5212
52172
—
12
5
5067
50880
21
28
4577
45789
Other urticaria
L50.8 [45562540]
1.3e+00
2.1e+00
—
1.0e+50
—
2.1e+00
1.5e+00
cases:0.25%
controls:0.07%
cases:0.19%
controls:0.02%
—
—
cases:0.13%
controls:0.00%
—
—
cases:0.24%
controls:0.03%
cases:0.33%
controls:0.08%
13
36
5208
52136
10
12
5211
52160
—
7
0
5214
52172
—
12
15
5067
50870
15
35
4583
45782
Treatment of reopened or infected surgical wound
SPAT1144 [2001700245]
9.2e-01
1.5e+00
2.2e+00
—
1.6e+00
1.2e+00
1.1e+00
cases:1.23%
controls:0.49%
cases:0.69%
controls:0.15%
cases:0.15%
controls:0.02%
—
—
cases:0.10%
controls:0.02%
cases:0.45%
controls:0.13%
cases:1.61%
controls:0.57%
64
257
5157
51915
36
77
5185
52095
8
9
5213
52163
—
5
10
5208
52065
23
67
5056
50818
74
260
4524
45557
Seborrhoeic dermatitis, unspecified
L21.9 [45572264]
1.9e+00
—
—
1.0e+50
—
3.3e+00
1.7e+00
cases:0.34%
controls:0.05%
—
—
—
—
cases:0.33%
controls:0.00%
—
—
cases:0.35%
controls:0.01%
cases:0.50%
controls:0.09%
18
27
5203
52145
—
—
17
0
5204
52172
—
18
7
5061
50878
23
40
4575
45777
Rheumatology
66 [38004491]
8.0e-01
1.0e+00
1.5e+00
—
1.4e+00
1.2e+00
9.6e-01
cases:4.88%
controls:2.24%
cases:3.58%
controls:1.32%
cases:1.19%
controls:0.26%
—
—
cases:1.06%
controls:0.27%
cases:4.13%
controls:1.31%
cases:6.66%
controls:2.66%
255
1171
4966
51001
187
689
5034
51483
62
135
5159
52037
—
55
141
5158
51934
210
666
4869
50219
306
1217
4292
44600
Bacteria [#/volume] in Urine by Culture
100906-7 [1761482]
8.4e-01
1.1e+00
2.4e+00
—
1.6e+00
9.6e-01
4.7e-01
cases:0.88%
controls:0.38%
cases:0.57%
controls:0.19%
cases:0.36%
controls:0.03%
—
—
cases:0.19%
controls:0.04%
cases:0.53%
controls:0.20%
cases:1.22%
controls:0.76%
46
199
5175
51973
30
101
5191
52071
19
18
5202
52154
—
10
20
5203
52055
27
104
5052
50781
56
350
4542
45467
ebastine; oral
R06AX22 [21603521]
7.5e-01
1.2e+00
1.5e+00
—
1.7e+00
9.6e-01
7.3e-01
cases:3.98%
controls:1.91%
cases:3.26%
controls:0.98%
cases:0.69%
controls:0.16%
—
—
cases:0.67%
controls:0.12%
cases:2.44%
controls:0.95%
cases:3.91%
controls:1.93%
208
999
5013
51173
170
510
5051
51662
36
82
5185
52090
—
35
65
5178
52010
124
483
4955
50402
180
886
4418
44931
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
8.7e-01
1.1e+00
2.1e+00
—
—
1.7e+00
1.1e+00
cases:1.57%
controls:0.66%
cases:0.73%
controls:0.25%
cases:0.17%
controls:0.02%
—
—
—
—
cases:1.18%
controls:0.23%
cases:2.41%
controls:0.81%
82
345
5139
51827
38
130
5183
52042
9
11
5212
52161
—
—
60
115
5019
50770
111
370
4487
45447
Gas panel - Central venous blood
97535-9 [1616796]
9.3e-01
1.2e+00
—
—
2.2e+00
1.2e+00
1.3e+00
cases:0.48%
controls:0.19%
cases:0.33%
controls:0.09%
—
—
—
—
cases:0.13%
controls:0.02%
cases:0.41%
controls:0.13%
cases:1.02%
controls:0.28%
25
99
5196
52073
17
49
5204
52123
—
—
7
8
5206
52067
21
64
5058
50821
47
130
4551
45687
Psoriasis, unspecified
L40.9 [45533641]
1.1e+00
2.4e+00
—
—
—
2.5e+00
1.8e+00
cases:0.15%
controls:0.05%
cases:0.29%
controls:0.02%
—
—
—
—
—
—
cases:0.32%
controls:0.03%
cases:0.48%
controls:0.08%
8
27
5213
52145
15
13
5206
52159
—
—
—
16
13
5063
50872
22
35
4576
45782
DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]
7.8e-01
1.1e+00
—
—
2.6e+00
1.2e+00
1.0e+00
cases:0.82%
controls:0.38%
cases:0.40%
controls:0.13%
—
—
—
—
cases:0.27%
controls:0.02%
cases:0.49%
controls:0.15%
cases:1.22%
controls:0.43%
43
198
5178
51974
21
69
5200
52103
—
—
14
10
5199
52065
25
76
5054
50809
56
197
4542
45620
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
5.2e-01
7.7e-01
1.3e+00
—
1.9e+00
1.1e+00
1.2e+00
cases:1.93%
controls:1.16%
cases:1.19%
controls:0.56%
cases:0.34%
controls:0.09%
—
—
cases:0.67%
controls:0.10%
cases:1.30%
controls:0.46%
cases:4.09%
controls:1.32%
101
607
5120
51565
62
290
5159
51882
18
47
5203
52125
—
35
52
5178
52023
66
233
5013
50652
188
604
4410
45213
Inpatient Visit
IP [9201]
1.9e-01
3.3e-01
8.4e-01
3.2e+00
1.2e+00
5.4e-01
6.0e-01
cases:4.65%
controls:3.88%
cases:2.41%
controls:1.74%
cases:0.42%
controls:0.18%
cases:0.29%
controls:0.01%
cases:0.75%
controls:0.23%
cases:2.68%
controls:1.58%
cases:8.57%
controls:4.87%
243
2026
4978
50146
126
910
5095
51262
22
95
5199
52077
15
6
5206
52166
39
121
5174
51954
136
803
4943
50082
394
2231
4204
43586
prednisone; oral
H02AB07 [21602735]
5.7e-01
1.4e+00
1.6e+00
1.0e+50
1.7e+00
7.4e-01
7.0e-01
cases:2.18%
controls:1.24%
cases:1.76%
controls:0.44%
cases:0.31%
controls:0.06%
cases:0.23%
controls:0.00%
cases:0.35%
controls:0.06%
cases:0.96%
controls:0.46%
cases:2.37%
controls:1.19%
114
649
5107
51523
92
228
5129
51944
16
33
5205
52139
12
0
5209
52172
18
33
5195
52042
49
236
5030
50649
109
547
4489
45270
prednisone
A07EA03 [21600655]
5.7e-01
1.4e+00
1.6e+00
1.0e+50
1.7e+00
7.4e-01
7.0e-01
cases:2.18%
controls:1.24%
cases:1.76%
controls:0.44%
cases:0.31%
controls:0.06%
cases:0.23%
controls:0.00%
cases:0.35%
controls:0.06%
cases:0.96%
controls:0.46%
cases:2.37%
controls:1.19%
114
649
5107
51523
92
228
5129
51944
16
33
5205
52139
12
0
5209
52172
18
33
5195
52042
49
236
5030
50649
109
547
4489
45270
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
2.8e-01
4.0e-01
9.9e-01
3.1e+00
9.4e-01
6.6e-01
6.0e-01
cases:2.95%
controls:2.24%
cases:1.55%
controls:1.04%
cases:0.44%
controls:0.16%
cases:0.21%
controls:0.01%
cases:0.40%
controls:0.16%
cases:1.87%
controls:0.97%
cases:4.63%
controls:2.59%
154
1169
5067
51003
81
543
5140
51629
23
86
5198
52086
11
5
5210
52167
21
82
5192
51993
95
496
4984
50389
213
1187
4385
44630
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
3.1e-01
8.8e-01
1.7e+00
1.0e+50
2.4e+00
9.0e-01
4.8e-01
cases:2.97%
controls:2.20%
cases:1.82%
controls:0.76%
cases:0.48%
controls:0.09%
cases:0.15%
controls:0.00%
cases:0.81%
controls:0.07%
cases:1.87%
controls:0.77%
cases:4.39%
controls:2.76%
155
1149
5066
51023
95
399
5126
51773
25
46
5196
52126
8
0
5213
52172
42
38
5171
52037
95
390
4984
50495
202
1263
4396
44554
benzylpenicillin
S01AA14 [21603565]
1.4e+00
2.0e+00
—
—
—
1.4e+00
1.9e+00
cases:0.27%
controls:0.07%
cases:0.21%
controls:0.03%
—
—
—
—
—
—
cases:0.20%
controls:0.05%
cases:0.54%
controls:0.09%
14
35
5207
52137
11
15
5210
52157
—
—
—
10
24
5069
50861
25
39
4573
45778
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
17791-5 [3027450]
7.0e-01
1.2e+00
—
—
3.0e+00
1.6e+00
8.7e-01
cases:0.48%
controls:0.24%
cases:0.27%
controls:0.08%
—
—
—
—
cases:0.19%
controls:0.01%
cases:0.49%
controls:0.10%
cases:0.83%
controls:0.35%
25
124
5196
52048
14
41
5207
52131
—
—
10
5
5203
52070
25
52
5054
50833
38
160
4560
45657
Supplier / Service Provider
OMOP5117446 [33004]
-1.1e+00
-9.1e-01
-6.5e-01
—
2.7e+00
2.7e+00
3.2e+00
cases:10.78%
controls:25.74%
cases:3.29%
controls:7.80%
cases:0.38%
controls:0.73%
—
—
cases:0.50%
controls:0.03%
cases:4.19%
controls:0.28%
cases:13.55%
controls:0.62%
563
13429
4658
38743
172
4069
5049
48103
20
382
5201
51790
—
26
18
5187
52057
213
145
4866
50740
623
285
3975
45532
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
6.2e-01
7.9e-01
1.3e+00
—
1.7e+00
1.1e+00
1.1e+00
cases:1.09%
controls:0.59%
cases:1.07%
controls:0.49%
cases:0.38%
controls:0.11%
—
—
cases:0.44%
controls:0.08%
cases:1.52%
controls:0.51%
cases:3.41%
controls:1.13%
57
307
5164
51865
56
255
5165
51917
20
56
5201
52116
—
23
42
5190
52033
77
259
5002
50626
157
518
4441
45299
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
7.9e-01
9.7e-01
2.6e+00
—
—
1.1e+00
1.2e+00
cases:0.84%
controls:0.38%
cases:0.38%
controls:0.15%
cases:0.15%
controls:0.01%
—
—
—
—
cases:0.35%
controls:0.12%
cases:1.17%
controls:0.36%
44
200
5177
51972
20
76
5201
52096
8
6
5213
52166
—
—
18
63
5061
50822
54
163
4544
45654
Abdominal ultrasound examination
JN3AE [2001305555]
4.1e-01
5.8e-01
1.6e+00
1.0e+50
2.3e+00
1.3e+00
1.0e+00
cases:1.65%
controls:1.10%
cases:0.67%
controls:0.38%
cases:0.23%
controls:0.05%
cases:0.25%
controls:0.00%
cases:0.23%
controls:0.02%
cases:0.98%
controls:0.28%
cases:3.18%
controls:1.17%
86
572
5135
51600
35
196
5186
51976
12
24
5209
52148
13
0
5208
52172
12
12
5201
52063
50
144
5029
50741
146
538
4452
45279
Essential (primary) hypertension
I10 [45591453]
3.5e-01
4.1e-01
6.4e-01
3.5e+00
8.0e-01
5.0e-01
4.0e-01
cases:17.30%
controls:12.87%
cases:9.81%
controls:6.73%
cases:1.88%
controls:1.00%
cases:1.92%
controls:0.06%
cases:2.30%
controls:1.05%
cases:10.65%
controls:6.76%
cases:24.47%
controls:17.79%
903
6715
4318
45457
512
3513
4709
48659
98
523
5123
51649
100
31
5121
52141
120
548
5093
51527
541
3440
4538
47445
1125
8149
3473
37668
Bacteria identified in Isolate by Culture
43409-2 [3042936]
4.5e-01
1.0e+00
1.8e+00
—
1.5e+00
1.0e+00
8.1e-01
cases:2.22%
controls:1.43%
cases:1.53%
controls:0.57%
cases:0.44%
controls:0.07%
—
—
cases:0.29%
controls:0.06%
cases:1.36%
controls:0.50%
cases:4.37%
controls:2.00%
116
747
5105
51425
80
297
5141
51875
23
39
5198
52133
—
15
33
5198
52042
69
253
5010
50632
201
915
4397
44902
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1.7e-01
4.4e-01
1.0e+00
3.0e+00
1.0e+00
5.0e-01
3.4e-01
cases:21.51%
controls:18.78%
cases:17.62%
controls:12.09%
cases:6.22%
controls:2.29%
cases:2.99%
controls:0.15%
cases:5.93%
controls:2.22%
cases:18.53%
controls:12.12%
cases:35.23%
controls:27.87%
1123
9797
4098
42375
920
6307
4301
45865
325
1194
4896
50978
156
79
5065
52093
309
1155
4904
50920
941
6169
4138
44716
1620
12771
2978
33046
Vascular Surgery
77 [38004496]
5.0e-01
8.3e-01
1.6e+00
—
1.7e+00
1.1e+00
8.2e-01
cases:3.18%
controls:1.96%
cases:1.95%
controls:0.86%
cases:0.69%
controls:0.14%
—
—
cases:0.73%
controls:0.14%
cases:2.60%
controls:0.90%
cases:5.55%
controls:2.51%
166
1020
5055
51152
102
449
5119
51723
36
72
5185
52100
—
38
73
5175
52002
132
456
4947
50429
255
1152
4343
44665
Skin disease other
S99 [2002001063]
7.1e-01
3.2e+00
—
—
—
1.8e+00
1.4e+00
cases:0.23%
controls:0.11%
cases:0.54%
controls:0.02%
—
—
—
—
—
—
cases:0.24%
controls:0.04%
cases:0.54%
controls:0.13%
12
59
5209
52113
28
11
5193
52161
—
—
—
12
19
5067
50866
25
61
4573
45756
Other specified local infections of skin and subcutaneous tissue
L08.8 [45601211]
1.1e+00
1.7e+00
—
—
—
2.4e+00
1.3e+00
cases:0.40%
controls:0.14%
cases:0.23%
controls:0.04%
—
—
—
—
—
—
cases:0.43%
controls:0.04%
cases:0.74%
controls:0.21%
21
72
5200
52100
12
21
5209
52151
—
—
—
22
20
5057
50865
34
97
4564
45720
methylprednisolone; oral, parenteral
H02AB04 [21602732]
6.1e-01
1.4e+00
1.4e+00
1.0e+50
1.5e+00
8.0e-01
7.7e-01
cases:3.18%
controls:1.75%
cases:2.41%
controls:0.62%
cases:0.40%
controls:0.10%
cases:0.31%
controls:0.00%
cases:0.44%
controls:0.10%
cases:1.50%
controls:0.68%
cases:3.09%
controls:1.46%
166
912
5055
51260
126
322
5095
51850
21
52
5200
52120
16
0
5205
52172
23
51
5190
52024
76
344
5003
50541
142
669
4456
45148
Bullous pemphigoid
L12.0 [45533635]
—
—
—
1.0e+50
1.0e+50
3.5e+00
3.0e+00
—
—
—
—
—
—
cases:0.11%
controls:0.00%
cases:0.17%
controls:0.00%
cases:0.32%
controls:0.01%
cases:0.35%
controls:0.02%
—
—
—
6
0
5215
52172
9
0
5204
52075
16
5
5063
50880
16
8
4582
45809
Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
71792-6 [42869547]
1.4e+00
—
—
—
—
3.3e+00
3.1e+00
cases:0.10%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.28%
controls:0.01%
cases:0.52%
controls:0.02%
5
12
5216
52160
—
—
—
—
14
5
5065
50880
24
11
4574
45806
Pain/tenderness of skin
S01 [2002000966]
1.2e+00
2.2e+00
—
—
—
1.7e+00
1.3e+00
cases:0.79%
controls:0.24%
cases:0.46%
controls:0.05%
—
—
—
—
—
—
cases:0.35%
controls:0.07%
cases:1.20%
controls:0.32%
41
126
5180
52046
24
27
5197
52145
—
—
—
18
34
5061
50851
55
148
4543
45669
saccharomyces boulardii; oral
A07FA02 [21600670]
5.6e-01
1.1e+00
1.8e+00
1.0e+50
2.6e+00
1.5e+00
6.3e-01
cases:0.86%
controls:0.49%
cases:0.42%
controls:0.13%
cases:0.11%
controls:0.02%
cases:0.13%
controls:0.00%
cases:0.17%
controls:0.01%
cases:0.51%
controls:0.12%
cases:1.24%
controls:0.66%
45
257
5176
51915
22
70
5199
52102
6
10
5215
52162
7
0
5214
52172
9
7
5204
52068
26
61
5053
50824
57
304
4541
45513
Other psoriatic arthropathies
M07.3*L40.5 [2000503010]
9.9e-01
1.1e+00
1.8e+00
—
1.6e+00
1.3e+00
1.2e+00
cases:0.48%
controls:0.18%
cases:0.40%
controls:0.13%
cases:0.13%
controls:0.02%
—
—
cases:0.10%
controls:0.02%
cases:0.43%
controls:0.12%
cases:0.65%
controls:0.20%
25
93
5196
52079
21
67
5200
52105
7
12
5214
52160
—
5
10
5208
52065
22
62
5057
50823
30
93
4568
45724
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
5.7e-01
7.7e-01
1.3e+00
—
1.5e+00
1.1e+00
1.1e+00
cases:1.17%
controls:0.67%
cases:1.11%
controls:0.52%
cases:0.42%
controls:0.12%
—
—
cases:0.42%
controls:0.09%
cases:1.63%
controls:0.55%
cases:3.61%
controls:1.27%
61
348
5160
51824
58
270
5163
51902
22
60
5199
52112
—
22
47
5191
52028
83
282
4996
50603
166
583
4432
45234
Allergic contact dermatitis, unspecified cause
L23.9 [45596369]
3.0e+00
—
1.0e+50
1.0e+50
1.0e+50
—
3.3e+00
cases:0.23%
controls:0.01%
—
—
cases:0.19%
controls:0.00%
cases:0.21%
controls:0.00%
cases:0.12%
controls:0.00%
—
—
cases:0.52%
controls:0.02%
12
6
5209
52166
—
10
0
5211
52172
11
0
5210
52172
6
0
5207
52075
—
24
9
4574
45808
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
5.3e-01
7.8e-01
1.3e+00
—
1.6e+00
1.1e+00
1.1e+00
cases:1.07%
controls:0.63%
cases:1.11%
controls:0.51%
cases:0.40%
controls:0.12%
—
—
cases:0.42%
controls:0.09%
cases:1.59%
controls:0.55%
cases:3.39%
controls:1.20%
56
330
5165
51842
58
267
5163
51905
21
60
5200
52112
—
22
46
5191
52029
81
280
4998
50605
156
550
4442
45267
clindamycin
D10AF01 [21602305]
7.3e-01
1.2e+00
—
1.0e+50
2.0e+00
1.3e+00
9.9e-01
cases:1.07%
controls:0.52%
cases:0.54%
controls:0.16%
—
—
cases:0.10%
controls:0.00%
cases:0.17%
controls:0.02%
cases:0.51%
controls:0.14%
cases:1.17%
controls:0.44%
56
272
5165
51900
28
85
5193
52087
—
5
0
5216
52172
9
12
5204
52063
26
69
5053
50816
54
201
4544
45616
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
3.7e-01
3.8e-01
5.7e-01
3.7e+00
8.6e-01
4.7e-01
4.9e-01
cases:5.71%
controls:4.02%
cases:3.08%
controls:2.13%
cases:0.59%
controls:0.34%
cases:0.54%
controls:0.01%
cases:0.82%
controls:0.35%
cases:3.58%
controls:2.27%
cases:8.92%
controls:5.68%
298
2095
4923
50077
161
1109
5060
51063
31
176
5190
51996
28
7
5193
52165
43
183
5170
51892
182
1155
4897
49730
410
2602
4188
43215
lidocaine; parenteral
C01BB01 [21600260]
1.2e+00
1.6e+00
1.3e+00
—
—
1.4e+00
2.0e+00
cases:0.36%
controls:0.11%
cases:0.29%
controls:0.06%
cases:0.10%
controls:0.03%
—
—
—
—
cases:0.30%
controls:0.07%
cases:0.72%
controls:0.10%
19
56
5202
52116
15
30
5206
52142
5
14
5216
52158
—
—
15
36
5064
50849
33
46
4565
45771
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
1.1e+00
1.1e+00
1.4e+00
—
2.2e-01
1.1e+00
1.5e+00
cases:0.50%
controls:0.17%
cases:0.50%
controls:0.17%
cases:0.21%
controls:0.05%
—
—
cases:0.10%
controls:0.08%
cases:0.57%
controls:0.19%
cases:1.07%
controls:0.23%
26
88
5195
52084
26
88
5195
52084
11
27
5210
52145
—
5
40
5208
52035
29
98
5050
50787
49
107
4549
45710
Other lichen planus
L43.8 [45577038]
1.1e+00
2.0e+00
2.1e+00
—
—
1.9e+00
1.2e+00
cases:0.31%
controls:0.11%
cases:0.17%
controls:0.02%
cases:0.10%
controls:0.01%
—
—
—
—
cases:0.28%
controls:0.04%
cases:0.33%
controls:0.10%
16
55
5205
52117
9
12
5212
52160
5
6
5216
52166
—
—
14
21
5065
50864
15
45
4583
45772
Urticaria, unspecified
L50.9 [45562541]
8.8e-01
2.2e+00
1.0e+50
—
—
1.8e+00
1.2e+00
cases:0.42%
controls:0.17%
cases:0.57%
controls:0.06%
cases:0.21%
controls:0.00%
—
—
—
—
cases:0.35%
controls:0.06%
cases:0.74%
controls:0.22%
22
91
5199
52081
30
32
5191
52140
11
0
5210
52172
—
—
18
29
5061
50856
34
103
4564
45714
Blasts/Leukocytes in Blood
26446-5 [3025159]
5.4e-01
7.3e-01
1.2e+00
—
1.5e+00
1.1e+00
1.0e+00
cases:0.98%
controls:0.57%
cases:1.07%
controls:0.52%
cases:0.40%
controls:0.12%
—
—
cases:0.44%
controls:0.10%
cases:1.59%
controls:0.54%
cases:3.28%
controls:1.19%
51
299
5170
51873
56
270
5165
51902
21
63
5200
52109
—
23
50
5190
52025
81
277
4998
50608
151
545
4447
45272
Psoriasis
L40 [45577035]
1.3e+00
1.6e+00
—
—
—
1.6e+00
1.6e+00
cases:0.42%
controls:0.11%
cases:0.21%
controls:0.04%
—
—
—
—
—
—
cases:0.18%
controls:0.04%
cases:0.61%
controls:0.12%
22
58
5199
52114
11
22
5210
52150
—
—
—
9
19
5070
50866
28
56
4570
45761
Nephrology
39 [38004479]
7.5e-01
9.0e-01
1.2e+00
1.5e+00
1.2e+00
1.1e+00
9.4e-01
cases:1.55%
controls:0.74%
cases:1.34%
controls:0.55%
cases:0.65%
controls:0.19%
cases:0.13%
controls:0.03%
cases:0.65%
controls:0.19%
cases:1.59%
controls:0.56%
cases:2.26%
controls:0.89%
81
385
5140
51787
70
288
5151
51884
34
100
5187
52072
7
15
5214
52157
34
100
5179
51975
81
284
4998
50601
104
410
4494
45407
Destruction of lesion of skin, site unspecified
QXA25 [2001310041]
1.1e+00
1.5e+00
—
1.0e+50
1.0e+50
1.9e+00
1.6e+00
cases:0.38%
controls:0.13%
cases:0.23%
controls:0.05%
—
—
cases:0.13%
controls:0.00%
cases:0.12%
controls:0.00%
cases:0.43%
controls:0.06%
cases:0.74%
controls:0.14%
20
69
5201
52103
12
28
5209
52144
—
7
0
5214
52172
6
0
5207
52075
22
32
5057
50853
34
66
4564
45751
furosemide; oral, parenteral
C03CA01 [21601518]
6.1e-01
6.7e-01
7.0e-01
2.0e+00
5.9e-01
7.9e-01
7.1e-01
cases:7.91%
controls:4.47%
cases:6.95%
controls:3.69%
cases:2.30%
controls:1.15%
cases:0.17%
controls:0.02%
cases:2.00%
controls:1.12%
cases:8.19%
controls:3.89%
cases:12.22%
controls:6.42%
413
2331
4808
49841
363
1926
4858
50246
120
600
5101
51572
9
12
5212
52160
104
583
5109
51492
416
1980
4663
48905
562
2941
4036
42876
Impetigo [any organism] [any site]
L01.0 [45572243]
1.5e+00
3.1e+00
—
1.0e+50
—
1.6e+00
1.5e+00
cases:0.21%
controls:0.05%
cases:0.36%
controls:0.02%
—
—
cases:0.23%
controls:0.00%
—
—
cases:0.12%
controls:0.02%
cases:0.46%
controls:0.11%
11
24
5210
52148
19
9
5202
52163
—
12
0
5209
52172
—
6
12
5073
50873
21
49
4577
45768
Removal of sutures
SPAT1153 [2001700254]
3.9e-01
9.5e-01
1.4e+00
—
1.9e+00
7.7e-01
6.5e-01
cases:5.29%
controls:3.64%
cases:2.72%
controls:1.07%
cases:0.46%
controls:0.12%
—
—
cases:0.58%
controls:0.09%
cases:2.28%
controls:1.07%
cases:7.22%
controls:3.89%
276
1900
4945
50272
142
559
5079
51613
24
62
5197
52110
—
30
47
5183
52028
116
546
4963
50339
332
1783
4266
44034
Split skin graft
ZZA00 [2001311610]
1.2e+00
2.0e+00
—
—
—
1.6e+00
1.1e+00
cases:0.52%
controls:0.15%
cases:0.44%
controls:0.06%
—
—
—
—
—
—
cases:0.22%
controls:0.05%
cases:0.48%
controls:0.15%
27
80
5194
52092
23
30
5198
52142
—
—
—
11
23
5068
50862
22
70
4576
45747
Feet X-ray examination with load
NH3EA [2001308283]
5.3e-01
2.4e+00
—
—
—
1.8e+00
1.8e+00
cases:0.23%
controls:0.14%
cases:0.27%
controls:0.02%
—
—
—
—
—
—
cases:0.14%
controls:0.02%
cases:0.46%
controls:0.07%
12
71
5209
52101
14
13
5207
52159
—
—
—
7
12
5072
50873
21
34
4577
45783
loratadine; oral
R06AX13 [21603514]
6.2e-01
1.1e+00
1.5e+00
—
1.3e+00
8.6e-01
5.6e-01
cases:2.76%
controls:1.50%
cases:1.93%
controls:0.64%
cases:0.40%
controls:0.09%
—
—
cases:0.31%
controls:0.08%
cases:1.44%
controls:0.61%
cases:2.17%
controls:1.25%
144
783
5077
51389
101
334
5120
51838
21
49
5200
52123
—
16
42
5197
52033
73
311
5006
50574
100
572
4498
45245
Treatment of major wounds
SPAT1151 [2001700252]
8.3e-01
2.2e+00
—
—
1.0e+50
2.2e+00
1.6e+00
cases:0.15%
controls:0.07%
cases:0.17%
controls:0.02%
—
—
—
—
cases:0.10%
controls:0.00%
cases:0.12%
controls:0.01%
cases:0.33%
controls:0.07%
8
35
5213
52137
9
10
5212
52162
—
—
5
0
5208
52075
6
7
5073
50878
15
30
4583
45787
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
2.8e-01
4.7e-01
6.3e-01
2.4e+00
1.0e+00
5.9e-01
5.9e-01
cases:8.56%
controls:6.61%
cases:5.67%
controls:3.62%
cases:1.34%
controls:0.72%
cases:0.36%
controls:0.03%
cases:1.86%
controls:0.68%
cases:6.30%
controls:3.60%
cases:15.96%
controls:9.51%
447
3446
4774
48726
296
1887
4925
50285
70
375
5151
51797
19
18
5202
52154
97
353
5116
51722
320
1831
4759
49054
734
4359
3864
41458
Helicobacter pylori Ab [Units/volume] in Serum
7900-4 [3017895]
1.2e-01
9.7e-01
2.5e+00
—
2.4e+00
1.1e+00
5.1e-01
cases:0.46%
controls:0.41%
cases:0.29%
controls:0.11%
cases:0.13%
controls:0.01%
—
—
cases:0.21%
controls:0.02%
cases:0.35%
controls:0.12%
cases:0.65%
controls:0.39%
24
212
5197
51960
15
57
5206
52115
7
6
5214
52166
—
11
10
5202
52065
18
61
5061
50824
30
180
4568
45637
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
2.7e-01
4.1e-01
6.8e-01
2.3e+00
1.1e+00
6.3e-01
5.5e-01
cases:15.11%
controls:12.01%
cases:10.73%
controls:7.39%
cases:2.80%
controls:1.44%
cases:0.63%
controls:0.06%
cases:3.80%
controls:1.34%
cases:12.96%
controls:7.37%
cases:26.42%
controls:17.19%
789
6264
4432
45908
560
3858
4661
48314
146
753
5075
51419
33
32
5188
52140
198
698
5015
51377
658
3748
4421
47137
1215
7877
3383
37940
Pulmonary Disease
29 [38004472]
5.0e-01
6.3e-01
4.2e-01
2.6e+00
7.4e-01
7.1e-01
7.3e-01
cases:10.82%
controls:6.88%
cases:6.44%
controls:3.53%
cases:1.11%
controls:0.73%
cases:0.33%
controls:0.02%
cases:1.38%
controls:0.66%
cases:7.07%
controls:3.59%
cases:14.94%
controls:7.79%
565
3587
4656
48585
336
1842
4885
50330
58
383
5163
51789
17
13
5204
52159
72
345
5141
51730
359
1826
4720
49059
687
3567
3911
42250
Orthopedic Surgery
20 [38004465]
4.1e-01
6.1e-01
9.2e-01
2.0e+00
8.0e-01
5.4e-01
5.3e-01
cases:16.66%
controls:11.67%
cases:8.22%
controls:4.63%
cases:1.95%
controls:0.79%
cases:0.25%
controls:0.03%
cases:1.67%
controls:0.76%
cases:7.68%
controls:4.62%
cases:21.51%
controls:13.91%
870
6088
4351
46084
429
2413
4792
49759
102
411
5119
51761
13
17
5208
52155
87
395
5126
51680
390
2350
4689
48535
989
6373
3609
39444
Tinea unguium
B35.1 [45590850]
4.4e-01
1.1e+00
—
1.0e+50
2.7e+00
2.0e+00
4.0e-01
cases:0.59%
controls:0.38%
cases:0.36%
controls:0.12%
—
—
cases:0.46%
controls:0.00%
cases:0.17%
controls:0.01%
cases:0.96%
controls:0.13%
cases:0.96%
controls:0.64%
31
200
5190
51972
19
63
5202
52109
—
24
0
5197
52172
9
6
5204
52069
49
66
5030
50819
44
295
4554
45522
Plastic And Reconstructive Surgery
24 [38004467]
5.2e-01
9.9e-01
1.5e+00
1.0e+50
1.5e+00
6.9e-01
5.8e-01
cases:3.43%
controls:2.07%
cases:2.20%
controls:0.83%
cases:0.67%
controls:0.15%
cases:0.15%
controls:0.00%
cases:0.52%
controls:0.12%
cases:1.65%
controls:0.83%
cases:4.26%
controls:2.44%
179
1079
5042
51093
115
435
5106
51737
35
76
5186
52096
8
0
5213
52172
27
60
5186
52015
84
424
4995
50461
196
1116
4402
44701
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 [46235759]
8.6e-01
1.1e+00
—
—
2.0e+00
1.0e+00
7.8e-01
cases:0.80%
controls:0.34%
cases:0.54%
controls:0.17%
—
—
—
—
cases:0.12%
controls:0.02%
cases:0.47%
controls:0.17%
cases:0.94%
controls:0.43%
42
178
5179
51994
28
90
5193
52082
—
—
6
8
5207
52067
24
87
5055
50798
43
198
4555
45619
Hospital outpatient
ZY010 [2001311599]
4.9e-01
5.6e-01
1.3e+00
1.0e+50
2.6e+00
1.8e+00
1.4e+00
cases:0.61%
controls:0.38%
cases:0.21%
controls:0.12%
cases:0.15%
controls:0.04%
cases:0.80%
controls:0.00%
cases:0.44%
controls:0.03%
cases:0.77%
controls:0.13%
cases:1.26%
controls:0.30%
32
196
5189
51976
11
63
5210
52109
8
22
5213
52150
42
0
5179
52172
23
18
5190
52057
39
64
5040
50821
58
139
4540
45678
Cardiovascular disease other
K99 [2002000624]
9.6e-01
1.4e+00
1.9e+00
—
1.6e+00
1.5e+00
4.3e-01
cases:0.46%
controls:0.18%
cases:0.33%
controls:0.08%
cases:0.17%
controls:0.02%
—
—
cases:0.13%
controls:0.03%
cases:0.28%
controls:0.06%
cases:0.35%
controls:0.23%
24
92
5197
52080
17
41
5204
52131
9
13
5212
52159
—
7
14
5206
52061
14
32
5065
50853
16
104
4582
45713
Crohn disease of large intestine
K50.1 [45601173]
1.3e+00
1.4e+00
—
—
—
1.8e+00
1.4e+00
cases:0.36%
controls:0.10%
cases:0.21%
controls:0.05%
—
—
—
—
—
—
cases:0.30%
controls:0.05%
cases:0.37%
controls:0.10%
19
53
5202
52119
11
28
5210
52144
—
—
—
15
25
5064
50860
17
44
4581
45773
Podiatric therapy
R4180 [2001310242]
1.1e+00
1.7e+00
—
1.0e+50
—
2.2e+00
1.9e+00
cases:0.11%
controls:0.04%
cases:0.17%
controls:0.03%
—
—
cases:0.10%
controls:0.00%
—
—
cases:0.24%
controls:0.03%
cases:0.50%
controls:0.08%
6
19
5215
52153
9
16
5212
52156
—
5
0
5216
52172
—
12
14
5067
50871
23
35
4575
45782
Short blood count panel - Blood
55429-5 [40758558]
-6.4e-02
2.1e-01
6.9e-01
3.1e+00
1.1e+00
4.7e-01
3.7e-01
cases:3.28%
controls:3.48%
cases:2.28%
controls:1.85%
cases:0.73%
controls:0.37%
cases:0.50%
controls:0.02%
cases:1.19%
controls:0.39%
cases:2.70%
controls:1.70%
cases:6.39%
controls:4.52%
171
1818
5050
50354
119
964
5102
51208
38
191
5183
51981
26
12
5195
52160
62
204
5151
51871
137
863
4942
50022
294
2070
4304
43747
Alcohol dependence continuous use
F10.25 [2000501682]
1.2e+00
1.8e+00
—
—
—
1.6e+00
1.1e+00
cases:0.36%
controls:0.11%
cases:0.21%
controls:0.03%
—
—
—
—
—
—
cases:0.26%
controls:0.05%
cases:0.54%
controls:0.19%
19
55
5202
52117
11
18
5210
52154
—
—
—
13
26
5066
50859
25
87
4573
45730
General Surgery
2 [38004447]
4.0e-01
5.0e-01
8.6e-01
2.4e+00
6.0e-01
5.1e-01
4.3e-01
cases:24.69%
controls:18.03%
cases:9.46%
controls:5.94%
cases:1.88%
controls:0.81%
cases:0.50%
controls:0.04%
cases:1.57%
controls:0.87%
cases:9.19%
controls:5.75%
cases:22.25%
controls:15.76%
1289
9407
3932
42765
494
3100
4727
49072
98
420
5123
51752
26
23
5195
52149
82
453
5131
51622
467
2927
4612
47958
1023
7220
3575
38597
Otolaryngology
4 [38004449]
4.1e-01
4.9e-01
6.4e-01
2.4e+00
7.1e-01
5.1e-01
5.0e-01
cases:13.58%
controls:9.43%
cases:5.78%
controls:3.62%
cases:1.00%
controls:0.53%
cases:0.31%
controls:0.03%
cases:1.07%
controls:0.53%
cases:5.71%
controls:3.50%
cases:15.57%
controls:10.03%
709
4921
4512
47251
302
1890
4919
50282
52
274
5169
51898
16
14
5205
52158
56
277
5157
51798
290
1781
4789
49104
716
4595
3882
41222
Normoblasts [#/volume] in Blood
715-3 [3021589]
1.3e-01
3.6e-01
7.9e-01
2.4e+00
1.1e+00
5.5e-01
5.2e-01
cases:6.47%
controls:5.72%
cases:6.22%
controls:4.44%
cases:2.16%
controls:1.00%
cases:0.71%
controls:0.07%
cases:2.82%
controls:0.98%
cases:7.60%
controls:4.54%
cases:13.72%
controls:8.66%
338
2985
4883
49187
325
2317
4896
49855
113
521
5108
51651
37
34
5184
52138
147
508
5066
51567
386
2309
4693
48576
631
3967
3967
41850
etanercept; parenteral
L04AB01 [21603908]
1.3e+00
1.6e+00
1.5e+00
—
1.0e+00
1.6e+00
1.2e+00
cases:0.44%
controls:0.13%
cases:0.44%
controls:0.09%
cases:0.13%
controls:0.03%
—
—
cases:0.12%
controls:0.04%
cases:0.49%
controls:0.10%
cases:0.54%
controls:0.16%
23
66
5198
52106
23
48
5198
52124
7
15
5214
52157
—
6
21
5207
52054
25
51
5054
50834
25
73
4573
45744
azathioprine; oral, parenteral
L04AX01 [21603927]
1.0e+00
7.5e-01
8.1e-01
—
1.2e+00
1.2e+00
1.4e+00
cases:1.26%
controls:0.46%
cases:0.67%
controls:0.32%
cases:0.21%
controls:0.09%
—
—
cases:0.25%
controls:0.07%
cases:1.02%
controls:0.31%
cases:1.65%
controls:0.40%
66
238
5155
51934
35
166
5186
52006
11
49
5210
52123
—
13
38
5200
52037
52
158
5027
50727
76
184
4522
45633
Type 1 diabetes mellitus, With peripheral circulatory complications
E10.5 [45595796]
1.6e+00
2.2e+00
—
—
—
—
1.8e+00
cases:0.19%
controls:0.04%
cases:0.13%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.33%
controls:0.05%
10
20
5211
52152
7
8
5214
52164
—
—
—
—
15
24
4583
45793
Cellulitis of finger and toe
L03.0 [45557691]
5.6e-01
1.3e+00
2.3e+00
—
—
7.8e-01
6.5e-01
cases:0.98%
controls:0.56%
cases:0.59%
controls:0.16%
cases:0.15%
controls:0.02%
—
—
—
—
cases:0.47%
controls:0.22%
cases:1.41%
controls:0.74%
51
292
5170
51880
31
84
5190
52088
8
8
5213
52164
—
—
24
110
5055
50775
65
341
4533
45476
Case Management Agency
251B00000X [38004193]
1.9e-01
2.6e-01
6.5e-01
3.4e+00
5.6e-01
2.5e-01
2.5e-01
cases:52.56%
controls:47.91%
cases:48.44%
controls:41.91%
cases:27.18%
controls:16.31%
cases:22.64%
controls:1.01%
cases:25.57%
controls:16.39%
cases:50.48%
controls:44.23%
cases:70.05%
controls:64.54%
2744
24997
2477
27175
2529
21865
2692
30307
1419
8509
3802
43663
1182
527
4039
51645
1333
8533
3880
43542
2564
22507
2515
28378
3221
29569
1377
16248
Inflammatory spondylopathy, unspecified
M46.9 [45533846]
1.1e+00
2.2e+00
—
—
—
1.9e+00
1.3e+00
cases:0.17%
controls:0.06%
cases:0.25%
controls:0.03%
—
—
—
—
—
—
cases:0.18%
controls:0.03%
cases:0.28%
controls:0.07%
9
29
5212
52143
13
14
5208
52158
—
—
—
9
13
5070
50872
13
34
4585
45783
Revision of wound of skin of lower limb
QDB05 [2001309969]
1.4e+00
1.8e+00
—
—
—
1.4e+00
8.7e-01
cases:0.50%
controls:0.13%
cases:0.33%
controls:0.05%
—
—
—
—
—
—
cases:0.22%
controls:0.05%
cases:0.52%
controls:0.22%
26
66
5195
52106
17
28
5204
52144
—
—
—
11
26
5068
50859
24
100
4574
45717
Fitting and adjustment of other specified devices
Z46.8 [45581035]
1.0e+00
1.7e+00
—
—
—
1.8e+00
9.3e-01
cases:0.31%
controls:0.11%
cases:0.27%
controls:0.05%
—
—
—
—
—
—
cases:0.39%
controls:0.06%
cases:0.54%
controls:0.22%
16
58
5205
52114
14
26
5207
52146
—
—
—
20
32
5059
50853
25
99
4573
45718
Dermatitis herpetiformis
L13.0 [45581937]
1.5e+00
2.6e+00
—
—
—
—
2.8e+00
cases:0.10%
controls:0.02%
cases:0.27%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.22%
controls:0.01%
5
11
5216
52161
14
10
5207
52162
—
—
—
—
10
6
4588
45811
Type 2 diabetes mellitus, with multiple complications
E11.7 [45561950]
5.4e-01
1.1e+00
1.1e+00
—
1.9e+00
9.6e-01
9.8e-01
cases:0.96%
controls:0.56%
cases:0.86%
controls:0.30%
cases:0.21%
controls:0.07%
—
—
cases:0.36%
controls:0.06%
cases:0.91%
controls:0.35%
cases:2.26%
controls:0.86%
50
291
5171
51881
45
158
5176
52014
11
36
5210
52136
—
19
29
5194
52046
46
178
5033
50707
104
396
4494
45421
Other dermatitis
L30 [45591633]
1.1e+00
2.7e+00
—
—
—
1.1e+00
1.6e+00
cases:0.25%
controls:0.08%
cases:0.48%
controls:0.03%
—
—
—
—
—
—
cases:0.12%
controls:0.04%
cases:0.61%
controls:0.12%
13
44
5208
52128
25
17
5196
52155
—
—
—
6
21
5073
50864
28
55
4570
45762
Atrial fibrillation and flutter
I48 [45596206]
2.7e-01
3.2e-01
4.6e-01
3.1e+00
7.0e-01
5.4e-01
4.5e-01
cases:5.09%
controls:3.94%
cases:3.06%
controls:2.24%
cases:0.67%
controls:0.43%
cases:0.42%
controls:0.02%
cases:0.86%
controls:0.43%
cases:3.54%
controls:2.09%
cases:7.42%
controls:4.86%
266
2056
4955
50116
160
1168
5061
51004
35
222
5186
51950
22
10
5199
52162
45
224
5168
51851
180
1064
4899
49821
341
2225
4257
43592
Emergency Room and Inpatient Visit
ERIP [262]
3.7e-01
4.4e-01
5.3e-01
3.5e+00
7.2e-01
5.8e-01
4.5e-01
cases:4.08%
controls:2.87%
cases:2.70%
controls:1.75%
cases:0.42%
controls:0.25%
cases:0.33%
controls:0.01%
cases:0.48%
controls:0.23%
cases:3.21%
controls:1.82%
cases:9.03%
controls:5.92%
213
1495
5008
50677
141
912
5080
51260
22
129
5199
52043
17
5
5204
52167
25
122
5188
51953
163
924
4916
49961
415
2714
4183
43103
Bacteria identified in Blood by Culture
600-7 [3023368]
4.6e-01
7.5e-01
1.3e+00
—
1.3e+00
9.0e-01
6.7e-01
cases:4.10%
controls:2.63%
cases:2.72%
controls:1.30%
cases:0.67%
controls:0.19%
—
—
cases:0.56%
controls:0.15%
cases:2.91%
controls:1.20%
cases:8.13%
controls:4.32%
214
1370
5007
50802
142
678
5079
51494
35
99
5186
52073
—
29
78
5184
51997
148
611
4931
50274
374
1981
4224
43836
Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
546-2 [3024135]
2.6e-01
6.9e-01
2.3e+00
—
1.5e+00
5.5e-01
3.1e-01
cases:3.14%
controls:2.45%
cases:1.47%
controls:0.75%
cases:0.50%
controls:0.05%
—
—
cases:0.38%
controls:0.08%
cases:1.28%
controls:0.74%
cases:4.02%
controls:2.99%
164
1276
5057
50896
77
390
5144
51782
26
26
5195
52146
—
20
44
5193
52031
65
376
5014
50509
185
1371
4413
44446
Localized oedema
R60.0 [45597193]
7.6e-01
9.4e-01
1.4e+00
—
1.8e+00
1.1e+00
7.2e-01
cases:1.70%
controls:0.80%
cases:0.69%
controls:0.27%
cases:0.15%
controls:0.04%
—
—
cases:0.23%
controls:0.04%
cases:0.98%
controls:0.33%
cases:2.39%
controls:1.18%
89
418
5132
51754
36
141
5185
52031
8
19
5213
52153
—
12
19
5201
52056
50
169
5029
50716
110
541
4488
45276
Thorax X-ray examination
GD1AA [2001303617]
4.0e-01
6.4e-01
1.1e+00
—
1.2e+00
1.0e+00
9.4e-01
cases:8.10%
controls:5.60%
cases:4.23%
controls:2.29%
cases:0.84%
controls:0.27%
—
—
cases:0.84%
controls:0.25%
cases:5.28%
controls:1.98%
cases:15.59%
controls:6.76%
423
2920
4798
49252
221
1194
5000
50978
44
141
5177
52031
—
44
132
5169
51943
268
1010
4811
49875
717
3097
3881
42720
Medication/prescr/renewal
-50 [2002000121]
8.1e-01
1.1e+00
—
—
2.0e+00
1.5e+00
9.7e-01
cases:0.44%
controls:0.20%
cases:0.21%
controls:0.07%
—
—
—
—
cases:0.12%
controls:0.02%
cases:0.30%
controls:0.07%
cases:0.63%
controls:0.24%
23
103
5198
52069
11
38
5210
52134
—
—
6
8
5207
52067
15
34
5064
50851
29
110
4569
45707
lansoprazole; oral
A02BC03 [21600098]
4.9e-01
4.1e-01
3.5e-01
2.8e+00
7.2e-01
3.9e-01
4.3e-01
cases:6.51%
controls:4.09%
cases:3.03%
controls:2.03%
cases:0.61%
controls:0.43%
cases:0.23%
controls:0.01%
cases:0.81%
controls:0.40%
cases:3.17%
controls:2.17%
cases:6.76%
controls:4.51%
340
2133
4881
50039
158
1061
5063
51111
32
226
5189
51946
12
7
5209
52165
42
206
5171
51869
161
1106
4918
49779
311
2066
4287
43751
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
64084-7 [40766800]
1.4e+00
1.1e+00
—
—
—
2.2e+00
1.6e+00
cases:0.34%
controls:0.09%
cases:0.13%
controls:0.05%
—
—
—
—
—
—
cases:0.22%
controls:0.02%
cases:0.52%
controls:0.10%
18
46
5203
52126
7
24
5214
52148
—
—
—
11
12
5068
50873
24
47
4574
45770
Microorganisms panel - Urine sediment
58435-9 [40761536]
6.9e-01
8.5e-01
4.8e-01
—
1.1e+00
1.3e+00
1.2e+00
cases:2.26%
controls:1.14%
cases:1.17%
controls:0.50%
cases:0.10%
controls:0.06%
—
—
cases:0.25%
controls:0.08%
cases:1.75%
controls:0.47%
cases:4.11%
controls:1.26%
118
597
5103
51575
61
261
5160
51911
5
31
5216
52141
—
13
42
5200
52033
89
241
4990
50644
189
576
4409
45241
oxycodone and naloxone; oral
N02AA55 [21604265]
6.8e-01
7.0e-01
1.1e+00
—
1.1e+00
9.1e-01
7.4e-01
cases:2.30%
controls:1.17%
cases:1.02%
controls:0.51%
cases:0.27%
controls:0.09%
—
—
cases:0.31%
controls:0.10%
cases:1.38%
controls:0.56%
cases:3.94%
controls:1.91%
120
612
5101
51560
53
265
5168
51907
14
49
5207
52123
—
16
52
5197
52023
70
286
5009
50599
181
877
4417
44940
Incision for biopsy of skin of head or neck
QAA05 [2001309761]
1.0e+00
2.1e+00
—
1.0e+50
—
2.1e+00
8.1e-01
cases:0.29%
controls:0.11%
cases:0.21%
controls:0.03%
—
—
cases:0.13%
controls:0.00%
—
—
cases:0.32%
controls:0.04%
cases:0.35%
controls:0.15%
15
55
5206
52117
11
14
5210
52158
—
7
0
5214
52172
—
16
19
5063
50866
16
71
4582
45746
Clinical & Laboratory Immunology (Internal Medicine) Physician
207RI0001X [38003875]
8.4e-01
1.8e+00
—
—
—
1.7e+00
1.8e+00
cases:0.23%
controls:0.10%
cases:0.21%
controls:0.04%
—
—
—
—
—
—
cases:0.16%
controls:0.03%
cases:0.46%
controls:0.08%
12
52
5209
52120
11
19
5210
52153
—
—
—
8
15
5071
50870
21
36
4577
45781
Skin colour change
S08 [2002000973]
8.9e-01
1.5e+00
2.8e+00
—
—
1.3e+00
2.6e-01
cases:0.69%
controls:0.28%
cases:0.50%
controls:0.11%
cases:0.15%
controls:0.01%
—
—
—
—
cases:0.22%
controls:0.06%
cases:0.52%
controls:0.40%
36
148
5185
52024
26
59
5195
52113
8
5
5213
52167
—
—
11
31
5068
50854
24
184
4574
45633
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
2.7e-01
6.1e-01
1.3e+00
—
1.5e+00
8.3e-01
6.0e-01
cases:6.44%
controls:4.98%
cases:2.49%
controls:1.37%
cases:0.44%
controls:0.12%
—
—
cases:0.52%
controls:0.11%
cases:2.87%
controls:1.27%
cases:9.63%
controls:5.52%
336
2596
4885
49576
130
717
5091
51455
23
62
5198
52110
—
27
59
5186
52016
146
647
4933
50238
443
2531
4155
43286
Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)
319 [2001600280]
1.9e+00
—
—
—
—
—
3.1e+00
cases:0.13%
controls:0.02%
—
—
—
—
—
—
—
—
—
—
cases:0.30%
controls:0.01%
7
10
5214
52162
—
—
—
—
—
14
6
4584
45811
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.3e-01
2.6e-01
6.7e-01
2.5e+00
8.8e-01
4.3e-01
2.4e-01
cases:23.54%
controls:21.36%
cases:19.90%
controls:16.03%
cases:5.44%
controls:2.87%
cases:1.44%
controls:0.12%
cases:6.37%
controls:2.74%
cases:23.25%
controls:16.48%
cases:39.30%
controls:33.69%
1229
11145
3992
41027
1039
8365
4182
43807
284
1495
4937
50677
75
64
5146
52108
332
1429
4881
50646
1181
8387
3898
42498
1807
15437
2791
30380
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
2.6e-01
3.3e-01
7.1e-01
2.8e+00
4.7e-01
4.6e-01
4.8e-01
cases:9.75%
controls:7.67%
cases:5.44%
controls:3.97%
cases:1.07%
controls:0.53%
cases:0.33%
controls:0.02%
cases:0.86%
controls:0.54%
cases:5.85%
controls:3.77%
cases:17.49%
controls:11.58%
509
4004
4712
48168
284
2073
4937
50099
56
277
5165
51895
17
10
5204
52162
45
281
5168
51794
297
1920
4782
48965
804
5306
3794
40511
Impetiginization of other dermatoses
L01.1 [45557685]
2.1e+00
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
2.9e+00
cases:0.11%
controls:0.01%
—
—
cases:0.13%
controls:0.00%
cases:0.19%
controls:0.00%
cases:0.10%
controls:0.00%
cases:0.16%
controls:0.00%
cases:0.24%
controls:0.01%
6
7
5215
52165
—
7
0
5214
52172
10
0
5211
52172
5
0
5208
52075
8
0
5071
50885
11
6
4587
45811
leflunomide; oral
L04AK01 [955035]
1.3e+00
1.3e+00
1.4e+00
—
1.0e+00
1.2e+00
1.2e+00
cases:0.69%
controls:0.19%
cases:0.50%
controls:0.13%
cases:0.13%
controls:0.03%
—
—
cases:0.10%
controls:0.03%
cases:0.35%
controls:0.10%
cases:0.59%
controls:0.18%
36
98
5185
52074
26
69
5195
52103
7
17
5214
52155
—
5
18
5208
52057
18
53
5061
50832
27
84
4571
45733
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
3.9e-01
9.7e-01
—
—
2.0e+00
1.2e+00
8.5e-01
cases:0.90%
controls:0.61%
cases:0.63%
controls:0.24%
—
—
—
—
cases:0.23%
controls:0.03%
cases:0.69%
controls:0.21%
cases:1.78%
controls:0.77%
47
320
5174
51852
33
126
5188
52046
—
—
12
16
5201
52059
35
109
5044
50776
82
354
4516
45463
Laboratory Visit
OMOP4822461 [32036]
6.9e-02
2.2e-01
6.8e-01
3.0e+00
6.6e-01
2.6e-01
1.4e-01
cases:29.02%
controls:27.62%
cases:30.36%
controls:25.99%
cases:14.67%
controls:8.02%
cases:9.02%
controls:0.47%
cases:14.27%
controls:7.93%
cases:32.59%
controls:27.19%
cases:46.24%
controls:42.86%
1515
14412
3706
37760
1585
13562
3636
38610
766
4182
4455
47990
471
245
4750
51927
744
4130
4469
47945
1655
13834
3424
37051
2126
19638
2472
26179
Peanut IgE Ab [Units/volume] in Serum
6206-7 [3012494]
2.1e+00
—
—
—
1.0e+50
—
2.9e+00
cases:0.15%
controls:0.02%
—
—
—
—
—
—
cases:0.10%
controls:0.00%
—
—
cases:0.24%
controls:0.01%
8
10
5213
52162
—
—
—
5
0
5208
52075
—
11
6
4587
45811
FEV1
20150-9 [3024653]
4.0e-01
4.5e-01
—
—
1.7e+00
1.2e+00
1.6e+00
cases:1.80%
controls:1.21%
cases:0.59%
controls:0.38%
—
—
—
—
cases:0.15%
controls:0.03%
cases:0.96%
controls:0.28%
cases:3.04%
controls:0.62%
94
631
5127
51541
31
197
5190
51975
—
—
8
14
5205
52061
49
145
5030
50740
140
285
4458
45532
FEV1/FVC
19926-5 [3011505]
4.0e-01
4.5e-01
—
—
1.7e+00
1.2e+00
1.6e+00
cases:1.80%
controls:1.21%
cases:0.59%
controls:0.38%
—
—
—
—
cases:0.15%
controls:0.03%
cases:0.96%
controls:0.28%
cases:3.04%
controls:0.62%
94
631
5127
51541
31
197
5190
51975
—
—
8
14
5205
52061
49
145
5030
50740
140
285
4458
45532
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
4.0e-01
4.5e-01
—
—
1.7e+00
1.2e+00
1.6e+00
cases:1.80%
controls:1.21%
cases:0.59%
controls:0.38%
—
—
—
—
cases:0.15%
controls:0.03%
cases:0.96%
controls:0.28%
cases:3.04%
controls:0.62%
94
631
5127
51541
31
197
5190
51975
—
—
8
14
5205
52061
49
145
5030
50740
140
285
4458
45532
Corn/callosity
S20 [2002000985]
7.5e-01
1.6e+00
—
—
2.5e+00
1.1e+00
8.9e-01
cases:0.21%
controls:0.10%
cases:0.17%
controls:0.03%
—
—
—
—
cases:0.12%
controls:0.01%
cases:0.16%
controls:0.06%
cases:0.43%
controls:0.18%
11
52
5210
52120
9
18
5212
52154
—
—
6
5
5207
52070
8
28
5071
50857
20
82
4578
45735
salbutamol; inhalant
R03AC02 [21603256]
4.7e-01
5.6e-01
7.1e-01
1.6e+00
5.5e-01
5.0e-01
6.1e-01
cases:16.38%
controls:10.91%
cases:9.29%
controls:5.54%
cases:1.88%
controls:0.93%
cases:0.21%
controls:0.04%
cases:1.65%
controls:0.96%
cases:9.12%
controls:5.72%
cases:21.88%
controls:13.20%
855
5692
4366
46480
485
2892
4736
49280
98
487
5123
51685
11
23
5210
52149
86
501
5127
51574
463
2912
4616
47973
1006
6047
3592
39770
Foot and toes extensive X-ray examination
NH3BA [2001308270]
7.6e-01
1.7e+00
—
—
—
1.7e+00
1.6e+00
cases:0.40%
controls:0.19%
cases:0.27%
controls:0.05%
—
—
—
—
—
—
cases:0.26%
controls:0.05%
cases:0.80%
controls:0.17%
21
98
5200
52074
14
26
5207
52146
—
—
—
13
24
5066
50861
37
77
4561
45740
Alcohol depence active use
F10.24 [2000501681]
1.5e+00
—
—
—
—
1.9e+00
1.6e+00
cases:0.31%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.22%
controls:0.03%
cases:0.48%
controls:0.10%
16
37
5205
52135
—
—
—
—
11
17
5068
50868
22
44
4576
45773
Intravenous
ZX120 [2001311495]
6.2e-01
1.0e+00
1.2e+00
—
1.4e+00
1.0e+00
9.4e-01
cases:1.30%
controls:0.70%
cases:0.73%
controls:0.26%
cases:0.21%
controls:0.06%
—
—
cases:0.25%
controls:0.06%
cases:0.69%
controls:0.26%
cases:1.85%
controls:0.73%
68
367
5153
51805
38
138
5183
52034
11
33
5210
52139
—
13
33
5200
52042
35
130
5044
50755
85
336
4513
45481
Alcoholic cirrhosis of liver
K70.3 [45596343]
1.1e+00
1.1e+00
—
1.0e+50
2.1e+00
1.4e+00
1.4e+00
cases:0.21%
controls:0.07%
cases:0.17%
controls:0.06%
—
—
cases:0.10%
controls:0.00%
cases:0.15%
controls:0.02%
cases:0.26%
controls:0.06%
cases:0.52%
controls:0.13%
11
38
5210
52134
9
29
5212
52143
—
5
0
5216
52172
8
10
5205
52065
13
31
5066
50854
24
58
4574
45759
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.3e-01
2.6e-01
7.2e-01
2.4e+00
7.8e-01
3.6e-01
2.4e-01
cases:25.01%
controls:22.64%
cases:22.70%
controls:18.53%
cases:7.60%
controls:3.84%
cases:2.57%
controls:0.23%
cases:7.81%
controls:3.75%
cases:25.00%
controls:18.88%
cases:41.15%
controls:35.44%
1306
11810
3915
40362
1185
9669
4036
42503
397
2001
4824
50171
134
119
5087
52053
407
1952
4806
50123
1270
9606
3809
41279
1892
16237
2706
29580
Social worker
Z2446 [2001311559]
4.2e-01
2.5e-02
—
—
2.9e+00
1.1e+00
9.0e-01
cases:0.67%
controls:0.44%
cases:0.15%
controls:0.15%
—
—
—
—
cases:0.17%
controls:0.01%
cases:0.39%
controls:0.13%
cases:1.02%
controls:0.42%
35
231
5186
51941
8
78
5213
52094
—
—
9
5
5204
52070
20
66
5059
50819
47
191
4551
45626
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
5.2e-01
9.1e-01
3.3e-01
—
1.6e+00
1.1e+00
8.1e-01
cases:1.32%
controls:0.79%
cases:0.90%
controls:0.37%
cases:0.10%
controls:0.07%
—
—
cases:0.31%
controls:0.06%
cases:0.96%
controls:0.34%
cases:2.33%
controls:1.05%
69
413
5152
51759
47
191
5174
51981
5
36
5216
52136
—
16
32
5197
52043
49
172
5030
50713
107
480
4491
45337
Tryptase [Mass/volume] in Serum or Plasma
21582-2 [3019420]
1.0e+00
1.8e+00
—
—
—
3.0e+00
1.9e+00
cases:0.11%
controls:0.04%
cases:0.10%
controls:0.02%
—
—
—
—
—
—
cases:0.20%
controls:0.01%
cases:0.22%
controls:0.03%
6
22
5215
52150
5
8
5216
52164
—
—
—
10
5
5069
50880
10
15
4588
45802

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
219
120
19.00
276.28
1.5
1.5
28.43
21.71
u/ml
0.58
28
28
619
1453
4.70
245.00
1.4
1.2
—
—
—
0
0
181
109
17.16
217.94
1.3
1.4
256.92
210.00
titre
—
13
9
177
102
17.92
217.76
1.3
1.4
48.00
71.67
titre
—
10
6
754
2512
3.34
179.35
1.5
1.3
689.91
149.72
u/ml
7.76
716
2328
1170
5079
2.68
172.13
2.2
1.7
—
—
—
0
0
1043
5183
2.26
108.88
1.7
1.4
—
—
—
0
0
1689
10082
2.00
108.73
6.8
4.5
—
—
—
0
0
2174
14449
1.86
98.88
3.3
2.7
58.95
66.25
u/l
0.66
2039
13405
3105
23041
1.85
98.84
8.6
6.1
0.62
0.59
e9/l
12.18
2864
19660
3108
23112
1.85
97.79
8.7
6.2
0.05
0.04
e9/l
11.12
2866
19733
3179
23840
1.85
96.95
8.9
6.3
0.23
0.19
e9/l
23.90
2945
20717
3132
23599
1.81
91.63
8.8
6.2
1.89
1.91
e9/l
0.27
2920
20667
3294
25847
1.74
77.12
11.6
9.6
4.33
4.14
e9/l
5.53
3062
22313
3090
23967
1.71
73.99
6.9
6.7
11.49
11.76
umol/l
0.37
2951
22880
2696
20317
1.67
70.58
6.2
5.2
34.88
35.66
g/l
9.70
2539
19087
2786
21182
1.67
70.43
18.4
15.3
1.24
1.26
inr
1.51
2433
17771
1924
13274
1.71
70.30
5.3
3.9
0.00
0.00
estimate
2.14
778
4646
1854
12682
1.72
69.78
5.5
4.3
—
—
—
0
0
1097
6477
1.88
67.82
2.5
2.0
—
—
—
0
0
2783
21320
1.65
66.88
9.0
6.5
9.05
8.88
%
2.23
2679
19967
2449
18209
1.65
65.88
5.2
3.7
0.01
0.18
estimate
0.74
714
4135
2772
21275
1.64
65.61
8.8
6.4
3.22
2.80
%
13.83
2663
19908
2760
21276
1.63
63.22
9.0
6.5
0.70
0.67
%
1.95
2653
19894
2817
21862
1.62
62.47
8.9
6.4
26.56
27.65
%
6.39
2723
20676
4053
34583
1.76
61.57
10.2
8.2
81.58
78.80
u/l
2.05
3910
32906
1527
10183
1.71
61.42
1.4
1.3
1.42
2.00
u/ml
1.80
490
2725
560
2743
2.17
58.02
5.3
4.7
—
—
—
0
0
3905
33199
1.69
57.49
6.0
4.2
14.10
11.83
mm/h
15.32
3671
31138
756
4150
1.96
57.38
5.2
4.3
0.76
0.93
%
1.61
233
1240
79
106
7.55
55.51
1.6
1.4
9.99
8.96
ug/l
0.74
79
106
721
3945
1.96
55.10
5.0
4.1
0.57
0.73
%
1.66
221
1176
2725
21420
1.57
53.82
8.7
6.3
57.80
57.44
%
0.92
2671
20439
2871
22856
1.57
53.46
9.4
7.3
1.21
1.21
mmol/l
4.03
2419
19801
718
4007
1.92
51.51
5.5
4.5
0.14
0.16
%
0.13
185
1013
711
3967
1.92
51.01
5.3
4.4
0.09
0.11
%
0.59
188
1059
3272
27015
1.56
50.39
6.7
5.0
6.78
6.71
mmol/l
1.04
3143
25592
558
2875
2.05
50.29
8.0
6.7
24.52
24.48
mmol/l
0.09
531
2752
986
6141
1.75
49.22
1.5
1.3
444.39
522.31
titre
0.87
228
1262
1918
14160
1.56
48.38
2.6
2.2
220.55
220.59
u/l
0.00
1799
13418
2978
24246
1.53
47.49
5.2
3.8
0.00
4.72
estimate
4.15
839
5167
2994
24409
1.53
47.41
5.2
3.8
0.04
0.07
estimate
0.17
779
4841
2244
17208
1.53
47.30
4.8
3.7
35.71
84.72
ng/l
1.13
1645
11956
1677
12097
1.57
46.40
2.7
2.3
2.93
2.77
mg/l
1.92
1483
10496
2944
23978
1.52
46.34
5.1
3.7
0.00
0.00
estimate
0.06
834
5043
650
3633
1.90
46.11
4.9
3.8
—
—
—
0
0
421
2062
2.13
43.20
4.2
3.4
25.17
25.27
mmol/l
0.22
409
1981
1833
13677
1.52
42.62
4.9
4.2
7.40
7.40
ph
0.62
1420
9828
912
5776
1.70
42.18
3.8
3.2
4.64
4.57
e9/l
0.11
828
5005
958
6151
1.68
42.08
7.3
6.1
1.05
1.04
mmol/l
0.98
895
5732
1357
9508
1.58
41.77
1.9
1.7
20911960.86
32519221.74
pmol/l
0.47
1119
7980
3937
34493
1.57
41.52
4.9
4.3
14.84
14.75
pmol/l
1.56
3629
31774
1799
13468
1.51
40.71
3.7
3.2
—
—
—
0
0
628
3608
1.84
40.57
5.0
3.8
1.23
1.23
mmol/l
0.47
549
3138
1150
7816
1.60
40.04
4.0
3.4
0.80
0.82
mmol/l
7.12
1088
7382
701
4216
1.77
38.76
2.5
2.3
363.82
380.12
nmol/l
1.15
651
3906
1737
13084
1.49
37.36
4.5
3.2
0.04
0.11
estimate
0.54
711
3964
1780
13489
1.48
37.08
3.7
3.2
1727.60
1396.18
ng/l
1.50
1529
11634
769
4810
1.70
36.82
5.0
3.9
7.37
7.38
ph
0.94
497
2766
854
5500
1.66
36.58
8.4
7.9
7.41
7.42
ph
0.66
520
3013
2519
20446
1.45
36.51
8.3
6.6
1.20
1.21
mmol/l
3.93
2336
18955
755
4712
1.70
36.41
5.0
3.8
5.86
5.82
kpa
0.58
733
4576
190
708
2.75
35.78
1.1
1.3
—
11.80
u/ml
—
0
14
850
5501
1.65
35.64
8.4
7.9
5.09
5.10
kpa
0.03
808
5298
849
5499
1.65
35.47
8.4
7.9
11.35
12.48
kpa
11.29
803
5292
335
1627
2.13
35.00
1.3
1.2
0.19
0.90
u/ml
2.56
24
126
1252
8917
1.53
34.76
1.5
1.5
2.75
2.46
g/l
4.43
832
5558
728
4565
1.69
34.36
8.9
8.8
120.84
121.71
g/l
0.50
706
4463
837
5453
1.64
34.04
8.3
7.9
1.24
0.92
mmol/l
1.56
659
4476
1142
8005
1.55
34.00
3.2
2.6
12.31
13.12
umol/l
3.09
1059
7494
768
4906
1.66
33.73
8.5
8.2
95.72
95.53
%
0.41
728
4735
1956
15344
1.44
32.99
4.8
4.2
12.66
8.54
mg/mmol
2.61
1270
9717
640
3919
1.72
32.88
4.6
3.2
4.44
4.54
kpa
0.73
616
3798
407
2179
1.94
32.44
5.8
5.0
1.72
1.60
%
1.42
384
2057
2358
19175
1.42
32.35
4.5
3.3
6.30
6.21
ph
3.16
1395
10776
1068
7468
1.54
31.88
2.0
1.7
1243.51
1153.52
nmol/l
2.41
814
5712
313
1552
2.08
30.92
1.2
1.3
—
—
—
0
0
717
4599
1.65
30.79
5.1
3.9
1.93
1.87
mmol/l
0.17
620
3990
2025
16144
1.41
30.52
4.0
3.4
7.37
7.73
mmol/l
3.18
1703
13676
1395
10404
1.46
30.18
3.3
2.7
5.15
5.28
e6/l
0.12
1296
9496
617
3825
1.69
30.16
2.2
2.7
66.54
66.34
g/l
0.26
574
3505
1908
15079
1.42
30.10
3.9
3.5
68.63
48.79
mg/l
2.62
1247
9751
1060
7485
1.52
30.01
3.2
2.6
2.32
2.31
g/l
0.21
977
6947
350
1827
1.98
29.99
1.4
1.6
3.00
17.34
iu/ml
—
6
47
936
6438
1.55
29.89
8.5
7.4
103.89
104.43
mmol/l
2.56
936
6433
2452
20268
1.39
29.62
16.6
11.3
0.00
0.00
e9/l
0.55
2171
16478
232
1039
2.29
29.58
4.9
3.7
—
—
—
0
0
295
1459
2.08
29.34
4.8
3.7
1.41
1.40
mmol/l
0.05
288
1434
327
1682
2.01
29.20
1.9
1.7
4.47
6.71
iu/ml
0.97
78
398
252
1179
2.19
28.91
5.2
4.1
3.86
3.90
mmol/l
0.61
247
1167
372
2008
1.92
28.87
6.1
5.2
0.88
0.88
%
0.08
349
1895
3379
29562
1.40
28.60
5.5
4.5
128.42
1390.70
e6/l
4.06
26
420
258
1225
2.16
28.52
1.6
1.7
1.16
1.19
g/l
0.84
247
1162
497
2951
1.76
28.31
4.5
3.2
125.46
129.80
g/l
4.16
484
2862
1962
15705
1.40
28.25
3.8
3.3
34.07
35.52
u/l
0.27
1835
14868
353
1901
1.92
27.57
2.0
1.9
1.53
2.74
ug/l
1.51
321
1689
421
2404
1.82
27.35
4.0
2.8
0.66
0.61
%
2.47
421
2392
640
4110
1.63
27.14
2.4
2.5
70.44
69.10
e9/l
0.45
510
3017
976
6911
1.51
26.93
3.3
2.6
21.48
22.92
%
2.60
895
6447
1404
10672
1.43
26.86
5.7
3.9
1.02
1.16
kg/l
0.50
963
7168
675
4409
1.61
26.69
2.5
2.3
0.20
0.21
g/l
2.46
626
4122
1331
10036
1.44
26.56
2.1
1.8
1.16
1.30
mg/l
1.04
1058
7792
45
74
6.13
26.23
1.1
1.1
3.12
1.79
u/ml
0.22
22
35
115
387
3.02
26.17
1.7
1.4
26.13
32.58
%
1.07
77
226
282
1431
2.03
26.14
6.1
5.7
1.25
1.30
mmol/l
0.40
246
1266
655
4273
1.61
25.99
10.0
7.5
10.85
10.00
mmol/l
2.06
629
4082
245
1184
2.12
25.89
1.7
1.7
0.24
0.24
g/l
0.16
230
1125
1560
12159
1.40
25.65
3.2
2.7
351.62
342.81
umol/l
2.51
1381
10786
1651
12995
1.40
25.61
1.8
1.7
18.66
20.09
nmol/l
3.89
1440
11066
71
180
3.98
25.03
1.6
1.7
7.38
10.81
ug/l
1.09
62
159
4426
41042
1.51
24.51
6.0
5.2
1.90
1.90
mu/l
0.07
4136
38097
132
501
2.68
24.07
1.6
1.5
58.20
57.58
%
0.05
85
309
31
38
8.20
23.49
1.1
1.0
0.68
0.30
u/ml
1.21
26
32
809
5702
1.50
22.44
3.1
2.4
146.81
134.12
ug/g
0.44
652
4554
53
117
4.57
22.37
3.3
2.7
154.00
97.01
au/ml
—
6
26
356
2058
1.78
22.12
1.2
1.1
67.50
131.87
titre
—
8
67
541
3509
1.60
21.81
3.3
2.8
11.04
10.65
g/l
1.05
506
3225
2401
20385
1.33
21.75
2.9
2.4
74.23
77.03
nmol/l
5.37
2223
18551
762
5342
1.50
21.64
2.3
2.5
1.88
1.79
%
1.34
678
4753
1903
15648
1.34
21.37
3.4
3.5
2.35
2.35
mmol/l
0.41
1746
14285
210
1033
2.08
21.20
2.1
3.9
—
—
—
0
0
1085
8214
1.40
20.35
1.4
1.3
27.89
30.75
iu/ml
0.41
378
2491
485
3120
1.61
20.18
3.9
3.8
5.17
5.15
kpa
0.25
465
2996
4669
44163
1.53
19.63
24.0
15.6
24.37
24.68
mg/l
0.26
4152
36397
470
3023
1.61
19.56
3.8
3.8
7.41
7.42
ph
0.92
410
2503
53
131
4.08
19.40
4.1
3.4
8.37
9.07
mg/l
0.30
41
104
192
946
2.07
19.32
5.8
4.0
3.02
2.53
mmol/l
1.20
141
626
25
30
8.37
19.25
1.0
1.0
4.38
0.41
u/ml
0.42
14
15
1149
8865
1.38
19.07
3.8
2.9
509.67
538.62
mosm/kgh2o
4.67
1047
7792
563
3801
1.54
18.96
2.7
2.5
0.38
0.44
e6/l
0.40
534
3660
1010
7644
1.40
18.79
1.3
1.3
10.08
11.99
u/ml
0.43
443
2996
202
1034
1.99
18.31
2.8
3.0
31.06
35.21
umol/l
1.75
181
940
4734
45019
1.54
18.22
26.8
18.5
139.31
139.70
mmol/l
21.72
4671
44189
285
1642
1.78
17.91
2.5
2.3
545.71
656.92
ug/l
0.26
272
1563
194
988
2.00
17.85
7.1
6.7
11.29
11.24
mmol/l
0.06
174
886
194
989
2.00
17.80
7.1
6.7
104.63
105.21
mmol/l
0.91
174
887
4738
45125
1.52
17.44
26.9
18.7
3.98
3.97
mmol/l
1.53
4673
44213
2490
21654
1.29
17.30
3.8
3.1
139.80
128.09
ug/l
1.03
2326
20297
3469
31481
1.30
17.25
4.9
4.0
0.29
6438.37
—
7
64
115
481
2.42
17.25
1.3
1.3
—
—
—
0
0
524
3591
1.51
16.38
3.6
3.0
208.24
195.79
ng/l
0.19
482
3288
3392
30804
1.29
16.14
4.2
3.3
56.84
47.65
u/l
5.82
3192
29021
418
2737
1.57
16.07
2.0
2.0
1.32
1.31
g/l
0.04
385
2515
63
200
3.18
15.97
1.5
1.4
4.13
3.05
%
0.27
16
37
222
1231
1.84
15.85
1.4
1.2
26.65
36.46
u/ml
0.30
13
62
2317
20110
1.27
15.81
2.3
2.1
94.14
95.50
pmol/l
0.75
1366
10768
2472
21637
1.27
15.69
3.3
2.8
—
—
estimate
—
0
0
208
1144
1.85
15.25
1.4
1.3
8.92
5.73
u/ml
0.24
17
106
127
592
2.17
14.84
2.1
2.7
—
—
—
0
0
261
1554
1.72
14.64
2.1
3.7
49.30
56.29
mg/l
0.26
195
1332
543
3835
1.46
14.56
2.7
2.3
6.33
7.92
ug/l
1.01
490
3393
438
2965
1.52
14.47
10.5
10.3
0.66
0.63
%
0.74
431
2943
260
1555
1.71
14.35
2.1
3.7
65.47
89.75
mg/l
0.31
195
1335
707
5253
1.40
14.33
1.8
1.6
—
—
—
0
0
450
3072
1.51
14.29
10.3
10.0
1.45
1.31
%
2.87
441
3052
204
1140
1.82
14.23
1.9
2.0
10.87
11.40
mg/l
0.33
190
1057
331
5034
0.63
14.18
1.8
2.0
3.61
3.51
ratio
0.64
249
3880
204
1144
1.81
14.08
1.4
1.3
12.30
6.78
u/ml
0.27
23
170
1042
8249
1.33
14.06
2.0
1.9
—
—
—
0
0
362
2372
1.57
13.86
1.4
1.2
—
—
—
0
0
412
2780
1.52
13.82
10.9
10.2
15.95
16.05
%
0.30
391
2682
922
7196
1.34
13.67
2.7
2.1
29.84
29.71
s
0.22
894
7012
70
262
2.69
13.29
1.1
1.0
—
—
—
0
0
257
1566
1.67
13.25
2.5
2.2
4906.17
6033.11
u/l
0.23
79
617
61
213
2.89
13.19
1.1
1.0
1.11
0.74
u/ml
0.22
32
52
577
4206
1.42
13.00
8.6
8.0
1.35
1.32
mmol/l
0.28
565
4121
230
1371
1.71
12.87
1.9
3.5
2.05
2.92
ratio
0.86
135
799
198
1132
1.78
12.84
2.8
2.2
129.10
129.48
g/l
0.08
174
873
1765
15098
1.25
12.78
4.0
3.4
40.49
89.42
e6/l
3.22
1476
11544
131
656
2.02
12.74
1.1
1.1
2.21
1.04
u/ml
0.68
88
293
37
98
3.80
12.42
2.1
1.7
22.46
222.43
au/ml
—
6
10
119
581
2.07
12.40
1.8
2.5
—
—
—
0
0
134
686
1.98
12.26
2.1
1.9
0.98
0.89
%
0.93
101
477
481
3437
1.44
12.08
4.8
3.9
101.60
90.65
ng/l
1.41
400
2959
58
209
2.79
11.87
1.6
1.6
186.24
136.66
umol/l
0.30
29
111
302
1971
1.56
11.79
2.2
1.7
0.43
0.30
mg/l
2.83
184
915
4384
41740
1.31
11.31
7.7
6.3
40.23
39.26
mmol/mol
9.79
4112
39241
21
854
0.24
11.22
1.5
1.6
—
—
—
0
0
65
256
2.56
11.21
1.4
1.2
—
—
—
0
0
178
1029
1.76
11.16
5.0
4.0
—
—
—
0
0
240
3716
0.63
11.06
1.5
1.7
3.57
3.49
mmol/l
0.49
163
2553
888
7091
1.30
10.99
1.8
1.7
—
—
—
0
0
44
142
3.12
10.96
2.4
2.1
9.03
9.30
mg/l
0.14
36
123
544
4049
1.38
10.80
10.5
9.3
—
—
—
0
0
226
1408
1.63
10.74
3.8
3.2
1.64
1.54
mg/l
1.04
201
1296
21
823
0.25
10.57
1.4
1.5
1.41
1.28
mm
0.32
14
573
22
838
0.26
10.55
1.5
1.5
—
—
—
0
0
59
229
2.59
10.51
1.1
1.1
1663.93
1389.21
miu/ml
1.00
59
229
1519
13013
1.24
10.35
3.9
3.2
0.37
0.44
e6/l
0.85
1251
9559
187
1121
1.69
10.32
1.9
1.6
12506.22
12321.71
e6/l
0.03
152
783
319
2172
1.50
10.26
1.6
1.7
1.55
1.52
g/l
0.20
267
1884
4442
42503
1.30
10.05
5.8
5.1
6.03
5.94
mmol/l
4.58
4095
39255
148
837
1.79
10.03
1.1
1.1
3.34
1.74
u/ml
0.80
90
424
70
302
2.34
9.97
1.3
1.3
3.87
0.78
u/ml
1.04
41
160
112
582
1.94
9.90
1.1
1.1
4.88
1.85
u/ml
1.71
76
260
84
396
2.14
9.68
1.6
1.3
61489.25
118623.37
e6/l
0.53
67
265
175
1052
1.69
9.58
2.4
2.4
139.13
100.03
ug/min
0.38
96
648
128
707
1.83
9.40
1.1
1.1
4.45
4.07
u/ml
0.10
74
348
136
768
1.79
9.30
1.5
1.6
0.76
0.80
g/l
0.15
97
597
4845
47034
1.40
9.28
29.8
20.4
79.81
78.17
umol/l
2.07
4814
46505
129
721
1.81
9.13
3.9
2.8
—
—
—
0
0
1064
8874
1.25
9.08
2.9
3.0
2.47
2.45
mmol/l
3.48
980
7959
95
481
1.99
9.08
1.4
1.3
2.92
3.00
g/l
0.18
63
354
53
212
2.52
8.93
1.0
1.0
0.72
0.43
u/ml
0.75
23
35
156
931
1.70
8.81
1.3
1.7
—
—
—
0
0
93
473
1.98
8.79
1.4
1.3
—
—
—
0
0
94
481
1.97
8.73
1.4
1.3
0.49
0.42
g/l
0.82
63
353
94
482
1.97
8.68
1.4
1.3
7.08
6.97
g/l
0.08
63
351
93
478
1.96
8.54
1.8
2.0
5.92
6.60
umol/l
0.20
74
340
16
16
10.03
8.51
1.0
1.0
0.30
0.02
u/ml
—
11
5
46
176
2.63
8.50
28.7
26.5
114.70
114.68
ug/l
0.00
37
140
129
743
1.75
8.29
3.8
3.4
1.31
1.68
%
0.42
119
656
772
6267
1.27
8.24
1.3
1.3
—
—
—
0
0
78
384
2.05
8.10
2.1
1.4
1.23
1.26
promille
0.06
61
300
207
1357
1.55
8.01
1.4
1.4
270.97
274.15
ug/g
0.07
127
783
33
109
3.04
7.99
1.2
1.4
36.32
33.41
%
0.15
22
73
463
3547
1.33
7.61
1.2
1.2
—
—
—
0
0
4800
46707
1.33
7.45
16.4
11.8
26.51
26.68
u/l
0.23
4697
45424
48
202
2.39
7.33
1.1
1.1
4.20
3.64
iu/ml
—
5
14
111
636
1.76
7.31
7.2
6.6
11.64
11.91
mg/l
0.23
105
589
173
1114
1.57
7.28
1.1
1.1
1.88
8.27
eliau/ml
—
8
142
371
2769
1.37
7.25
5.3
4.0
24.06
24.21
mmol/l
0.44
363
2741
1053
8963
1.22
7.25
5.0
3.9
335.69
528.48
ng/l
0.85
817
7000
2103
19046
1.17
7.20
2.1
1.9
1.41
1.36
mmol/l
1.90
1704
16061
45
186
2.43
7.15
1.1
1.2
15.40
12.50
u/ml
—
5
16
117
686
1.72
7.12
1.1
1.1
0.72
0.80
u/ml
0.09
64
261
1914
17215
1.18
7.10
4.5
3.9
93.38
97.26
e6/l
0.08
1526
12163
47
200
2.36
7.02
43.8
37.9
7.22
7.47
ug/l
0.37
41
181
133
817
1.64
6.82
1.4
1.4
60.77
62.92
mmol/l
0.24
98
653
93
517
1.81
6.81
3.0
2.2
4.13
4.08
mmol/l
0.49
93
510
93
517
1.81
6.81
3.0
2.2
106.69
105.38
mmol/l
1.70
93
510
33
120
2.76
6.78
1.1
1.0
9.91
10.04
u/ml
0.01
23
83
43
180
2.40
6.67
2.6
2.9
—
—
—
0
0
41
169
2.44
6.58
1.5
1.9
0.52
1.09
u/ml
—
6
50
23
69
3.34
6.54
1.1
1.1
—
—
—
0
0
90
504
1.80
6.45
3.1
2.3
1.21
1.20
mmol/l
1.36
90
497
308
2275
1.38
6.45
2.5
2.4
—
—
—
0
0
88
492
1.80
6.35
2.8
2.3
—
—
—
0
0
74
393
1.90
6.28
2.4
2.5
995.48
1116.62
e6/l
0.84
69
348
36
143
2.53
6.26
1.3
1.5
14.72
12.66
g/l
0.60
29
107
4307
41538
1.21
6.22
4.9
4.2
1.35
1.29
mmol/l
6.96
3961
38470
101
596
1.71
6.07
1.6
1.4
—
—
—
0
0
101
596
1.71
6.07
1.6
1.4
—
—
—
0
0
101
596
1.71
6.07
1.6
1.4
—
—
—
0
0
101
596
1.71
6.07
1.6
1.4
—
—
—
0
0
198
1373
1.46
5.94
3.0
2.1
—
—
—
0
0
147
2206
0.66
5.94
1.8
1.7
—
—
—
0
0
110
669
1.66
5.92
1.3
1.4
89.83
52.86
mu/l
0.55
103
608
81
452
1.80
5.91
1.5
2.2
—
—
—
0
0
322
4217
0.75
5.91
1.3
1.4
—
—
—
0
0
227
1620
1.42
5.84
2.9
2.2
—
—
—
0
0
143
930
1.55
5.84
1.4
1.2
72.27
37.85
u/ml
0.93
14
82
90
521
1.74
5.81
4.4
18.0
7.78
7.29
mmol/l
0.63
79
441
225
1606
1.42
5.79
1.8
1.7
345.17
295.82
mu/l
0.68
205
1463
88
507
1.75
5.78
1.4
1.4
277.74
278.35
mosm/kgh2o
0.09
70
394
51
245
2.09
5.76
1.3
1.5
4.75
6.77
u/l
1.76
40
211
254
1860
1.38
5.64
1.7
2.4
4.02
3.69
g/l
1.24
230
1712
254
1861
1.38
5.62
1.7
2.4
4.34
4.21
g/l
1.28
230
1713
254
1862
1.38
5.61
1.7
2.4
7.57
7.37
g/l
1.17
230
1714
66
352
1.89
5.58
1.3
1.2
—
—
—
0
0
1544
13861
1.16
5.55
7.8
6.3
—
—
—
0
0
646
5373
1.23
5.50
2.7
2.8
10.18
8.40
umol/l
0.81
536
4733
824
9597
0.83
5.43
3.0
3.3
0.75
0.77
ug/l
0.16
546
6330
3869
37106
1.16
5.35
27.2
19.4
13.88
13.61
%
27.13
3832
36610
102
626
1.64
5.34
5.5
5.5
387.08
358.74
umol/l
1.31
95
548
11
14
7.87
5.34
1.2
1.0
—
—
—
0
0
4508
43801
1.21
5.29
5.9
5.1
4.52
4.61
mmol/l
8.39
4204
41188
444
3558
1.27
5.25
1.5
1.5
—
—
—
0
0
27
102
2.66
5.23
2.6
2.3
102.00
318.11
ug/l
0.34
27
102
190
1344
1.43
5.18
1.2
1.2
776.00
1020.54
titre
—
10
37
171
1186
1.46
5.18
3.8
3.0
—
—
—
0
0
192
1362
1.43
5.15
1.3
1.2
115.48
117.08
titre
0.01
42
130
100
618
1.63
5.11
1.2
1.3
328.60
354.06
pmol/l
0.17
85
525
228
1670
1.38
5.09
1.6
1.6
18.82
16.94
u/ml
0.19
46
414
10
12
8.35
5.05
1.0
1.0
2.36
0.01
u/ml
—
5
6
201
1445
1.41
5.02
1.3
1.2
—
—
—
0
0
4561
44407
1.21
5.00
6.4
5.7
2.64
2.70
mmol/l
4.68
4239
41591
90
547
1.66
4.92
1.2
1.1
8.71
3.10
u/ml
1.12
56
211
237
1759
1.36
4.89
2.8
2.1
—
—
—
0
0
236
1752
1.36
4.86
2.8
2.0
—
—
—
0
0
617
5174
1.22
4.85
1.5
1.4
—
—
—
0
0
50
256
1.96
4.81
1.1
1.2
1.05
1.06
ratio
0.22
44
203
234
1741
1.36
4.76
2.8
2.1
—
—
—
0
0
50
258
1.95
4.71
2.3
2.1
481.37
492.62
min
0.34
30
190
136
920
1.49
4.70
3.0
1.9
0.88
0.86
nmol/l
0.09
117
787
162
1135
1.44
4.69
1.3
1.2
—
—
—
0
0
4474
43540
1.19
4.62
5.6
5.0
1.41
1.45
mmol/l
6.25
4145
40700
103
659
1.57
4.60
1.1
1.1
1.56
1.53
g/l
0.37
93
603
1229
10980
1.16
4.58
5.0
3.6
0.18
0.18
0.02
11
127
91
566
1.62
4.57
1.5
1.3
—
—
nmol/l
—
0
0
106
687
1.55
4.49
1.4
1.3
0.88
0.33
nmol/l
—
10
39
29
123
2.37
4.47
1.1
1.0
—
—
—
0
0
29
123
2.37
4.47
1.1
1.0
—
—
—
0
0
29
123
2.37
4.47
1.1
1.0
—
—
—
0
0
94
594
1.59
4.44
2.5
2.6
13.32
13.16
%
1.09
94
588
31
136
2.29
4.44
1.5
1.2
38.79
39.58
g/l
0.10
15
68
52
278
1.88
4.44
1.5
1.5
75.81
84.08
umol/l
1.10
52
278
230
1736
1.34
4.30
1.8
2.5
2.86
2.92
g/l
0.41
206
1589
62
355
1.76
4.26
1.1
1.3
2.03
2.09
mmol/l
0.29
57
331
36
172
2.10
4.21
2.8
2.4
124.47
151.36
nmol/l
1.06
30
154
228
1728
1.33
4.15
2.7
2.0
—
—
—
0
0
37
180
2.06
4.14
1.2
1.1
219.74
183.22
iu/ml
0.34
37
180
280
2191
1.29
4.06
1.2
1.1
0.88
1.98
u/ml
—
6
22
46
244
1.89
4.05
1.2
1.5
—
—
—
0
0
61
355
1.73
3.99
2.4
2.2
681.14
628.58
ml
0.38
35
231
62
1024
0.60
3.95
1.9
1.9
—
—
—
0
0
211
1597
1.33
3.90
1.6
2.5
9.96
10.24
g/l
0.45
186
1433
37
185
2.01
3.87
1.9
2.1
697.75
4882.60
e6/l
0.48
28
126
349
2827
1.25
3.83
1.3
1.3
38.23
53.70
au/ml
1.26
21
194
14
38
3.69
3.79
1.0
1.4
—
—
—
0
0
351
2852
1.25
3.76
3.3
3.5
4.36
4.50
pmol/l
1.93
315
2559
78
494
1.59
3.71
1.4
1.4
6.51
6.25
mmol/l
0.32
72
464
28
129
2.18
3.63
1.3
1.2
28.53
12.03
pmol/l
0.88
13
51
90
593
1.53
3.62
1.6
1.4
2572.74
3820.50
e6/l
0.35
68
414
25
110
2.28
3.61
2.6
2.3
0.09
0.16
e9/l
1.34
19
47
91
602
1.52
3.59
1.1
1.1
—
—
—
0
0
268
2124
1.28
3.56
4.0
3.9
—
—
—
0
0
19
74
2.57
3.54
1.2
1.3
83.14
478.63
u/l
0.48
14
54
54
315
1.72
3.54
1.0
1.2
31.52
36.54
mmol/l
1.19
48
277
47
264
1.79
3.51
2.1
2.6
475.92
492.64
e6/l
0.10
39
214
181
1372
1.33
3.36
10.3
9.5
—
—
—
0
0
4895
48233
1.23
3.33
35.5
23.8
256.13
249.48
e9/l
9.39
4844
47316
78
509
1.54
3.30
1.1
1.0
0.21
0.08
u/ml
0.71
42
138
13
38
3.43
3.30
3.2
1.6
52.29
56.64
%
—
7
22
4895
48240
1.23
3.28
35.3
23.7
30.39
30.34
pg
1.18
4858
47756
33
169
1.96
3.28
2.2
1.9
—
—
—
0
0
4895
48241
1.23
3.27
35.4
23.7
91.37
91.08
fl
4.37
4858
47757
260
2076
1.27
3.27
2.1
1.9
—
—
—
0
0
373
3099
1.22
3.27
1.3
1.3
—
—
—
0
0
4895
48246
1.22
3.24
35.5
23.8
4.44
4.50
e12/l
15.19
4837
47193
4895
48246
1.22
3.24
36.1
24.3
40.01
40.91
%
4.21
4855
47738
79
520
1.53
3.23
2.2
2.0
23.57
22.57
mg/l
0.09
36
178
30
150
2.01
3.19
1.2
1.1
—
—
—
0
0
26
123
2.12
3.19
1.3
1.3
28.11
24.57
g/l
0.42
20
89
4895
48257
1.22
3.16
35.8
23.9
133.77
135.61
g/l
14.19
4859
47780
86
580
1.49
3.14
2.7
2.4
1.17
1.25
g/24h
0.14
55
338
4894
48250
1.22
3.13
35.5
23.8
7.13
6.72
e9/l
25.52
4834
47188
119
1633
0.72
3.10
1.1
1.1
0.61
0.64
ratio
—
9
213
57
351
1.63
3.10
1.2
1.3
16.19
13.89
u/l
0.31
52
321
21
92
2.29
3.09
1.2
1.3
1.29
1.64
mmol/l
0.63
15
59
31
159
1.96
3.08
1.7
1.9
2546.67
5333.12
e6/l
0.78
15
82
41
233
1.77
2.99
1.8
1.7
—
—
—
0
0
26
127
2.05
2.96
1.0
1.2
—
—
—
0
0
492
4236
1.18
2.95
1.9
1.8
—
—
—
0
0
183
1419
1.30
2.94
2.9
2.6
3.61
3.55
g/l
0.22
171
1355
119
866
1.38
2.92
3.2
3.2
0.84
0.82
nmol/l
0.16
88
690
140
1047
1.35
2.90
1.3
1.3
3.85
3.79
mmol/l
0.32
132
987
46
273
1.69
2.90
1.3
1.4
1.18
1.23
nmol/l
0.13
39
195
18
76
2.37
2.89
1.3
1.5
—
—
—
0
0
55
860
0.64
2.88
1.4
1.6
—
—
—
0
0
48
289
1.67
2.87
3.1
2.3
16.50
16.30
%
0.15
48
289
367
3088
1.20
2.86
2.6
2.4
15.09
21.21
au/ml
1.30
28
321
42
244
1.73
2.86
1.4
1.2
140.01
137.20
nmol/l
0.15
42
244
36
200
1.81
2.84
1.0
1.0
0.47
0.23
u/ml
0.43
19
31
19
83
2.29
2.83
1.3
1.3
0.26
2.30
mmol/l
1.43
13
59
46
275
1.68
2.83
2.3
2.8
203.95
226.37
e6/l
0.38
41
235
32
174
1.84
2.71
2.7
2.1
31.06
30.66
%
0.05
32
174
171
1333
1.29
2.67
1.4
1.4
10.12
9.89
u/l
0.09
138
1080
1611
15052
1.10
2.65
3.0
2.5
—
—
—
0
0
72
488
1.48
2.63
1.5
1.4
—
—
—
0
0
86
604
1.43
2.62
1.3
1.3
7.01
7.29
mmol/l
0.45
72
548
154
1191
1.30
2.56
1.3
1.3
723.27
551.58
mg/l
0.56
147
1131
205
1644
1.26
2.56
4.1
3.9
24.72
24.83
mmol/l
0.16
188
1517
72
491
1.47
2.56
2.6
3.3
53.25
57.92
%
0.91
66
417
339
2866
1.20
2.54
10.9
10.0
24.04
24.26
mmol/l
0.63
326
2813
30
164
1.83
2.52
1.7
1.7
—
—
—
0
0
108
795
1.37
2.52
1.1
1.1
—
—
—
0
0
83
584
1.43
2.51
1.4
1.3
0.20
0.21
nmol/l
0.17
60
465
72
493
1.47
2.51
2.3
1.6
759.21
361.84
mu/l
1.73
61
382
10
31
3.23
2.51
1.0
1.1
0.07
0.03
u/ml
—
10
31
10
31
3.23
2.51
1.0
1.1
—
383.44
—
0
9
11
37
2.98
2.48
2.5
2.4
0.73
0.51
u/field
0.23
11
37
8
21
3.81
2.46
4.1
3.4
—
—
—
0
0
504
4416
1.16
2.45
2.2
2.1
0.03
0.01
estimate
0.25
137
937
191
1529
1.26
2.44
1.1
1.1
—
—
—
0
0
74
515
1.44
2.39
1.6
1.4
34504.38
71783.49
e6/l
0.97
45
283
258
2139
1.22
2.39
1.3
1.4
25.79
27.50
iu/l
0.35
215
1836
31
175
1.78
2.37
2.5
2.0
6.81
8.78
%
0.79
31
169
63
426
1.48
2.36
1.3
1.1
—
—
—
0
0
35
206
1.70
2.33
1.2
1.3
162.56
164.67
mmol/24h
0.04
35
206
87
628
1.39
2.31
1.8
2.2
—
5.79
—
0
14
269
2249
1.21
2.30
2.1
2.1
0.00
0.37
estimate
0.54
95
725
12
47
2.56
2.27
1.4
1.3
7.49
5.56
mmol/l
—
7
19
42
262
1.61
2.26
2.8
2.8
39.49
40.28
%
0.15
30
146
9
29
3.11
2.22
1.0
1.0
—
—
—
0
0
120
919
1.31
2.20
1.4
1.2
255.10
277.02
u/ml
0.36
78
581
99
739
1.35
2.16
1.7
1.3
—
—
—
0
0
27
151
1.79
2.15
4.3
4.8
—
—
—
0
0
16
74
2.17
2.14
2.8
2.3
14.84
14.95
ml/dl
0.05
16
69
182
2225
0.81
2.07
1.1
1.1
—
—
—
0
0
678
7479
0.89
2.06
3.8
3.1
3.78
2.28
e6/l
1.24
380
3667
103
784
1.32
2.00
1.9
1.9
5.13
5.02
mmol/24h
0.12
91
696
480
5395
0.88
1.99
5.1
4.9
31.30
32.26
%
1.16
327
3628
26
148
1.76
1.98
1.3
1.4
1129.85
147.88
nmol/24h
0.44
26
148
28
163
1.72
1.97
2.4
2.0
51.89
61.12
ug/l
0.41
28
158
10
39
2.57
1.94
1.4
2.4
—
—
—
0
0
269
2296
1.18
1.88
4.9
3.2
1.02
1.02
ratio
0.14
255
2064
16
79
2.03
1.85
1.4
2.0
2.93
2.85
mmol/l
0.03
16
67
27
159
1.70
1.85
1.5
1.4
15.59
15.28
pmol/l
0.10
22
136
70
513
1.37
1.77
1.5
1.6
—
—
—
0
0
21
363
0.58
1.77
5.8
2.7
43.26
32.00
mg/l
0.42
14
258
130
1039
1.26
1.77
1.4
1.4
39.33
27.05
e6/l
0.20
108
761
69
506
1.37
1.74
1.5
1.5
—
—
—
0
0
6
18
3.34
1.74
1.0
1.1
0.08
0.07
—
6
11
49
338
1.45
1.74
1.1
1.1
33.16
45.43
mg/l
2.19
40
280
7
24
2.92
1.72
1.3
1.0
—
—
—
0
0
53
373
1.43
1.70
1.2
1.2
100.70
105.64
pmol/l
0.36
53
373
21
118
1.78
1.69
8.5
7.0
5.61
5.41
kpa
0.17
21
118
105
1322
0.79
1.62
1.1
1.1
—
—
—
0
0
86
661
1.31
1.62
1.2
1.2
—
—
—
0
0
5
14
3.57
1.61
1.0
1.1
0.06
0.06
u/ml
—
5
14
27
166
1.63
1.61
1.6
1.6
3776.00
2931.61
titre
—
10
31
8
32
2.50
1.59
1.0
1.0
—
—
—
0
0
14
70
2.00
1.59
3.1
7.0
8.31
8.07
mmol/l
0.09
14
70
19
106
1.80
1.58
1.3
1.2
—
166.67
—
0
6
207
1760
1.18
1.57
2.5
2.1
20.55
21.07
s
0.89
172
1554
11
50
2.20
1.56
1.3
1.2
—
—
mmol/l
—
0
0
11
50
2.20
1.56
1.3
1.2
—
—
mmol/l
—
0
0
108
860
1.26
1.55
1.8
1.4
136.93
152.75
au/ml
0.53
25
249
12
57
2.11
1.55
1.0
1.1
—
—
—
0
0
47
332
1.42
1.51
1.4
1.4
13.23
12.83
u/l
0.17
47
319
533
4850
1.11
1.50
3.8
4.4
33.48
22.02
ug/l
0.31
443
3936
129
1054
1.23
1.49
1.4
1.4
1947.90
1104.13
e6/l
0.31
115
821
49
350
1.40
1.49
1.3
1.4
—
—
—
0
0
9
38
2.37
1.45
2.1
1.2
—
—
—
0
0
91
718
1.27
1.43
1.2
1.2
—
—
—
0
0
46
637
0.72
1.43
1.9
1.8
—
—
—
0
0
117
951
1.24
1.43
1.7
1.4
10.68
16.09
u/ml
—
5
18
171
1444
1.19
1.42
1.4
1.3
195.24
221.48
miu/ml
0.45
66
660
125
1024
1.23
1.42
2.6
3.8
210.66
822.76
u/ml
1.31
112
933
117
952
1.23
1.42
1.7
1.4
—
—
—
0
0
38
262
1.45
1.40
1.4
1.3
7.44
7.40
ph
0.53
30
182
21
126
1.67
1.39
6.5
4.0
50.57
55.35
%
0.39
21
121
16
90
1.78
1.32
1.2
1.2
—
—
—
0
0
185
1586
1.17
1.31
3.6
3.1
640.61
358.24
mg/l
0.51
93
715
340
3044
1.13
1.31
1.2
1.2
115.42
138.22
u/ml
0.58
120
1083
17
98
1.74
1.30
1.0
1.2
0.68
157.00
mg/l
1.26
12
66
45
326
1.38
1.29
1.1
1.1
262.71
279.55
mg/l
0.27
38
284
30
201
1.50
1.29
5.4
5.0
70.37
61.89
mg/l
0.26
19
142
27
177
1.53
1.28
3.0
2.7
0.58
0.61
mmol/l
1.40
27
177
147
1239
1.19
1.28
5.2
3.1
63.21
61.60
%
0.39
137
1211
12
62
1.94
1.27
3.8
2.5
—
25.71
—
0
12
18
107
1.68
1.25
1.2
1.5
—
—
—
0
0
59
449
1.32
1.25
1.1
1.1
—
—
—
0
0
3678
37437
0.94
1.24
30.2
20.0
332.27
332.50
g/l
0.80
3653
37235
85
1055
0.80
1.23
1.1
1.2
—
—
—
0
0
15
86
1.75
1.18
2.1
2.0
13.62
17.53
umol/l
0.85
15
86
1882
18157
1.06
1.16
2.2
2.1
—
—
—
0
0
0
34
0.00
1.16
0.0
1.3
—
—
—
0
0
75
598
1.26
1.14
1.4
1.4
26.87
27.19
u/l
0.03
62
497
24
160
1.50
1.09
1.5
1.8
0.00
0.04
estimate
0.80
24
160
53
407
1.31
1.09
1.2
1.2
—
—
—
0
0
35
476
0.73
1.04
1.7
1.5
—
—
—
0
0
9
46
1.96
1.03
1.4
1.2
6.63
5.94
mmol/l
—
9
46
434
3995
1.09
1.03
1.5
1.4
—
—
—
0
0
1358
13027
1.06
1.02
3.6
2.8
0.20
0.06
0.71
40
321
9
47
1.92
1.02
1.0
1.1
7.09
8.60
u/ml
—
9
47
29
205
1.42
1.00
2.0
1.6
1.43
2.76
u/field
1.02
24
148
60
476
1.26
0.98
1.1
1.1
—
—
—
0
0
16
100
1.60
0.96
4.1
1.9
—
—
—
0
0
21
141
1.49
0.94
1.1
1.1
—
—
—
0
0
77
633
1.22
0.93
1.2
1.2
—
—
—
0
0
6
27
2.22
0.93
1.2
1.1
—
31.75
—
0
8
63
507
1.25
0.93
1.1
1.2
—
—
—
0
0
6
28
2.14
0.91
1.7
1.4
—
—
—
0
0
20
134
1.49
0.91
1.4
1.3
62.46
174.30
ug/l
0.73
14
60
167
1893
0.88
0.91
1.6
1.6
990.99
1011.01
mu/l
0.10
145
1576
89
747
1.19
0.89
1.1
1.1
153.44
14466.98
iu/ml
0.53
19
162
65
530
1.23
0.87
2.3
2.4
31.16
26.91
iu/ml
0.13
12
57
6
30
2.00
0.87
1.8
1.7
—
—
—
0
0
1129
11763
0.95
0.86
5.4
4.2
86.80
88.95
%
2.11
1087
11532
25
345
0.72
0.85
2.2
1.7
7.93
6.60
mmol/l
1.45
19
239
24
170
1.41
0.85
1.2
1.2
1033.33
960.61
titre
—
6
33
6
31
1.94
0.84
2.3
1.9
—
—
—
0
0
6
31
1.94
0.84
1.2
1.2
—
—
—
0
0
457
4264
1.08
0.83
4.5
4.3
7.37
7.35
ph
1.01
346
3067
31
231
1.34
0.82
1.2
1.1
—
—
—
0
0
11
65
1.69
0.82
1.3
1.2
56.45
65.74
ug/l
1.01
11
65
57
699
0.81
0.82
1.5
1.5
0.18
0.40
nmol/l
4.66
34
543
22
306
0.72
0.80
1.1
1.1
16.32
19.96
u/ml
—
9
134
6
33
1.82
0.79
1.0
1.0
—
—
—
0
0
6
33
1.82
0.79
1.0
1.0
—
—
—
0
0
45
357
1.26
0.78
1.2
1.2
290.00
183.77
titre
—
5
61
45
357
1.26
0.78
1.2
1.2
—
275.00
—
0
8
47
375
1.26
0.78
1.1
1.1
—
—
—
0
0
13
82
1.59
0.78
1.9
1.9
—
—
—
0
0
40
505
0.79
0.76
3.0
2.7
—
—
—
0
0
417
4460
0.93
0.75
3.1
2.4
39.91
50.51
u/l
0.46
362
3777
20
141
1.42
0.74
1.0
1.0
—
—
—
0
0
28
210
1.34
0.73
1.1
1.2
11.18
9.53
mm/h
0.28
28
210
9
57
1.58
0.71
4.9
8.1
0.33
0.18
%
—
9
57
7
41
1.71
0.70
1.1
1.5
57.86
45.15
umol/l
—
7
41
17
118
1.44
0.69
1.1
1.2
—
—
—
0
0
12
77
1.56
0.68
1.0
1.4
—
109.64
—
0
11
65
769
0.84
0.68
1.1
1.1
—
—
—
0
0
7
119
0.59
0.67
2.3
1.4
0.50
0.48
e9/l
—
7
119
27
205
1.32
0.67
1.1
1.2
—
—
—
0
0
65
767
0.85
0.66
1.1
1.1
—
—
—
0
0
5
95
0.53
0.66
1.0
1.0
10.80
36.47
iu/ml
—
5
95
10
62
1.61
0.65
2.3
2.4
62.64
91.73
pmol/l
—
10
56
84
968
0.87
0.64
4.0
3.3
26.90
26.70
mg/l
0.02
55
665
190
1731
1.10
0.64
2.7
3.7
541.28
2501.34
u/ml
0.69
168
1498
16
223
0.72
0.62
2.7
2.0
66.00
244.67
ug/min
—
7
55
12
79
1.52
0.62
1.5
2.1
—
—
—
0
0
42
342
1.23
0.62
2.0
2.0
2.96
1.70
u/field
0.89
27
181
56
471
1.19
0.61
1.3
1.2
—
—
—
0
0
51
426
1.20
0.60
3.0
3.0
37.99
35.71
mg/l
0.04
37
314
32
254
1.26
0.59
1.4
1.2
0.53
0.62
ratio
1.50
21
145
15
106
1.42
0.57
1.8
2.9
—
—
—
0
0
40
328
1.22
0.57
1.1
1.0
—
—
—
0
0
137
1239
1.11
0.55
2.3
2.0
3.76
8.39
iu/l
0.51
58
515
35
284
1.23
0.55
2.3
2.1
7.19
8.09
mmol/l
0.91
35
284
14
99
1.42
0.54
2.6
2.2
7.54
7.69
mmol/l
—
7
53
1643
16059
1.03
0.53
5.1
5.6
1.98
3.18
ug/l
4.12
1477
14563
23
178
1.29
0.52
1.7
1.8
40.92
40.35
g/l
0.18
23
178
57
496
1.15
0.45
2.1
2.3
—
—
—
0
0
61
535
1.14
0.44
1.2
1.4
—
—
—
0
0
132
1212
1.09
0.43
1.9
1.9
206.93
203.91
pmol/l
0.14
123
1140
1262
12913
0.97
0.42
4.6
4.5
22.54
21.97
%
0.62
612
6452
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
37
433
0.85
0.40
4.7
3.5
10.15
12.63
index
2.27
27
256
12
88
1.36
0.40
2.4
1.5
—
—
—
0
0
608
6287
0.96
0.38
1.3
1.3
—
—
—
0
0
5
37
1.35
0.37
2.4
2.6
0.98
0.58
ug/l
—
5
37
88
801
1.10
0.36
1.1
1.1
—
—
—
0
0
6
42
1.43
0.35
1.0
1.2
—
—
—
0
0
16
126
1.27
0.35
1.0
1.0
—
—
—
0
0
10
73
1.37
0.34
2.5
2.0
46.49
35.25
pmol/l
—
10
62
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
6
47
1.28
0.32
1.0
1.3
2.00
1.68
umol/24h
—
6
47
11
83
1.33
0.32
2.0
1.9
2.58
1.95
ug/l
—
6
50
830
8105
1.03
0.31
3.5
3.0
1.28
1.13
e6/l
0.46
528
4304
18
218
0.83
0.30
3.5
3.1
—
—
—
0
0
1329
13509
0.98
0.28
1.5
1.5
—
—
—
0
0
18
216
0.83
0.28
1.0
1.1
—
—
—
0
0
1801
17781
1.02
0.27
3.8
3.1
—
—
—
0
0
411
4243
0.97
0.27
2.4
2.3
12.35
13.10
nmol/l
1.17
364
3825
232
2222
1.05
0.26
3.1
3.7
68.40
63.58
u/ml
0.11
226
2145
13
104
1.25
0.26
1.1
1.2
887.38
297.81
pmol/l
—
8
74
17
141
1.21
0.26
1.2
1.1
—
—
—
0
0
9
75
1.20
0.25
1.2
1.1
—
—
—
0
0
25
217
1.15
0.24
1.5
1.8
—
—
—
0
0
49
447
1.10
0.23
3.2
2.0
—
—
—
0
0
119
1126
1.06
0.22
1.3
1.3
—
—
—
0
0
64
592
1.08
0.22
1.1
1.1
9.56
3.68
eliau/ml
0.51
22
277
17
200
0.85
0.22
3.5
3.1
—
—
—
0
0
92
868
1.06
0.20
1.2
1.3
27.62
31.68
u/l
0.19
85
754
73
684
1.07
0.19
1.3
1.2
2.41
5.17
u/ml
2.41
37
312
12
99
1.21
0.19
1.0
1.4
114.96
60.97
mu/l
—
7
77
11
91
1.21
0.17
1.0
1.2
0.66
0.69
umol/24h
—
6
47
26
287
0.91
0.15
3.6
7.6
42.96
107.41
ug/l
0.51
16
190
33
305
1.08
0.13
1.2
1.2
—
—
—
0
0
48
508
0.94
0.12
1.3
1.4
—
—
—
0
0
47
444
1.06
0.11
1.2
1.2
—
—
—
0
0
184
1794
1.03
0.11
2.8
2.7
—
—
—
0
0
374
3678
1.02
0.11
3.4
2.6
6.05
6.07
ph
0.11
257
2499
38
358
1.06
0.10
1.1
1.1
367.86
376.41
nmol/l
0.09
21
314
31
331
0.94
0.10
1.0
1.0
870.89
722.28
ng/l
0.84
19
230
30
320
0.94
0.09
1.1
1.1
6.79
9.40
iu/ml
—
7
94
5
46
1.09
0.09
3.4
2.8
—
—
—
0
0
31
329
0.94
0.09
1.0
1.0
276.16
315.80
ng/l
0.44
19
236
13
117
1.11
0.08
2.3
1.4
—
—
—
0
0
36
346
1.04
0.05
1.3
1.1
—
—
—
0
0
14
151
0.93
0.05
1.2
1.1
—
—
—
0
0
42
434
0.97
0.05
2.7
5.8
406.13
48.48
u/ml
—
7
145
124
1259
0.98
0.04
3.6
3.4
1.96
2.08
index
0.06
77
663
22
209
1.05
0.04
3.2
2.7
—
—
—
0
0
98
996
0.98
0.04
1.3
1.3
—
—
—
0
0
31
321
0.97
0.03
1.3
1.1
—
—
—
0
0
14
149
0.94
0.03
1.3
1.2
28.93
28.49
s
0.14
14
149
40
393
1.02
0.01
1.1
1.1
313.83
290.76
mg/l
0.58
35
358
32
318
1.01
0.00
1.3
1.3
165.53
194.14
pmol/l
0.40
32
318
75
748
1.00
0.00
1.1
1.1
28.63
16.76
au/ml
0.35
14
192
55
546
1.01
0.00
2.6
2.3
0.09
0.64
mmol/l
0.55
55
532
0
6
0.00
0.00
0.0
1.0
—
3150.00
—
0
6
6
65
0.92
0.00
1.3
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
0.32
—
0
6
0
6
0.00
0.00
0.0
1.0
—
37.17
—
0
6
113
1130
1.00
-0.00
1.1
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
0.02
—
0
7
6
69
0.87
-0.00
1.0
1.0
98.07
75.81
ug/l
—
6
54
0
5
0.00
-0.00
0.0
1.6
—
41.48
—
0
5

Mortality – FinRegistry

↥

Association

Association between endpoint L12_INFECT_DERM and mortality.

Females

Parameter HR [95% CI] p-value
L12_INFECT_DERM 1.469 [1.34, 1.61] < 0.001
Birth year 0.99 [0.98, 1.0] 0.014

During the follow-up period (1.1.1998 — 31.12.2019), 2882 out of 16388 females with L12_INFECT_DERM died.

Males

Parameter HR [95% CI] p-value
L12_INFECT_DERM 1.857 [1.71, 2.02] < 0.001
Birth year 0.991 [0.98, 1.0] 0.05

During the follow-up period (1.1.1998 — 31.12.2019), 4766 out of 17856 males with L12_INFECT_DERM died.

Mortality risk

Mortality risk for people of age

years, who have L12_INFECT_DERM.

N-year risk Females Males
1 0.141% 0.336%
5 0.862% 2.178%
10 1.864% 6.076%
15 3.692% 11.038%
20 6.611% 18.34%

Relationships between endpoints

↥

Index endpoint: L12_INFECT_DERM – Infective dermatitis

GWS hits: 7

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data